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EDHF is the endothelium-dependent but nitric oxide (NO) and prostacyclin (PGI2) -
independent vasodilatation pathway that is the dominant relaxation mechanism in the 
microcirculation, and has been shown to require IKCa and SKCa channel activation and 
also functional myoendothelial gap junctions. Reactive oxygen species (ROS) have 
been implicated in the response, but their precise role remains uncertain. To 
investigate this, the cremaster muscle circulation of freshly killed rats was perfused 
with a Krebs buffer solution containing albumin (1 g.l
-1
) and either FITC-albumin (2 
g.l
-1
) to measure changes in diameter, or Fura-PE3AM (10 µM) for 60 minutes to 
selectively load the endothelium, allowing endothelial [Ca
2+
]i to be recorded. The 
preparation was placed on the stage of an intravital microscope to measure vessel 
diameter, and endothelial [Ca
2+
]i was estimated from the 360/380 nm excitation ratio, 
emission at > 510 nm. The preparation was superfused with phenylephrine (30 µM), 
L-NAME (300 µM) and indomethacin (3 µM) to evoke arteriolar constriction while 
preventing the synthesis of NO and PGI2. Carbachol (10 µM) caused a 74.5 ± 2.3%  
(n = 65) relaxation and the 360/380 nm ratio increased by 25.6 ± 1.6% (n = 69). Both 
responses were substantially reduced by a ROS scavenging combination of 
superoxide dismutase and catalase (100 U.ml
-1
 each). The possibility that ROS are 
important for Ca
2+
 release from stores was examined by applying carbachol in Ca
2+
-
free solution containing EGTA. Carbachol application then resulted in a transient 
[Ca
2+
]i increase that was reduced by SOD and catalase. The CYP 2C9 inhibitor 
sulfaphenazole (10 µM) reduced relaxation and the endothelial [Ca
2+
]i increase, as did 
the phospholipase C blocker U73122. These and other data to be presented suggest 
that ROS produced by arachidonic acid metabolism via CYP 2C9 promote EDHF 
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mediated relaxation mainly by enhancing the inositol trisphosphate-mediated release 
of Ca
2+
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List of abbreviations 
 
18-GA    18 alpha-glycyrrhetinic acid 
ATP     Adenosine triphosphate 
BH4     Tetrahydrobiopterin 





cAMP     cyclic adenosine monophosphate 
cGMP     cyclic guanosine monophosphate 
CNP     C-natriuretic pepetide 
COX `    Cyclooxygenase 
CPA     Cyclopiazonic acid 
CYP450    Cytochrome P450 
CRAC     Ca
2+
 release activated Ca
2+ 
DFO     Desferrioxamine 
EGTA     Ethylene glycol tetraacetic acid 
DAG     Diacylglycerol 
DCF     Dichlorofluorescein 
DHE     Dihydroethidium 
DMSO    Dimethylsulphoxide 
EC     Endothelial cell 
EDH     Endothelium dependent hyperpolarisation 
EDHF     Endothelium derived hyperpolarising factor 
EDRF     Endothelium derived relaxing factor 
EETs     Epoxyeicosatrienoic  acids 
eNOS     Endothelial nitric oxide synthase 
ER     Endoplasmic reticulum 
H2O2     Hydrogen peroxide 
H2S     Hydrogen sulphide 






IL-1β     Interleukin-1beta 
IP3     Inositol trisphosphate 
IP3R     Inositol trisphosphate receptor 
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KATP     ATP sensitive K
+
 channels 





KIR     Inwardly rectifying K
+
 channels 
KO     Knock out 
KV     Voltage-dependent K
+
 channels 
L-NAME    L-N
G
-Nitroarginine methyl ester 
L-NNA    Nω- Nitro-L-arginine 
LOX     Lipoxygenase 
MEGJ     Myoendothelial gap junction 
MLC     Myosin light chain 
NO     Nitric oxide 
NOS     Nitric oxide synthase 
Nox     NADPH oxidase 
NPR     Natriuretic peptide receptor 
O2




     
Hydroxyl radical 
PGI2     Prostacyclin 
PIP2     Phosphatidylinositol 4,5-bisphosphate 
PLA2     Phospholipase A2 
PLC     Phospholipase C 
PKA     Protein kinase A 
PKG     Protein kinase G 
PSS     Physiological saline solution 
ROS     Reactive oxygen species 
sEH     Soluble epoxide hydrolase 





SMC     Smooth muscle cells 
SERCA    Sarco/endoplasmic reticulum Ca
2+
 ATPase 
SOD     Superoxide dismutase 
SR     Sarcoplasmic reticulum 
TEA     Tetraethylammonium 
TNF     Tumour necrosis factor alpha 
TPR     Total peripheral resistance 
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TRP     Transient receptor potential 
VDCC     Voltage dependent Ca
2+
 channels 
VSM     Vascular smooth muscle 
VSMC    Vascular smooth muscle cell 









Chapter 1: General introduction 
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1.1 Vascular Physiology 
1.1.1 Vascular tone 
Blood vessels exhibit vascular tone, a state of partial constriction from which they can 
either dilate or further constrict. The intravascular pressure which drives the flow of 
blood is highly dependent on vascular diameter (pressure is inversely proportional to 
the 4
th
 power of the diameter). Therefore, local changes in vascular tone exert a 
profound effect on blood flow within tissues, and at the level of the entire system the 
vascular tone of the arteries and arterioles determines the total peripheral resistance 
and the arterial blood pressure (arterial blood pressure = cardiac output x total 
peripheral resistance) (Levick, 2010).   
 
The regulation of vascular tone in arteries (hereafter the term arteries will be used to 
encompass both arteries and arterioles except where noted) is influenced by the 
architecture of the individual vessels. Arteries are composed of three main layers, the 
intima, media and adventitia (Tharp & Bowles, 2009). The intima is the inner layer 
that surrounds the lumen through which the blood flows. The lumen of the entire 
cardiovascular system is lined by a monolayer of endothelial cells. The endothelium 
not only acts as a semi-permeable barrier between the blood and underlying tissue and 
governs tissue exchange, but is also vital in the regulation of the cardiovascular 
system through releasing factors that can act locally and systemically (Sanders et al., 
2000).  The endothelium can sense changes in shear stress from blood flow and has 
receptors for agonists that can influence vascular tone by causing the release of 
vasoactive substances. The endothelium can secrete vasodilators such as nitric oxide 
(NO) and prostacyclin (PGI2) and vasoconstrictors like endothelin which act on the 
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underlying smooth muscle. Overall, however, the vasodilating effect of the 
endothelium predominates over its constricting effect (Carvajal et al., 2000). 
 
The internal elastic lamina separates the intima from the media which is composed of 
smooth muscle cells and matrix proteins such as collagen and elastin. In larger 
conduit arteries this smooth muscle layer can be many layers thick whereas in smaller 
arterioles there may only be a single layer of smooth muscle cells (Levick, 2010).  
 
Finally there is the adventitia, which is separated from the media by the external 
elastic lamina. The adventitia is composed of fibroblasts and loosely arranged 
collagen, and contains sympathetic nerves fibres which release noradrenaline, the 
most important physiological vasoconstrictor.  
 
My project examined the regulation of vascular tone in smaller resistance vessels of 
the rat cremaster circulation. The resistance vessels include the smaller arteries and 
arterioles that are the major determinants of total peripheral resistance. Arterioles give 
rise to capillaries where oxygen and nutrient exchange takes place in tissues and are 
part of the microcirculation. Arterioles have diameters of 10-100µm and dominate the 
resistance to flow (Levick, 2010). While constriction of a large proportion of 
arterioles would increase TPR, local contraction can regulate blood flow to tissue and 
organs by directing blood flow away from areas of greater resistance (Aaronson & 
Ward, 2007). Regulation of vascular tone in resistance vessels, primarily by the 
endothelium acting on smooth muscle cells, is therefore important for local blood 





 regulation  
 
Vascular tone is determined by the degree to which the smooth muscle cells (SMCs) 
in the media are contracted. These elongated spindle-shaped cells wrap around blood 
vessels in a helical manner, so as they shorten and thicken the vascular diameter is 





 sensitisation (Ignarro, 2002).  
 
1.1.3 Regulation of [Ca
2+




 is an important second messenger in many types of cells, and provides one of the 
main pathways by which extracellular signals can be transduced to intracellular sites. 
The location, concentration and duration of the Ca
2+
 rise defines the signal that is 
transferred. In the vasculature, many endothelial and smooth muscle cell responses 
are triggered by changes in cytosolic Ca
2+
 concentration, including the release of 
vasoactive substances and changes in membrane permeability (Levy, 2005). 
 
The intracellular basal cytosolic Ca
2+
 concentration is approximately 0.1µM while the 
extracellular concentration is about 1.5 mM. This leads to a large electrochemical 
Ca
2+
 gradient across the plasma membrane (Levick, 2010). Cytosolic [Ca
2+
] can 
increase following the influx of extracellular Ca
2+
 through ion channels in the 
membrane, or by release of Ca
2+
 from intracellular stores. There are a range of Ca
2+
 
channels whose expression in different cell types varies, and there are different 
pathways that regulate their activity. Intracellular [Ca
2+
] normally increases following 
an extracellular signal such as the binding of an agonist to a receptor on the plasma 
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membrane. This can then cause activation of ion channels on the plasma membrane 










The influx of extracellular Ca
2+
 can occur through a number of cation channels that 
are activated by different signals such as membrane depolarisation, shear stress or 
agonist binding to receptors, or from intracellular signalling following the depletion of 
the sarcoplasmic reticulum, an intracellular Ca
2+
 store (Webb, 2003). 
 
1.2.2 Voltage dependent Ca
2+
 channels (VDCC). 
 
Voltage-dependent or -gated Ca
2+
 channels are found in a range of excitable cells 
including vascular SMCs, where they are important in Ca
2+
 regulation (Marrelli, 
2000). There is little evidence of their expression in endothelial cells. Their opening is 
voltage dependent, and at resting membrane potentials the channels are mainly closed. 
They open as a result of membrane depolarisation, causing calcium influx down the 
electrochemical gradient. This increase in intracellular calcium can then cause the 
activation of different calcium dependent pathways including release of regulatory 
factors, up-regulation of gene expression, and muscle contraction. They also allow 
entry of sodium ions but they have 1000 fold greater selectivity for Ca
2+
 (Levick, 
2010). There are different families of voltage dependent Ca
2+
 channels and the L-type 
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calcium channel is the form mainly found in vascular smooth muscle cells (Aaronson 
& Ward, 2007). 
 
1.2.3 VSMC membrane potential and its control of VDCC  
 
The open probability of L-type VDCC is determined by the membrane potential. 
Under resting conditions, most but not all of these channels are closed, so they 
mediate a small tonic Ca
2+
 influx (Bychkov et al., 2000).  
 
The resting membrane potential in vascular smooth muscle is -60 to -75 mV and -40 
to -55 mV when measured in vitro and in vivo, respectively (Nelson et al., 1993). This 
negative potential is thought to be partly due to large negatively charged molecules, 
mainly proteins, present in the cytosol. The membrane is somewhat permeable to K
+
, 
which is drawn into cells by this negative charge. This would cause its concentration 
within cells to become higher than it is outside, until it reached a concentration at 
which its electrochemical gradient would be in balance (i.e. its tendency to move out 
of cells due to this high concentration would be exactly balanced by its tendency by 
its tendency to enter cells due to the negative intracellular charge). K
+
 is also actively 




 ATPase, which pumps 2 K
+
 ions into the cell while 
extruding 3 Na
+
 ions. These factors mean that the K
+
 concentration in cells is much 
higher (~130 mM) than outside (~4 mM) (Aaronson & Ward, 2007). As a result, the 
opening of K
+
 channels in the cell membrane leads to an efflux of K
+
 ions, and this 
movement of positive charge out of cells drives the membrane towards the K
+
 
equilibrium potential, which is close to -90 mV. However, the membrane potential is 
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which have more positive reversal potentials.  
 
The result of this arrangement is that the opening of K
+





 ATPase, causes the membrane to hyperpolarise towards -90 mV. This 
diminishes the open probability of L-type channels, leading to a fall in Ca
2+
 influx and 
vasorelaxation (Bellien et al., 2008). This regulation of membrane potential and 
therefore Ca
2+
 influx by K
+




 ATPase is important in the 
control of VSMC by EDHF ( see section 1.7.4).  
 
1.2.4 Receptor operated calcium channels. 
 
Receptor operated calcium channels are activated by the binding of a specific 
molecule to a receptor, for example G protein coupled receptors such as the 1 





 ions, and in smooth muscle are thought to mainly mediate Na
+
 influx, 
leading to cell depolarisation and the opening of voltage-gated Ca
2+
 channels (de Wit, 
2010). The molecular identities have not been clearly defined and different candidates 
have been put forward as being part of this group, for example transient receptor 
potential (TRP) channels such as TRPC1, C3, C6 and C7 have now all been shown to 
be activated by DAG following ligand binding to G protein coupled receptors (Inoue 





1.2.5 Store operated calcium channels.  
 
When the endoplasmic reticulum in endothelial cells, or the sarcoplasmic reticulum in 
smooth muscle cells, is depleted of Ca
2+
, store operated channels in the plasma 
membrane open. This influx of calcium is called store operated or capacitative Ca
2+
 
entry and helps to replenish the stores and may also be involved directly with Ca
2+
 
signalling. The plasma membrane channel involved in some types of cells (e.g. 
lymphocytes) is referred to as the Ca
2+
 release activated Ca
2+
 (CRAC) channel, and it 
is the decrease in calcium concentration in the lumen of the organelles that leads to its 
activation. This is a major calcium influx pathway in some cells (for example 
endothelial cells) so is important in signal transduction (Alaiwi et al., 2009). 2 main 
protein families are recognised as being important in the function of store operated 
Ca
2+
 entry, STIM and Orai. The stromal interaction molecule (STIM) is a single 
spanning transmembrane protein. STIM functions as a Ca
2+
 sensor on the 
endoplasmic reticulum and following Ca
2+
 depletion rearranges to a site near the 
plasma membrane where it interacts with the CRAC channel. STIM1 and 2 
expression have been demonstrated in endothelial and vascular smooth muscle cells 
and they have differing affinities for Ca
2+
 but STIM1 is thought to mainly control the 
CRAC current (Smyth et al., 2010). The Orai channel family form the pore of the 
CRAC channel. Orai 1-3 are 4 transmembrane spanning proteins which form a highly 
Ca
2+
 selective channel. Following Ca
2+
 store depletion the Orai channel subunit is 
activated by STIM1 leading to Ca
2+
 entry (Putney, 2011). The TRP channel subfamily 
TRPC, and in particular TRPC1 have been suggested to be involved in CRAC current, 
forming a separate channel to the Orai family. It has been suggested that Orai 
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channels may be involved with the initial phase of Ca
2+
 entry while the TRPC1 
channel may allow sustained entry (Smyth et al., 2010).  
 
1.2.6 Transient receptor potential (TRP) channels 
 
TRP channels are a group of non-selective cation channels and they can function as 
sensors for internal and external stimuli (Kwan et al., 2007). There are around 28 TRP 
channels which have so far been identified, including the TRPC, TRPV and TRPM 
channel families. They have been suggested to be involved in receptor and store 
operated calcium entry (Beech, 2005).  There are a number of TRP channels that are 
mainly located on the plasma membrane of nearly all cell types including endothelial 
cells and SMC. The cation channels have a varying selectivity for calcium vs other 
cations such as Na
+ 
(Venkatachalam & Montell, 2007). The TRP channels share 
similar structural features such as 6 transmembrane spanning domains with 
intracellular N and C terminals. They are activated by range of stimuli including shear 
stress, temperature changes and agonists (Mendoza et al., 2009). They appear to be 
important ion channels for acting as sensors for changes in the environment such as 
pressure and flow.  The 6 subfamilies are TRPC, TRPV, TRPM, TRPA, TRPP and 
TRPML. The channels are made up of 4 subunits which can be formed from the same 
type, homomeric, or from different subunits and be heteromultimeric which alters its 
function.  
 
The TRPC (canonical) subfamily has 7 members (C1-C7) but TRPC2 is not 
functional in humans. They are Ca
2+
 permeable but not Ca
2+
 selective and are not 




either on its own or by forming a complex with Orai channels (Song et al., 2011). 
TRPC1, C3, C6 and C7 also act as receptor operated Ca
2+
 channels through direct 
activation by DAG following binding of a ligand to a G protein coupled receptor. For 
example Ca
2+
 entry through TRPC1 on vascular smooth muscle cells can cause 
constriction following binding of endothelin to a GPCR (Earley & Brayden, 2010).  
 
The TRPV (vanilloid) subfamily has 6 members with TRPV1, V3, V4 and possibly 
V2 present in endothelial cells and TRPV2 and TRPV4 found to be functional in 
vascular smooth muscle cells. TRPV1 is activated by capsaicin, the active ingredient 
in chilli peppers, while V2 is involved in the sensation of thermal pain (Earley & 
Brayden, 2010). While TRPV5 and V6 are constitutively active and Ca
2+
 selective, 
TRPV4 on vascular smooth muscle can be activated by EETs, leading to Ca
2+
 entry 
and activation of the BKCa channels causing hyperpolarisation and relaxation (Di & 
Malik, 2010). 
 
The TRPM (melastatin) subfamily has 8 members with varying selectivities. While 
TRPM1 and M2 are non-selective cation channels, M6 and M7 are selective for Mg
2+
 
and are important in its homeostasis. All the TRPM channels other than M5 have been 
shown to be expressed in endothelial cells but only TRPM2 has been shown to be 
functionally active (Earley & Brayden, 2010). All of the members are expressed in 
vascular smooth muscle cells with TRPM4 thought to be an important mechanosensor 




The TRPA (ankyrin) subfamily only has one member, TRPA1. This has been shown 
to be present in cerebral arteries and is activated by electrophilic compounds, 
including those in mustard oil and garlic and it may mediate the endothelium 
dependent relaxation to these compounds through the activation of the IKCa and SKCa 
channels (Earley & Brayden, 2010). 
 
The TRPP (polycystic) and TRPML (mucoliptin) subfamilies each have 3 members 
and have not been shown to be active in the cardiovascular system. TRPP1 mutations 
cause polycystic kidney disease while TRPML channels are important in lysosome 
function (Earley & Brayden, 2010).  
 




A major pathway in causing an increase in intracellular [Ca
2+
] during stimulation is its 
release from intracellular stores (the endoplasmic or sarcoplasmic reticulum) 
following agonist binding to Gq protein coupled receptors which are linked to 
membrane bound phospholipase C. Examples are the muscarinic M3 receptor in the 
endothelial cells and the 1 adrenergic receptor in vascular SMCs. Following binding 
by an agonist such as acetylcholine, the G protein acts to cause the release of second 
messengers. The M3 receptor is coupled to Gq which activates phospholipase C 
(PLC), which hydrolyses phosphatidylinositol 4,5-bisphosphate (PIP2), a 
phospholipid in the cell membrane, into the second messengers IP3 and DAG (Levick, 
2010). DAG stays within the membrane (where it can, for example, activate TRPC 
channels (Venkatachalam et al., 2007) whereas IP3 is soluble and can diffuse to the 
ER/SR and bind to its receptor. The IP3 receptor is a membrane glycoprotein complex 
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that acts as a Ca
2+
 channel following its activation and causes Ca
2+
 release from the 
stores. This causes an increase in cytoplasmic Ca
2+
 concentration (Takahashi et al., 
2008). As described above, this store depletion can lead to the activation of store 
operated Ca
2+







1.2.8 Ryanodine receptor 
 
The ryanodine receptor is another Ca
2+
 channel present on intracellular membranes 
including the sarcoplasmic reticulum in SMCs and other excitable cells such cardiac 
myocytes and neurons. The receptors are similar to the IP3 receptor and activated by 
increases in cytoplasmic [Ca
2+
] from IP3 mediated release or influx of extracellular 
Ca
2+




 release and acts as a positive 
feedback mechanism causing a further Ca
2+
 release into the cytosol (Carvajal et al., 
2000). In skeletal muscle the activation may occur via direct coupling with a receptor 
rather than calcium-induced calcium release. The ryanodine receptor is particularly 
important in the Ca
2+
 signalling that leads to the contraction of skeletal and cardiac 








 concentration controls vascular smooth muscle contraction and 
relaxation. An increase in intracellular Ca
2+
 leads to Ca
2+
 binding to the messenger 
protein calmodulin forming a Ca
2+
-calmodulin complex. This complex causes the 
activation of myosin light chain (MLC) kinase which phosphorylates MLC. The 
 28 
phosphorylated MLC then becomes active and it can form crossbridges with actin 
which causes the contraction (Carvajal et al., 2000). MLC phosphatase 
dephosphorylates the myosin filaments which stop the crossbridging between the 
myofilaments. When the Ca
2+
 concentration is lowered, MLC kinase activity is 
reduced and the MLC phosphatase activity dominates leading to relaxation (Sandow 






The contractile state of vascular smooth muscle is also regulated by Ca
2+
 sensitisation 
as well as the change in intracellular Ca
2+
 concentration (Somlyo & Somlyo, 1994). 
The monomeric G protein rhoA is activated when agonists bind to G protein coupled 
receptors, and in turn stimulates its substrate Rho kinase. This can directly 
phosphorylate MLC allowing crossbridging with actin filaments leading to 
contractions, but its predominant mode of action is to phosphorylate MLC 
phosphatase, thus inhibiting its activity. This increases the sensitivity of the 
contractile apparatus to Ca
2+
 as there is enhanced MLC phosphorylation with the 
MLC phosphatase inactivated (Gupte et al., 2008). The net effect is to enable 




1.4 Mechanisms of vascular SMC relaxation 
 
Relaxation of the vascular smooth muscle cell occurs when there is a decrease in 
intracellular [Ca
2+
], as this leads to a reduction in activation of the MLC kinase by the 
Ca
2+
-calmodulin complex and the dominance of the MLC phosphatase. This causes 
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dephosphorylation of the MLC and prevents crossbridge cycling with actin (Caravajal 
et al., 2000). This reduction in Ca
2+
 can be from the active efflux of Ca
2+
 out of the 
cell, its pumping into internal stores and the closure of Ca
2+
 channels. Reduced Ca
2+
 
sensitisation also causes relaxation. Different stimuli such as acetylcholine or shear 
stress lead to relaxation following the activation of receptors which produce a 
signalling cascade. This produces second messengers or acts through a pathway which 
ultimately decreases VSM [Ca
2+




 removal from the cytoplasm  
 
The decrease in [Ca
2+
] in the VSM cell during vasorelaxation is often partly due to the 
closure of voltage-gated Ca
2+
 channels which inhibits Ca
2+
 influx. This happens 
following hyperpolarisation of the smooth muscle cell. Ca
2+
 is also actively removed 
from the cytoplasm by a number of different mechanisms (Somlyo & Somlyo, 1994). 
There is active Ca
2+
 extrusion via pumps on the cell membrane, as well as 




 ATPase ion pumps actively 
remove Ca
2+
 from the cytoplasm and are present on the plasma membrane and the 
sarcoplasmic reticulum (Ishida & Paul, 2005).  
1.4.2 Plasma membrane Ca
2+
 ATPase 
The plasma membrane Ca
2+
 ATPase is an ion pump which actively removes Ca
2+
 into 
the extracellular space. It is widely expressed in tissue including the VSM cells. Ca
2+
 
is being moved against its electrochemical gradient so the pump requires energy from 




concentration is restored towards its basal level, thus permitting it to be increased 
again (Somlyo & Somlyo, 1994).  
1.4.3 Sarcoplasmic reticulum membrane Ca
2+
 ATPase 
The sarcoplasmic reticulum membrane Ca
2+
 ATPase (SERCA) is an ion pump on the 
internal Ca
2+
 store with smooth muscle cells. Following contraction, the SERCA 
pump actively transports Ca
2+
 against its concentration gradient from the cytoplasm 
into the sarcoplasmic reticulum. This lowers in the intracellular Ca
2+
 concentration 










 exchanger is an antiporter protein in the plasma membrane. It reduces 
the intracellular Ca
2+
 concentration by removing Ca
2+
 from the cells. It uses the 
electrochemical gradient of Na
+
 which is at a higher concentration outside the cell to 
power the exchange. The energy lost by Na
+
 moving into the cell is used to provide 
energy for Ca
2+
 extrusion, with one Ca
2+
 ion removed for three Na
2+
 ions entering 
(Somlyo & Somlyo, 1994). There are 3 main isoforms of the exchanger, NCX with 
varying expression in different tissues. NCX1 family are the most important in the 
cardiovascular system with NCX1.1 primarily in cardiac cells, and NCX1.3 in 
vascular smooth muscle. Along with the Ca
2+
 ATPase pumps this mechanism is 
responsible for maintaining and restoring the low resting levels of intracellular [Ca
2+
] 




1.4.5 VSMC relaxation induced by cyclic nucleotides 
 
Following stimulation by agonists, the pathway that leads to relaxation often involves 
cyclic nucleotides such as cGMP or cAMP. cGMP is generated by soluble guanylate 
cyclase which converts GTP to cGMP, and cAMP is synthesised from ATP by 
adenylate cyclase. The cyclic nucleotides are broken down by phosphodiesterases into 
inactive products. cGMP and cAMP activate specific protein kinases, PKG and PKA 
respectively (Somlyo & Somlyo, 1994). These kinases phosphorylate target proteins 
which leads to a reduction in intracellular Ca
2+
 and relaxation. For example, PKG and 
PKA can directly open K
+
 channels on the smooth muscle leading to 
hyperpolarisation and closure of voltage-gated Ca
2+
 channels (Jackson, 2005; 
Aaronson & Ward, 2007). The plasma membrane Ca
2+
 ATPase and SERCA can also 
be activated directly to increase Ca
2+
 efflux and sequestration into the sarcoplasmic 
reticulum. These pumps are regulated by phospholamban which is phosphorylated by 
the kinases and increases activity. IP3 is a second messenger that is produced by PLC 
activity and causes release of Ca
2+
 from the sarcoplasmic reticulum. PKG 
phosphorylates the IP3 receptor which reduces the Ca
2+
 channel’s activity. It also 
reduces IP3 production by directly inhibiting PLC and through phosphorylation of the 
GPCR that stimulates PLC (Caravajal et al., 2000). During contraction there is Ca
2+
 
sensitisation which, as described above, increases the contractile state due to MLC 
phosphatase inhibition. However, PKG stimulates the MLC phosphatase leading to 
dephosphorylation of MLC and therefore Ca
2+
 desensitisation (Khatri et al., 2001). 
The cyclic nucleotides therefore cause relaxation by directly lowering intracellular 
Ca
2+
, and also by inhibition of the contractile mechanism.  
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1.5 Hyperpolarisation and K
+
 channels 
The membrane potential of the cell is important in regulation of vascular tone, as this 
affects the open probability of the voltage-gated Ca
2+
 channels. A number of types of 
K
+
 channels on the endothelial cells and smooth muscle cells are important in the 
regulation of the membrane potential (Nelson et al., 2005; Jackson, 2005). The 
opening of the K
+
 channels leads to efflux of the cation down its electrochemical 










 channels (KCa) are ion channels which are stimulated by an 
increase in intracellular Ca
2+
. They are categorised by their conductance into BKCa, 
IKCa and SKCa types (for big, intermediate and small conductance). The BKCa 
channels have been found to be widely expressed while IKCa and SKCa are 
predominately found on endothelial cells (Jackson, 2000, 2005). The discovery or 
development of specific inhibitors for each of the different subtypes has allowed for 
investigation of their different roles in regulating vascular tone.  
1.5.2 SKCa channels 
The SKCa channel has a conductance of 5-18pS and is opened by 200-500nM [Ca
2+
]i 
(de-Allie et al., 1996). The channel is voltage independent and has been found to be 
blocked by the peptide apamin from bee venom (Tharp & Bowles, 2009). The 
channel’s Ca2+ sensitivity is due to Ca2+ binding to calmodulin which is associated 
with the C terminal; this increases its open probability. It is a tetramer of 4 α subunits 
each consisting of 6 transmembrane spanning domains that form the pore. There are 3 
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types of subunits, KCa 2.1, 2.2 and 2.3 but in endothelial cells KCa 2.3 is the only one 
found to be expressed (Edwards et al., 2010). 
1.5.3 IKCa channels  
The IKCa channel has a conductance of 20-80pS and is activated by 100-300nM 
[Ca
2+
]i (Tharp & Bowles, 2009). The IKCa channel also has a C terminal with 
calmodulin acting as the Ca
2+
 sensing domain. The channel is inhibited by the 
scorpion venom charybdotoxin, which also inhibits BKCa channels, and is specifically 
blocked by TRAM 34. Like the SKCa channel it is formed of 4 α subunits which are 
constitutively associated with calmodulin. It is a homotetramer formed of the KCa 3.1 
subunit (Jackson, 2005). 
1.5.4 BKCa channels 
 
The BKCa channel has a conductance of 100-200pS and is regulated by membrane 
potential voltage as well as by [Ca
2+
]i (Tharp & Bowles, 2009).  The BKCa channels 
have a voltage sensor as well as a Ca
2+
 sensing domain at the C terminal. In the 
vascular system, the BKCa channels are located primarily on the VSM cells, and are 
inhibited by iberiotoxin (Gutterman et al., 2005). The BKCa channels are made of 4 α 
subunits, from the KCNMA1 gene, that form the pore, and 4 β subunits, from the 
KCNMB1-4 genes, that modulate the Ca
2+
 sensitivity so calmodulin is not required. 
Under normal conditions it does not contribute to the resting membrane potential and 
on vascular smooth muscle cells is primarily activated by Ca
2+
 rather than membrane 
depolarisation. These channels are activated by the cAMP/PKA signal transduction 
pathway, for example following stimulation of vascular smooth muscle cells by -
adrenergic receptor agonists, prostacyclin, and adenosine (Jackson, 2005). 
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1.5.5 Inward rectifying K
+
 channels (KIR) 
 
KIR channels are K
+
 selective ion channels which are so named because they pass an 
inward K
+
 current more easily than an outward current, although at the normal resting 
potential they, like other K
+
 channels, mediate Ca
2+
 efflux (Petersson et al., 1997). 
They have the unusual property of being stimulated by small increases in extracellular 
[K
+
], which therefore can cause cell hyperpolarisation if these channels are present. 
They have been found in many cell types including vascular smooth muscle cells and 
endothelial cells, where they may be involved in the response to shear stress. The 
KIR2.1 is the main isoform in these cells, and like other K
+
 channels is formed from 4 
α subunits that make a pore. KIR channel expression is greater in smaller vessels 
which could lead to differing responses between vessels (Jackson, 2000, 2005). 
 
1.5.6 ATP sensitive K
+
 channel (KATP) 
 
KATP channels are inhibited by increases in cellular [ATP] and are present in different 
membranes of the cell including the mitochondria and plasma membrane (Jackson, 
2000). These channels are particularly important in pancreatic  cells, where their 
inhibition due to a rise in cellular [glucose] leads to depolarisation, a rise in Ca
2+ 
influx, and insulin release, but they are also found on other cell types including 
vascular smooth muscle cells (Gutterman et al., 2005). They are formed from a 
tetramer of KIR6.1 α subunits that make the pore, and 4 regulatory sulfonylurea 





 channels (KV) 
KV channels are sensitive to changes in the membrane potential, being opened by 
depolarisation. Like BKCa channels they contain a voltage sensor and they are 
important in returning cells to a resting state following depolarisation, and contribute 
to the resting membrane potential (Tharp & Bowles, 2009). These channels can be 
directly activated by cAMP leading to hyperpolarisation and relaxation in smooth 
muscle cells (Gutterman et al., 2005). They are expressed in endothelial cells but their 
function is not clear. They are formed from a tetramer of KVα subunits which make 
the ion conducting pore, along with 4 modulatory KVβ subunits. The tetramer is 
normally homotetrameric and over 40 KVα subunits have been described. In vascular 
smooth muscle cells, KV1.5 and KV1.6 from the delayed rectifier group appear to be 
the most widely expressed and in hypertension models there is functional 
downregulation of these channels (Edwards et al., 2010; Jackson, 2005). 
 
1.6 Endothelium-dependent relaxation 
 
The endothelium can release a number of identified factors which can activate 
signalling pathways in VSMC leading to vasodilatation. These include nitric oxide 
(NO), which activates the cGMP/PKG pathway and prostacyclin/PGI2, which 
activates the cAMP/PKA pathway. The endothelium also releases the vasoconstricting 
peptide endothelin, which is not directly relevant to this thesis so will not be 





1.6.1 NO  
 
Endothelium derived NO is recognised as playing a significant role in the control of 
vascular tone to stimuli such as histamine which increase NO synthesis (Feletou & 
Vanhoutte 1988; Groschner et al., 1994). Following activation of the endothelial cell 
and a rise in intracellular [Ca
2+
], NO is released and diffuses to the vascular smooth 
muscle cells, where it binds to soluble guanylate cyclase cauings the production of 
cGMP. This then acts through PKG to cause Ca
2+
 desensitisation, a reduction in the 
intracellular Ca
2+
 concentration in the smooth muscle (Carvajal et al., 2000; Cary et 
al., 2006), and vasodilatation. NO and nitric oxide synthase (NOS), in particular 
endothelial NOS (eNOS) which generates NO in the endothelium, are important in 
physiological regulation of the vasculature (Vallance et al., 1989). The NO induced 





PGI2 is another important factor released by the endothelium. It is produced from the 
breakdown of arachidonic acid by cyclooxygenase (COX), and causes vasodilatation 
by binding to the G protein coupled prostanoid IP receptor. This stimulates adenylate 
cyclase, causing production of cAMP (Fetalvero et al., 2007) and the activation of 
PKA which can activate channels including the KATP channel to cause 






Following activation of the endothelial cell by an agonist such as acetylcholine or 
bradykinin, or by the physiologically more important stimulus of shear stress, there is 
a rise in intracellular Ca
2+
 levels. This leads to the hyperpolarisation of the endothelial 
cell and then the subsequent hyperpolarisation of the vascular smooth muscle cell and 
relaxation (Edwards et al., 2010). It has been shown that the rise in endothelial 
intracellular calcium leads to the activation of SKCa and IKCa channels (Andersson et 
al., 2000), and it is the efflux of K
+
 through these channels that leads to the 
hyperpolarisation of the endothelial cell. The response is termed endothelial-
dependent hyperpolarisation (EDH) and is independent of the NO and PGI2 pathways 
that have been described above. The involvement of the two endothelial KCa channels 
is a defining characteristic of the EDHF process (Edwards et al., 2010). Inhibitors of 
the SKCa and IKCa channels, apamin and charybdotoxin (or TRAM-34) respectively, 
are used to selectively inhibit the EDHF response (Doughty et al., 1999).  
 
The exact nature of EDH is not yet known despite extensive research. Originally it 
was believed that EDH was caused by a substance that was released from endothelial 
cells and diffused to the vascular smooth muscle to directly cause hyperpolarisation. 
This substance was christened EDHF (Busse et al., 2002). Research now suggests that 
EDHF is not due only to a diffusible factor, but is rather a process that leads to 
hyperpolarisation of the endothelial cell and then the vascular smooth muscle cell, 
with this latter step probably requiring a diffusible factor and also electrical coupling 
between the endothelium and VSM, with the balance between these mechanisms 
dependent on the particular vascular bed and the level of stimulus (Mather et al., 
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2005; Parkington et al., 2008). However, for convenience I will hereafter refer to this 
process as the EDHF response. 
 
1.7.1 The discovery of the EDHF response 
 
The EDHF response was first described more than 20 years ago. It was found that in 
rat aorta and pulmonary arteries, acetylcholine caused a relaxation that was 
endothelium dependent, but was independent of COX and NOS (Chen et al., 1988).  
These enzymes produce PGI2 and NO respectively, mediators of the main relaxation 
pathways, so this suggested there was a third endothelium dependent mechanism. In 
canine coronary artery, this mechanism was found to involve hyperpolarisation which  
leads to relaxation of the smooth muscle cell (see Fig. 1.1, taken from Feletou & 
Vanhoutte, (1988). 
 
Acetylcholine caused this relaxation, independent of NOS and COX, and oubain 
inhibited the smooth muscle hyperpolarisation, suggesting the involvement of the Na-
K ATPase. Following these studies, it was suggested that there was a diffusible factor, 
Figure 1.1. Endothelium dependent relaxation and hyperpolarisation to 
acetylcholine. (Feletou & Vanhoutte, 1988). 
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produced by the endothelium, that was causing hyperpolarisation of the smooth 
muscle cell, and the term endothelial derived hyperpolarising factor (EDHF) was 
coined (Taylor & Weston, 1988). Further work in rabbit carotid artery found that the 
EDHF response involved an increase in intracellular Ca
2+
 levels within the endothelial 
cells (Chen et al., 1990). This supported the idea of EDHF as a diffusible factor as 
like NO, with an increase in Ca
2+
 from store release and extracellular Ca
2+
 entry 
triggering release of the EDHF from the endothelial cell where it could then diffuse to 
the VSM leading to relaxation. Work then began to identify this EDHF, much as NO 
had been found to be the endothelial derived relaxing factor  a few years before. 
 
1.7.2 Candidates for a diffusible EDHF 
When EDHF was originally described it was believed to be a single diffusible factor  
which, like NO, is produced and released from the endothelium and then acts on 
thevascular smooth muscle to cause relaxation. This hypothesis now seems unlikely  
due to the large amount of research that has demonstrated a number of different 
substances to be involved rather than one particular factor (Feletou & Vanhoutte, 
Figure 1.2. Scheme showing the different candidates for EDHF and the 
mechanisms leading to hyperpolarisation and relaxation of the smooth muscle. 
Smooth muscle cell 







































2009) (see Fig. 1.2). There appear to be significant species and tissue differences 
between the pathways involved in causing hyperpolarisation of the vascular smooth 
muscle. These pathways have been suggested to act through various substances, 
including hydrogen peroxide (H2O2), the arachidonic acid metabolites 
epoxyeicosatrienoic (EET) acids, potassium ions (K
+
), as well as through an electrical 
coupling mechanism in which myoendothelial gap junctions provide communication 
between the endothelial cells and smooth muscle  (Bellien et al., 2008).  
 
There are also thought to be a number of different substances that may be involved in 
modulating the EDHF response, for example through actions on channels which will 
affect the EHDF response (Dora et al., 2001). It is important to understand the exact 
mechanisms involved in the EDHF process so that its contribution in vascular 
regulation and possible therapeutic approaches can be explored (Yanga et al., 2007). 
 
1.7.3 EETs 
EETs are made from arachidonic acid by cytochrome P450 and have been 
demonstrated to be produced by endothelial cells (Campbell et al., 2010). They were 
proposed to be a possible diffusible EDHF as they are able to activate large calcium 
activated potassium (BKCa) channels on vascular smooth muscle leading to 
hyperpolarisation (Campbell et al., 1996). This was shown in bovine coronary arteries 
where EETs were produced in response to methacholine, a synthetic muscarinic 
receptor agonist. The addition of exogenous EETs could directly cause 
hyperpolarisation of the smooth muscle and relaxation. EETs were shown by patch 
clamping to increase the open-state probability of the BKCa channels on the coronary 
artery smooth muscle cells. The addition of arachidonic acid, which would increase 
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EETs production, also directly caused relaxation in the bovine coronary arteries and 
this response was inhibited by cytochrome P450 blockers. This study concluded that 
in the bovine coronary arteries investigated EETs were the primary EDHF.  
 
Others have provided support for this view by showing the importance of cytochrome 
P450 in the EDHF response, implying that a product of the pathway could be the 
factor. For example, 17-ODYA blocked the response to acetylcholine recorded using 
intravital microscopy in hamster cremaster muscle (de Wit et al., 1999).  However, 
more recently it has been proposed that mechanism by which EETs act could involve 
regulation of the Ca
2+
 influx into the endothelial cells; this would cause the opening of 
K
+
 channels and subsequent hyperpolarisation. This was supported by evidence that 
elevated EETs cause the translocation to the cell membrane of a TRP channel in the 
endothelial cells (Fleming et al., 2007). The exact involvement of EETs is still to be 
clarified as in other tissues the arachidonic acid metabolite has also been shown to not 





The EHDF response is characterised by a rise in endothelial [Ca
2+





channels. As well as leading to hyperpolarisation of the endothelial 
cells, there is evidence that K
+
 released from the endothelium may also act to directly 





 ATPase (Edwards & Weston 2004). The activation of KIR and 
the ATPase can hyperpolarise the smooth muscle and lead to relaxation (Edwards et 
al., 1998). This study was carried out in small resistance vessels in rats in the hepatic 
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and mesenteric circulation, and showed that EDHF-induced relaxation was inhibited 
by Ba
2+




ATPase, respectively. A small 
increase of extracellular [K
+
] was found to mimic the EDHF effect leading to 
hyperpolarisation of the smooth muscle. The response to K
+
 was endothelium 
independent suggesting that the K
+
 ions were affecting the smooth muscle cell 
directly. The authors proposed that in response to acetylcholine the IKCa and SKCa 
channels open leading to hyperpolarisation of the endothelial cell due to K
+
 efflux. 
This will increase the K
+
 concentration in the myoendothelial space leading to 





ATPase. In accordance with this model, apamin and charybdotoxin abolished 
the relaxation to acetylcholine, but not affecting smooth muscle hyperpolarisation to 
the added K
+
.    
 
This scheme has been supported by work in the renal interlobar artery and porcine 
coronary arteries which demonstrated that the EDHF response corresponds to K
+ 




 ATPase (Beny & 
Schaad 2000; Bussemaker et al., 2002). The EDHF response to bradykinin was 
inhibited by ouabain, but not by barium or gap junction uncouplers. The involvement 
of K
+
 was supported by the use of K
+
 scavenger Kryptofix 2.2.2 which blocked the 





 ATPase and the KIR channel by the ions was seen not to be involved as Ba
2+
 
and ouabain had no effect (Andersson et al., 2000). This conclusion was also 
supported by electrophysiological studies which demonstrated that the 
hyperpolarisation of the vascular smooth muscle in the EDHF process was unlikely to 
be meditated by K
+
 (Dong et al., 2000; Coleman et al., 2001). These discrepant results 
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may have been due to species and tissue differences, but they it is also possible that 
they arose from differences in the conditions used to study the EDHF response (see 
section 1.7.11). The species and tissue differences could be due to varying expression 





C-type natriuretic peptide (CNP) has also been proposed to be involved in the EHDF 
response. CNP is part of the family of vasoactive peptides that also includes ANP and 
BNP, which are involved in cardiovascular homeostasis. CNP has been shown to be 
found in high concentrations in vascular endothelial cells (Sandow & Tare, 2007). It 
is thought to activate NPR-C, one of the three natriuretic peptide receptors on the 
smooth muscle. In rat mesenteric resistance arteries, a selective NPR-C agonist 
mimicked the EDHF response and exogenous CNP elicited the same 
hyperpolarisation as acetylcholine (Chauhan et al., 2003). Following stimulation with 
acetylcholine there was an EDHF mediated relaxation that was blocked by barium and 




ATPase involvement. The relaxation was also 
blocked by 18-GA a gap junction inhibitor. It is a possible diffusible mediator as it 
has been shown to lead to hyperpolarisation of the smooth muscle through activation 
of potassium channels (Simon et al., 2009). However subsequent work suggested that 
CNP does not play a significant physiological role in the EDHF process in a number 
of arteries. In mouse mesenteric arteries, for example, a CNP agonist did not cause 
relaxation and mice with NPR-C knocked out had the same EDHF response to wild 
types (Sandow & Tare 2007, see also Dora et al., 2008). 
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1.7.6 S-nitrosothiols  
 
Additional substances may also have EDHF type activity. In porcine coronary 
microvessels S-nitrosothiols were seen to cause the activation of endothelial IKCa and 
SKCa channels, leading to hyperpolarisation of endothelial cells. These substances 
also have some direct effects on the vascular smooth muscle which could be involved 
in the EDHF response (Batenburg et al., 2004). The s-nitrosothiols may be able to 




ATPase via guanylate cyclase leading to relaxation. 
However, there is only limited research showing the involvement of s-nitrosothiols in 




Anandamide is an endogenous cannabinoid and has been suggested as having a role in 
the EDHF response, possibly through direct activation of BKCa channels (Griffith, 
2004). However its role in the EDHF response has not been widely observed. For 
example, in rat cerebral arteries a blocker of anandamide had no effect on the EDHF 
response and inhibiting its uptake did not potentiate the response. This suggests that 
anandamide does not act as an EDHF in a wide range of tissues and may work down a 






Hydrogen sulphide (H2S) has been suggested as an EDHF as it could act as a 
diffusible gas like NO (Feletou & Vanhoutte, 2007). However though H2S can cause 
relaxation it appears to work through a different pathway to that of EDHF. It has also 
been shown to be produced in smooth muscle rather than the endothelium suggesting 
that it is not EDHF (Baragatti et al., 2009). 
 
1.7.9 NO and PGI2 
 
NO and PGI2 are important mediators of endothelium dependent relaxation. They can 
directly cause hyperpolarisation but this is only weak. They also work through 
different pathways by acting directly on channels on smooth muscle with no 
involvement of the IKCa and SKCa channels which are characteristic of the EDHF 
response. The EDHF response has also been shown to be independent of these 
mediators by the use of L-NAME and indomethacin to block their production 
(Brakemeier et al., 2003).  
 
1.7.10 MEGJ and the ‘EDHF response’ as a result of electrical coupling between 
the endothelium and VSMC 
 
With a large amount of research failing to find a universal EDHF, the idea of the 
response as a process rather than a single diffusible factor has become more 
prominent (de Wit & Wolfle, 2007). Myoendothelial gap junctions (MEGJs) provide 
for the diffusion of current and small molecules between endothelial and smooth 
muscle cells.  
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Gap junctions are formed from the proteins called connexins. 12 of these subunits (6 
from each cell) unite to form connexons which span both cell membranes at sites at 
which cells are closely apposed, with arrays of connexons forming gap junctions. Ions 
can flow through these channels, allowing changes in potential, and therefore in 
electrical excitation, to flow between cells. MEGJs spans intercellular gap between 
endothelial and adjacent VSMCs. Endothelial cells are also linked with each other via 
homocellular gap junctions, as well as by the heterocellular MEGJs with the 
underlying VSM cells (Levick, 2010). The vascular connexion subtypes are 37, 40, 43 
and 45. The construction of gap junctions by these subtypes varies between species 
and tissues with differing formation in different size vessels (de Wit & Griffith, 
2010). 
 
Taking into account the existence of MEGJ, it was proposed (Chaytor et al., 1998; 
Chaytor et al., 2003) that following the hyperpolarisation of endothelial cells caused 
by the opening of KCa channels as a consequence of the action of agonists or shear 
stress, hyperpolarising current may spread to the VSMCs through the MEGJs (de Wit 
& Griffith, 2010). The tunica media of arterioles is only a few cells wide and MEGJ 
are abundant so there is good electrical coupling between these cells types in the 
resistance vasculature (Levick, 2010). This will then lead to smooth muscle cell 
hyperpolarisation and relaxation. In vitro in the vasculature of the hamster cheek, 
endothelial cells and smooth muscle were shown to be electrically coupled as their 
electrical responses were identical (Xia et al., 1995). The importance of 
communication between the cells in the EDHF process was demonstrated by the use 
of gap 27 which inhibits gap junction function. This was shown to inhibit EDHF 
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relaxations, indicating that gap junctions were underpinning the smooth muscle 
hyperpolarisations (Chaytor et al., 1998, Chaytor et al., 2003).  
 
There is now extensive corroborating evidence for the involvement of MEGJs in the 
EDHF response. In rat mesenteric arteries, for example, angiotensin II reduced the 
EDHF response and part of this inhibition was due to decreased expression of 
connexins which form the gap junctions in the arterial wall (Dal-Ros et al., 2008). The 
involvement of MEGJs may also help explain some of the species and tissue 
differences that have been found with EDHF. This could also account in part for 
differences between results obtained in vivo and in vitro where there could be 
different regulation of the gap junctions (de Wit et al., 2008). The increased role of 
EDHF in smaller vessels may also be explained by MEGJ involvement as there would 
be greater communication between the endothelial cells and smooth muscle due to the 
smaller number of layers of smooth muscle. Studies on the localisation of KCa 
channels and MEGJs have shown differences in channel density which correlate with 
functional EDHF activity (Sandow et al., 2006). It has also been shown that SKCa 
channels may cause hyperpolarisation of the smooth muscle mainly through MEGJs 




 ATPase, supporting a role for both 
MEGJs and K
+
 in the EDHF response (Dora et al., 2008).  Studies on an extract from 
a leaf used as a Chinese herbal remedy for hypertension have even shown that it acts 
through activation of the EDHF response involved K
+
 channel activation and gap 
junctions (Jin et al., 2008). The use of a connexin 40 antibody which inhibited gap 
junction function demonstrated the importance of MEGJ communication in EDHF 
mediated dilatation (Mather et al., 2005). MEGJs not only help explain the EDHF 
response in physiological conditions but also pathological states as well. In diabetes 
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communication between cells has been found to be affected which could be 
responsible for the reduced EDHF response and the vascular problems associated with 
the disease (Figueroa & Duling, 2009). 
 
The spread of the electrical current through gap junctions following endothelial cell 
hyperpolarisation has shown to be sufficient to cause hyperpolarisation and relaxation 
in the vascular smooth muscle (Sandow et al., 2002; de Wit et al., 2008). The 
localisation and density of MEGJs may help to explain some of the differences found 
in the EHDF response between tissues (Sandow & Hill, 2000). The electrical coupling 
also supports the hypothesis of EDHF being a process rather than a factor and may 
provide a general mechanism that underlies the hyperpolarisations (Griffith, 2004). It 
is therefore possible that ROS and other substances which have been proposed to be 
EDHFs may act on the processes that lead to the endothelial hyperpolarisation and the 
spread to the smooth muscle cell through the MEGJs, rather than themselves acting to 
hyperpolarise vascular smooth muscle. 
 
1.7.11 Interaction between MEGJ and K
+
 channels in EDHF response 
 
Current work suggests that K
+
 may be acting as an EDHF at low levels of VSMC 
excitation. K
+
 released from the opening of SKCa and IKCa channels on the 





ATPase (Mather et al., 2005). At greater levels of VSMC excitation, the 
opening of BKCa channels on the VSMCs causes a large amount of K
+
 efflux from 
these cells. This leads to an increased K
+
 concentration in the myoendothelial space 
(the ‘K+ cloud’) and this swamps any effect of K+ released from the endothelium, 
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which therefore loses its ability to act as an EDHF (Edwards & Weston, 2004). 
However the relaxation to acetylcholine is still maintained by another mechanism, and 
there is evidence that the EDHF response at higher levels of VSMC stimulation is due 
to EC/VSM coupling via MEGJs. The gap junction inhibitor gap 27 blocked the 
smooth muscle hyperpolarisation only when the vessel was being stimulated by a 
higher concentration of phenylephrine (Richards et al., 2001).  This suggests that K
+
 
acts as an EDHF under basal conditions, but when there is greater excitation, MEGJs 
become the dominant mechanism (Mather et al., 2005; Dora et al., 2008). These 
separate pathways working together under different conditions may to some extent 
explain the varying results found in different studies. 
 
1.7.12 Hydrogen Peroxide as an EDHF 
 
H2O2 is a ROS which is produced from superoxide either spontaneously or by the 
action of superoxide dismutase (SOD). H2O2 can be converted into the more reactive 
hydroxyl radical through the Fenton reaction (1) or be broken down by catalase. As 
described in this section, there is evidence that H2O2 can function as an EDHF in 
some vascular beds. The production of H2O2 and other ROS, and their effects on 











Matoba and co-workers originally reported that H2O2 caused an EDHF-like 
hyperpolarisation in small mesenteric arteries from the mouse (Matoba et al., 2000). 
In support of the concept that H2O2 was acting as an EDHF in these arteries, they 
reported that catalase inhibited the EDHF relaxation and hyperpolarisation. They 
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suggested that eNOS was a major source of the ROS, since eNOS KO mice had 
reduced EDHF responses to acetylcholine. In endothelium denuded arteries, 
exogenous H2O2 caused VSM relaxation and hyperpolarisation, suggesting it was 
working directly on the smooth muscle. Using peroxide sensitive fluorescent dyes and 
laser confocal microscopy they showed that H2O2 was produced in the endothelium 
following acetylcholine stimulation (Matoba et al., 2003). The group presented 
evidence that in human mesenteric arteries H2O2 could act as a primary EDHF, but 
also found that gap junctions are involved (Matoba et al., 2002). Others have also 
reported that endogenously produced H2O2 can act as an EHDF in vivo and is 
important in the regulation of coronary vascular tone (Yada et al., 2003). Shear stress 
has been shown to cause endothelial release of H2O2 and application of SOD, which 
should increase H2O2 levels, enhanced EDHF mediated relaxation in human 
mesenteric arteries, consistent with H2O2 being involved (Miura et al., 2003; 
Morikawa et al., 2004). In human coronary arterioles taken from patients undergoing 
cardiopulmonary bypass, H2O2 was shown to be involved in the EDHF response to 
shear stress (Liu et al 2011). In this study, 2 arterioles were cannulated and perfused 
in series. In response to shear stress applied to the upstream artery only, effluent from 
this vessel caused an iberiotoxin- and PEG-catalase-sensitive relaxation in the 
downstream endothelium denuded vessel. This suggests that H2O2 produced from the 
endothelium in response to shear stress was acting on the BKCa channels on the 
smooth muscle to cause relaxation. The opening of BKCa channels was confirmed 
using patch clamp studies on the smooth muscle cells. 
 
These studies suggest that H2O2 is an EDHF, at least in some vascular beds. In 
porcine coronary arteries, H2O2 can cause relaxation through activation of BKCa 
 51 
channels (Barlow & White, 1998), and it is possible that this could account for its 
hyperpolarising effect. However activation of the BKCa channel is not generally a 
characteristic of the EDHF response and it has been shown that although H2O2 can 
hyperpolarise and relax smooth muscle, in some arteries it seems to be distinct from 
EDHF itself because catalase did not block the EDHF response to substance P or 
bradykinin (Beny & von der Weid, 1991). It is also questionable whether the 
endothelium is able to produce concentrations of H2O2 which are sufficient to cause 
relaxation (Griffith, 2004).  
 
In contrast to the proposal of Matoba’s group that H2O2 is EDHF, there is now much 
evidence showing that H2O2 is involved in the EDHF response but is not a diffusible 
factor acting on the smooth muscle. For example, several studies found that 
exogenous H2O2 and catalase did not affect vascular smooth muscle (Hamilton et al., 
2001; Gluais et al., 2005). Other studies have shown that while MEGJs are the main 
mechanism in the spread of hyperpolarisation to the smooth muscle, H2O2 is involved 
in the process (Chaytor et al., 2003). This was supported by the finding that in human 
gut mucosal arteries H2O2 is produced in response to acetylcholine and catalase 
inhibited the EDHF response, but that exogenous H2O2 did not cause relaxation of 
these arteries when they were denuded of endothelium (Hatoum et al., 2005). This 
supports the possibility that H2O2 acts in an autocrine or paracrine fashion on the 
endothelium itself to potentiate the EDHF response. Notably, Edwards and colleagues 
proposed in 2008 that H2O2 may enhance the EDHF response by increasing 
intracellular calcium in the endothelial cell which causes hyperpolarisation. This was 
based on experiments which showed that H2O2 and thimerasol, a thiol oxidant, 
enhanced endothelial Ca
2+
 release and endothelium-dependent relaxation caused by 
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the SERCA inhibitor CPA. The relaxation to CPA was diminished by catalase and 
also by the connexion blocking peptide 
43
Gap 26. These results suggested that H2O2 
might be promoting endothelial cell Ca
2+
 release through the IP3 receptor which 
would cause hyperpolarisation that spreads to the vascular smooth muscle via MEGJs, 
or possibly could cause the release of other factors (Edwards et al., 2008). This 
hypothesis fits with the central role of MEGJs which have been shown in many 
studies. H2O2 may also act directly on KCa channels through thiol group modification 
(Cai & Sauve 1997), thus promoting endothelial cell hyperpolarisation. H2O2 can 
signal through a number of mechanisms including kinases and calcium rises in 
endothelial cells in response to H2O2 have been demonstrated (Hu et al., 1998; Jornot 
et al., 1999; Sobey & Miller 2005). Phospholipase C is a possible pathway that H2O2 
activates and it seems to be the main ROS involved rather than superoxide or the 
hydroxyl radical (Volk et al., 1997; You et al., 2002). However, while many papers 
have demonstrated the involvement of H2O2 in the EDHF response, research into the 
actual mechanisms and the possible involvement of other ROS is limited. It is 
therefore important to understand how H2O2 and ROS are involved in the EDHF 
response, and if they are potentiating the rise in intracellular calcium in the 
endothelial cells what pathways are involved.  
 
1.8 ROS  
 
ROS are molecules that are chemically reactive and contain oxygen. These include 
free radicals which have one or more unpaired electron and also H2O2, which does not 
have an unpaired electron. There are many sources of ROS and the different types of 
ROS such as superoxide (O2 
-
), H2O2 and the hydroxyl radical (
.
OH), can have a wide 
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range of varying effects (see Fig. 1.3) (Li & Shah, 2004). Superoxide is produced by a 
number of oxidases as part of normal cellular metabolism. This can then be converted 
to H2O2 by superoxide dismutase. In the presence of iron the Fenton reaction can take 
place which produces the hydroxyl radical, or H2O2 can be broken down by catalase 
to produce water. Superoxide can also react with NO to produce the ROS 
peroxynitrite (Faraci et al., 2006).  
 
There are many enzymes and processes involved in ROS production including 
NADPH oxidase, xanthine oxidase, NOS, COX and cytochrome P450. In endothelial 
cells the metabolism of arachidonic acid by cytochrome P450 enzymes is an 
important source of ROS generation (Fleming et al., 2001). Another source of ROS is 
also from aerobic respiration in the mitochondria (Husain et al., 2008). For example, 




























following ischemia-reperfusion the tissue injury seems to be partly due to increased 
ROS production by xanthine oxidase and mitochondrial complexes (Baudry et al., 
2008). 
 
Oxidative stress due to overproduction of ROS is thought to be involved in 
cardiovascular disease (Rojas et al., 2006). However there is now growing evidence 
that at lower concentrations ROS are important in physiological signalling, and the 
cellular redox state is important in regulating cellular function (Janssen-Heininger et 
al., 2008). Changes in redox balance and in particular the effects on NO 
bioavailability can affect vascular function, but at normal levels ROS are being 
increasingly proposed to play an important role in signal transduction (Hare et al., 
2004), an example of this being the concept that H2O2 is EDHF. This may partly 
explain why the use of anti-oxidants therapeutically has not had the beneficial effects 
that were hoped for (Bjelakovic et al., 2008).  
 
1.8.1 Sources of ROS  
 
1.8.2 NADPH oxidase 
 
NADPH oxidases (Nox), of which there are 5 types, are an important source of ROS, 
and the different Nox proteins could be targeted pharmacologically for therapeutic 
purposes (Brandes & Schroder 2008). The enzyme transports electrons across the 
plasma membrane and reduces oxygen, generating superoxide and other downstream 
ROS. The different enzymes can be modulated by other factors such as the GTP 
binding protein Rac 1 which in several types of Nox can cause an increase in 
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superoxide generation (Hassanain et al., 2007). Nox, originally described in 
phagocytes where it has a role in host defence, now is thought to have roles in cell 
signalling and gene expression.   
 
The Nox subtypes are expressed in different cells and have different subunits and 
regulatory proteins. Nox1 is found to be expressed in the endothelium and VSMC, as 
well as other tissues and organs including the colon. It is activated by Rac and PKC 
can increase its expression. Nox2 is also expressed in endothelial cells and VSMC, 
and was the originally described enzyme that was found in phagocytes. Nox2 
expression is increased by angiotensin II. Nox3 seems to not be important in the 
vasculature but is present in the inner ear. Nox4 is found in endothelial cells and VSM 
as well as fibroblasts. It is thought to be constitutively active so does not require cell 
stimulation but it can be unregulated by angiotensin II or TNF and increased 
expression occurs following shear stress and hypoxia. Nox5 is found in testis and 
lymphoid tissue as well as VSM and endothelial cells. The DUOX1 and 2 enzymes 
are also Nox subtypes and are found in glands including the thyroid and testis as well 
as the epithelial cells in the airway (Bedard & Krause, 2007).  
 
Nox2 is the best described Nox subtype. It is made up of 6 transmembrane domains 
with the COOH terminus and NH2 terminus facing the cytoplasm. It consists of the 
Gp91phox catalytic subunit (also called Nox2) which is bound to p22phox in the cell 
membrane. The active Nox associates with the p40phox, p47phox and p67phox 
regulatory cytosolic subunits which form a complex (Li & Shah, 2004). All the 
subtypes have a conserved NADPH binding site at the COOH terminus. Activation of 
Nox2 requires translocation of the cytosolic subunits to the Nox2-p22phox complex 
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in the cell membrane. This occurs by the phosphorylation of p47phox which organises 
the translocation of the other cytosolic subunits. This causes a conformational change 
which allows the direct interaction of p67phox with p22phox. The GTP binding 
proteins Rac1 and Rac2 can then interact with Nox-2 via the activator subunit 
p67phox (Bedard et Krause. 2007). The p47phox acts as an organiser subunit and 
PKC is thought to be one of the kinases that can activate it via phosphorylation 
(Fontayne et al., 2002). The activated complex can then generate superoxide by the 
transfer of an electron from NADPH in the cytosol to oxygen in the extracellular or 
luminal space. Nox1 and Nox3 also require the p22phox subunit and Rac for 
activation. Nox4 requires p22phox but is constitutively active. Nox5 and DUOX1 and 
2 are activated by Ca
2+
 and do not require the translocation of subunits for activation. 
In the endothelial cell the subunits may be intracellular rather than plasma membrane 
bound and there may be a constant low level of superoxide production by Nox4 (Li & 
Shah. 2004). Unlike other sources of ROS, the primary role of the Nox enzymes 
appears to be the production of superoxide rather than it being a byproduct, so it may 
be important in cell signalling that involves ROS (Brandes & Schroder, 2008).   
 
1.8.3 Cytochrome P450  
 
Cytochrome P450s (CYP450) are a family of heme containing enzymes. In mammals 
they are membrane bound, in particular on the endoplasmic reticulum and 
mitochondria. They are involved in the metabolism of a number of substances 
including cholesterol, vitamins, steroids and exogenous compounds such as drugs like 
ethanol or the anticoagulant warfarin (Myasiedova et al., 2008). The CYP450 
enzymes are involved in oxidation, peroxidation, hydroxylation and reduction of 
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different compounds. The enzymes are found in most cell types and are especially 
important in metabolism in the liver. CYP450 is also expressed in endothelial cells 
and VSMC. CYP450 enzymes can produce ROS, particularly members of the CYP2 
family (Fisslthaler et al., 2000). During metabolism superoxide can be produced by 
the electron transfer from the heme iron to a oxygen molecule in an NADPH 
dependent reaction. This has been shown to occur during the metabolism of ethanol 
by CYP2E1 in hepatocytes (Myasiedova et al., 2008). CYP450 are expressed in 
endothelial cells and could be involved in vascular regulation. CYP2C9 has been 
shown to be present in porcine coronary arteries and human coronary arteries where it 
was shown to be a significant source of ROS (Fleming et al., 2001). CYP2C9 can 
metabolise arachidonic acid to produce a number of products including ROS (Li & 
Shah, 2004). This suggests that CYP450 could be important in vascular regulation 




NOS is the enzyme involved in NO production. eNOS is the type of NOS found in 
endothelial cells; it is Ca
2+
 dependent and generates NO and L-citrulline by the 
oxidation of L-arginine which involves the reduction of molecular oxygen. This 
happens by eNOS shuttling the electrons from the reductase domain to the oxidase 
domain (Rabelink et al., 2006). Tetrahydrobiopterin (BH4) is a cofactor that couples 
the reduction of the molecular oxygen to the L-arginine oxidation. BH4 bioavailability 
is reduced when there is increased oxidative stress as it is susceptible to oxidative 
degradation into BH2. If BH4 levels are reduced, eNOS can become uncoupled 
leading to the generation of superoxide rather than NO (Landmesser et al., 2003). 
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Oxidative stress therefore is amplified as it leads to further ROS production by 
uncoupling eNOS. If there are low levels of L-arginine, the eNOS complex can 
dissociate leading to the production of H2O2. This ROS production by uncoupled 
eNOS could be important in redox signalling. It has been suggested that this could be 
involved in the development of atherosclerosis, as well as a physiological role in host 




Mitochondria can be a major source of ROS in cells. During aerobic metabolism, the 
mitochondrial respiratory chain produces superoxide (Husain et al., 2008). Substrates 
such as fatty acids are broken down to produce the electron donors NADH and 
FADH2. Electrons from these donors are then shuttled into the electron transport 
chain. The electron transport chain transfers electrons through different complexes 
down a redox gradient. This provides energy which is used to pump protons from the 
mitochondrial matrix to the intermembrane space. The energy from the proton 
gradient is then used by ATP synthase in complex V to generate ATP (Burwell & 
Brookes, 2008). Molecular oxygen is the final electron acceptor for cytochrome C 
oxidase at the terminal end of the respiratory chain leading to the producing of water. 
However 1-4% of the oxygen may be incompletely reduced resulting in the 
production of superoxide, mainly at complex I and III (Li & Shah, 2004). There is 
thought to be increased production of ROS by mitochondria during certain diseases 
such as diabetes and mitochondrial dysfunction has been implicated in ischemia-





Xanthine oxidase is an oxidoreductase which is important in ROS production (Baudry 
et al., 2008). Xanthine oxidase is generated by post-translational modification of 
xanthine dehydrogenase which is constitutively expressed in vivo in most cells. 
Xanthine oxidase catalyses the oxidation of hypoxanthine to xanthine and xanthine 
urate Kozlovski et al., 2006). This involves the reduction of molecular oxygen which 
acts as an electron acceptor.  This generates superoxide and is also a major source of 
H2O2 which is produced from the oxidation of hypoxanthine and xanthine (Li & Shah, 
2004). Conversion of xanthine dehydrogenase to xanthine oxidase involves reversible 
thiol modification of sulfhydryl residues which is increased during hypoxia and by 
inflammatory mediators like TNF. Xanthine oxidase has been shown to be 
expressed at high levels on the luminal surface of the vascular endothelium so could 
be a major source of ROS generation (Li & Shah, 2004). 
 
1.8.7 H2O2 and cell signalling 
 
H2O2 is a ROS that is produced from superoxide by superoxide dismutase (SOD). 
CuZnSOD is present in almost all cells and is located in the cytosol while MnSOD is 
mainly found in the mitochondria (Halliwell and Gutteridge, 2007). H2O2 can then be 
broken down by catalase into water, or by the Fenton reaction converted into the 
hydroxyl radical. H2O2 itself is not a free radical as it does not have an unpaired 
electron. This means it is less reactive and this increased stability means that it is well 
suited as a potential intracellular signalling molecule, rather than causing oxidative 
damage. Its stability allows it to diffuse through aquaporins or directly though the cell 
 60 
membrane where it could act on downstream targets (Janssen-Heininger et al., 2008). 
Superoxide on the other hand is also not very reactive but is quite unstable and its 
negative charge makes it poorly diffusible through cell membranes. The hydroxyl 
radical is highly reactive with a very short half life so would lead to less specific 
oxidation and would not be able to diffuse to target proteins. In most tissues it is 
thought that H2O2 is produced continually, with normal concentrations thought to be 
around 10-100nM range, though this could be higher in microdomains where there 
can be a localised concentration. Microdomains are a region in the cytoplasm that 
have distinct conditions or function. This can form around channels or enzymes which 
lead to a local increase in concentration which can be higher than in the rest of the cell 
allowing for specific signalling within this region. Microdomains can form in 
caveolae, which are lipid rafts that form at invaginations of the plasma membrane and 
allow for specific singal transduction due to the localisation of channels such as gap 
junctions (D’Autreaux et al., 2007). Though it is poorly reactive in general, it can 
cause oxidative modifications of thiol groups on cysteine residues, which can alter 
protein function. The cysteine residue can cycle between different stable forms 
depending on the redox state and the residues have different susceptibility to 
undergoing redox modification. This selective reactivity makes H2O2 ideal for 
signalling and the reversible modifications of the cysteine residues allow for 
regulation (Forman et al., 2004).  
 
H2O2 can cause specific oxidation of target cysteine residues within proteins which 
causes production of sulfenic acid intermediates. These intermediates are then 
glutathionylated by the addition of the peptide glutathione. H2O2 can also cause the 
formation of disulfide bonds between two cysteine residues forming cysteine (Gupte 
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et al., 2008). This covalent modification leads to a change in the tertiary structure 
which can alter the function of the protein.  These redox modifications can be specific 
because different cysteine residues have differing levels of reactivity. The ionisation 
state of cysteine is important with residues with a low pKa in the thiolate form (S
-
) 
more available for oxidation. The groups in the thiolate form are more nucleophilic so 
are more able to donate an electron and be oxidised (DiChiara et al., 1997). The 
cysteine residues themselves can serve in redox regulation by interacting with zinc as 
this metal’s binding can lower the pKa of the thiol thereby modifying its reactivity. 
The reactivity of the residues is only determined by their localisation within the 
protein, with neighbouring positively charged residues stabilising the bonds by raising 
the pKa (D’Autreaux et al., 2007). This leads to the reaction rates with the thiol 
groups varying which confers specificity and selectivity. The specificity of ROS 
signalling will also be conveyed by the regulation of ROS production, and by ROS 
levels being locally compartmentalised allowing for tight modulation of ROS levels. 
The redox state will also be determined by the balance with antioxidant pathways 
(Winterbourn & Hampton, 2008).  
 
These modifications have been shown on a range of proteins including enzymes such 
as tyrosine kinase and channels (Janssen-Heininger et al., 2008). ROS and in 
particular H2O2 could be therefore important in specific and reversible cell signalling 
through direct modification of protein function. 
1.9 Effects of ROS  
 
As described above, ROS can have a role in cell signalling via redox modification of 
proteins which can alter their function. This could involve the activation or inhibition 
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of transcription factors, membrane channels or enzymes (Winterbourn & Hampton, 
2008). As described, the oxidation and reduction of thiol groups of reactive cysteine 
residues of proteins is thought to be a major mechanism of regulating different 
pathways. The role of redox modification in the control of vascular tone, and in 




The IP3 receptor is activated by the release of IP3 which is produced with DAG by 
hydrolysis of PIP2 by PLC. The negatively charged molecule diffuses to the 
sarcoplasmic reticulum where it binds to the IP3 receptor causing the opening and 
release of Ca
2+
 from the internal stores. This increases the intracellular Ca
2+
 
concentration which has downstream effects as previously described (Hidalgo et al., 
2008). Thiol groups on the IP3 receptor could be modified by ROS which can increase 
the sensitivity of the receptor to IP3. This happens by conformational change of the 
channel which makes it more sensitive to IP3 binding.  
 
In human aortic endothelial cells, NOX derived H2O2 increased the sensitivity of 
stores to IP3. Pre-incubation with concentrations of 100µM H2O2 were used to 
potentiate the response to acetylcholine by increasing the store release of Ca
2+
 leading 
to increased relaxation (De Wit 2010). In rabbit iliac arteries, exogenous H2O2 was 
found to enhance the EDHF response elicited by the SERCA inhibitor cyclopiazonic 
acid (CPA) (Edwards et al., 2008). This effect was mimicked by using the sulfhydryl 
reagent thimerosal which can oxidise the thiol group on the IP3 receptor. This 
enhanced release of Ca
2+
 from endothelial stores potentiates the EDHF response by 
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increasing endothelial KCa channel activity. The response to H2O2 was sensitive to 
KCa channel inhibition showing that it is acting on the endothelial cells to enhance to 
EDHF response, rather than working directly on the smooth muscle. The response 
was also blocked by catalase and potentiated by a catalase inhibitor, further 
supporting the role for H2O2.  
 
In human aortic endothelial cells, the addition of exogenous H2O2 itself has been 
shown to cause transient increases in [Ca
2+
]. This was shown to be from store release 
of Ca
2+
 as removal of Ca
2+
 from the buffer solution did not block the increase 
whereas prior depletion with thapsigargin did abolish the rise (Hu et al., 2008). This 
suggests that H2O2 can directly open the Ca
2+
 store channels.  
 
The EDHF response to histamine was shown to involve an increase in ROS 
production, demonstrated by an increase fluorescence of DCF in human aortic 
endothelial cells (Hu et al., 2002). 10µM H2O2 had no effect on [Ca
2+
] in the 
endothelial cells but the Ca
2+
 increase to histamine was enhanced by pre-incubation 
with H2O2. This response was not blocked by removal of extracellular Ca
2+
 so it was 
suggested that H2O2 was increasing the sensitivity of the endoplasmic reticulum to 
IP3.  
 
These observations suggest that H2O2, rather than being an EDHF factor itself, could 
potentiate the response by increasing Ca
2+
 release from endothelial stores (Edwards et 





ROS may be able to directly modulate the activity of channels, including the TRP 
family of cation channels. For example, TRPC2 is widely expressed and exogenous 
H2O2 could directly open the cation channel. Increased levels of arachidonic acid 
which could increase ROS production also increased channel activity (Hara et al., 
2002). The activation of the TRPC2 channel by H2O2 appears to be by direct 
modification, rather than by affecting regulators of the channel such as ADP ribose. 
This was shown in a patch clamp study by the addition of H2O2 increasing the current 
through the TRPC2 channel (Wehange et al., 2002). TRPM2 in particular has been 
demonstrated to be sensitive to redox modification and could have a role in regulation 
of vascular tone (Yao 2005; Kwan 2007). H2O2 was shown to stimulate ADP ribose 
formation which leads to the opening of the TRPM2 channel (Kraft 2004). This could 
be important for vascular regulation as TRPM2 expression was shown in endothelial 
cells and could cause an increase in Ca
2+
 entry in response to H2O2 (Hecquet et al., 
2008). This effect was blocked by the use of a TRPM2 antibody using a model with 
TRPM2 overexpressed which enhanced the Ca
2+
 entry in response to H2O2. The redox 
sensitivity of the TRPM2 channel could be involved in the EDHF response as Ca
2+
 is 









 channel activation, in particular of KCa channels, is an important part of the EDHF 
response. ROS may be able to directly modify the K
+
 channels to enhance the EDHF 




in the KCa channels which could increase their sensitivity. ROS have been shown to 
directly affect the activation of KCa channels, KATP and KV channels (Gutterman et al., 
2005).  
 
In human coronary arterioles, H2O2 was shown to be produced in response to shear 
stress (Liu et al 2011). The H2O2 appeared to act on the smooth muscle via BKCa 
channel activation as its vasodilating effect was sensitive to iberiotoxin. Patch clamp 
studies showed that exogenous H2O2 increased the open probability of the channel. 
However, the effect of ROS may be concentration dependent, or vary between tissues 
as in porcine renal arteries, H2O2 was found to cause a concentration dependent 
inhibition of BKCa channel activity (Brakemeier et al., 2003). This demonstrates that 
redox modification can have differing effects on a channel, possibly due to an 
alteration in the sensitivity of the thiol group to the ROS or other regulatory factors. 
This could be affected by the concentration of ROS, as well as the tissue and location 
(Gutterman et al., 2005). 
 
In bovine aortic endothelial cells patch clamping was used to investigate the effect of 
oxidative reagents on KCa channel activity (Cai et al., 1997). The use of oxidative 
reagents such as thimerosal reduced the KCa channel activity. This was also shown by 
the addition of H2O2 also suppressing channel activity, which could be restored by 
using reducing agents. However in rat cerebral arteries, relaxation was found to be 
blocked by catalase and by BKCa channel inhibitors (Sobey et al., 1998). This 
suggests that H2O2 was working through activation of the BKCa channels to cause 
relaxation. This variation was shown within one study in rat skeletal muscle arterioles 
(Samora et al., 2008). In juvenile rats, the relaxation to acetylcholine was blocked by 
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catalase and the K
+
 channel inhibitors TEA and glibenclamide. There was also an 
increase in DCF fluorescence in response to acetylcholine signalling an increase in 
ROS production. This relaxation could be repeated by the addition of exogenous 
H2O2, also working through the KCa and KATP channels. However, in younger 
weanling rats, catalase did not block the relaxation to acetylcholine, and exogenous 
H2O2 had no effect. This suggests that H2O2 in juvenile rats caused relaxation through 
the opening of K
+
 channels, but in weanling rats a different mechanism was involved. 
These differences could be due to an alteration in the channel structure which changes 
the sensitivity of the thiol groups to redox modification.  
 
Studies of BKCa channels on human embryonic kidney cells characterised the effect of 
redox reagents on channel activity (DiChiara et al., 1997). The application of a 
reducing reagent increased channel activation whereas H2O2 reduced the channel 
open-probability. This shows that as well as being modulated by the intracellular Ca
2+
 
concentration, BKCa channel activity can be regulated by redox modification. The 
variability was demonstrated in electrophysiology studies on endothelial cells with 
low H2O2 concentrations inhibiting KIR currents, whereas a higher H2O2 concentration 
increased the outward KCa current (Bychkov et al., 1999). The studies suggest that 
ROS, in particular H2O2 can directly modify K
+
 channel activity, and this varies 
between tissues and can be concentration dependent.  
1.9.4 Lipid peroxidation 
 
There is increasing evidence for the role of ROS in cell signalling, and the 
modification of thiol groups allows for a specific and reversible pathway. However, 
ROS may also be able to alter function by direct lipid peroxidation which will affect 
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the structure and function of the cell (Khatchadourian et al., 2009). Oxidised lipids 
can affect signalling pathways and protein function. The hydroxyl radical is the most 
active species in lipid peroxidation as it is very reactive (Smith et al., 1994). The 
hydroxyl radical is formed via the Fenton reaction from H2O2. This requires Fe
2+
 to be 
present which catalyses the reaction to form the hydroxyl radical, and the reaction can 
be stopped by using iron chelators (Halliwell & Gutteridge, 2007). Lipid peroxidation 
occurs as ROS react with arachidonic acid in the cell membrane, producing an alkyl 
radical which can then react with neighbouring arachidonic acid molecules forming 
further radicals and lipid hydroperoxide. This cycle continues and can produce toxic 
aldehydes which can react with cysteine residues on proteins (Hall et al., 2010). The 
role of this process in cell signalling is less clear as lipid peroxidation is not specific 
or easily regulated like thiol modification.  
 
Lipid peroxidation has primarily been implicated in oxidative damage, such as 
following trauma. Using the lipid soluble antioxidant vitamin E, which will scavenge 
ROS in the lipid layer, it has been shown that oxidative damage following trauma can 
be reduced in the brain (Mabile 1995).  
 
1.10 EDHF in humans 
 
1.10.1 Role in pathology and disease 
 
Understanding the process by which EDHF causes relaxation is vital as it is thought to 
be important in normal physiological functioning and pathological states of the 
vascular system. EDHF seems to be of particular significance in the smaller vessels 
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and the microcirculation. NO is the primary relaxing factor in large conducting 
arteries, whereas in smaller vessels EDHF seems to be the dominant pathway 
(Garland et al., 1995). This could be partly due to lower expression of eNOS in the 
smaller arterioles (Shimokawa et al., 1996). As these are the resistance vessels, EDHF 
may well have a significant role in the control of blood pressure. EDHF also seems to 
be important in pathological states, and is thought to be upregulated in some 
conditions and reduced in others (Bellien et al., 2008). Significantly, when NO is 
suppressed, EDHF action has been shown to be increased, which may mean it can 
partially compensate for the loss in NO regulation. EDHF therefore may play a 
protective role through maintaining blood flow and organ perfusion (Bryan et al., 
2005). EDHF and the mechanisms underlying the relaxation may therefore be a 
potential therapeutic target. Drugs that selectively activate the IKCa or SKCa channels 
could have potential benefits, particularly in diseases such as diabetes and 
atherosclerosis when the NO response is reduced (Feletou & Vanhoutte, 2004). The 
EDHF response was also found to be impaired in rat models of diabetes (Fitzgerald et 
al., 2005), and this could contribute to the poor vascular condition associated with this 
disease, particularly in the periphery. There appear to be species differences as in a 
mouse model of diabetes EDHF response was enhanced and in type 2 diabetes it was 
able to compensate for the diminished NO action (Fitzgerald et al., 2005; Park et al., 
2008). The EDHF response has also been found to be reduced in pre-eclampsia, with 
this being particularly important due to the its role regulation of blood pressure by 
resistance arteries (Luksha et al., 2008). Due to EDHF’s apparent involvement in 
pathologies and its potential as a therapeutic target it is important that the mechanisms 
are identified and the process understood. 
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1.11 Research flaws 
 
There has been a significant amount of research looking at the identity of EDHF and 
much of it has resulted in conflicting observations and proposals. Though there will 
inevitably be variation in results due to species and tissues differences, part of this 
may be due to problems with the experimental design or unsafe conclusions being 
derived from the work. A good example of this is the use of ouabain which has been 




 ATPase, with the inhibition 









ATPase itself will lead to a rise in intracellular 
[Na
+




 exchanger leading to an increase 
in cytosolic [Ca
2+
] which itself will inhibit relaxation. This means that the ouabain 
itself is directly inhibiting relaxation as it causes a calcium rise in the smooth muscle. 




 ATPase by examining the 
effects of ouabain on tension is difficult, unless membrane potential has also been 
recorded (Sandow et al., 2004).  
 
The use of drugs which have a wide range of actions and drugs which cannot pass into 
cells also must be recognised. For example Volk’s group used an iron chelator which 
does not readily move into cells so its lack of effect does not necessarily show 
intracellular hydroxyl radicals are not involved (Volk et al., 1997). A major flaw with 
much of the work with ROS and H2O2 is the use of high exogenous concentrations. 
ROS at higher concentrations will affect the redox balance of cells so could have a 
wide range of varying effects. H2O2 can have differing effects depending on the 
concentration used as well so it is difficult to draw conclusions about the mechanisms 
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when high concentrations are used which may not be physiologically relevant 
(Forman, 2007). 
 
1.12 Summary and aims 
 
Following the identification of nitric oxide (NO) as the main endothelium derived 
relaxing factor (EDRF) other important factors have been recognised. This includes 
the finding in canine coronary arteries that there is an endothelium dependent 
hyperpolarisation which leads to relaxation (Feletou & Vanhoutte 1988). The 
mechanism behind the hyperpolarisation was found to be independent of NO and 
prostacyclin and it was termed endothelium derived hyperpolarizing factor. Despite 
its characterisation over 20 years ago the identity of EDHF is still controversial. One 
suggestion is that that reactive oxygen species (ROS) are involved. ROS have often 
been seen as having a damaging effect on vascular function through oxidative stress, 
but it now seems that they play important physiological roles in cellular signalling 
(Faraci et al., 2006).  
 
The aim of my PhD project was to investigate the part played by ROS in the EDHF 
signalling pathway. This would lead to a better characterisation of the mechanisms 
involved in EDHF-induced relaxation, and provide an improved understanding of the 
physiological role of ROS. A more complete picture of the role of ROS in the 
regulation of the vasculature might also help explain findings from clinical trials that 




Taking into the account evidence supporting an important but indirect role of H2O2 in 
the EDHF response, I hypothesised that endothelium- or smooth muscle derived H2O2 
acts in an autocrine or paracrine manner on the endothelium to promote the rise in 
intracellular calcium in response to a stimulus such as acetylcholine. This would lead 
to a greater opening of KCa channels, and more of a rise in extracellular [K
+
] and 
endothelial cell hyperpolarisation which spreads to the smooth muscle through 
MEGJs. H2O2 would therefore potentiate the EDHF response rather than being the 
factor itself. I attempted to prove this hypothesis by simultaneously measuring the 
vascular diameter and endothelial cell Ca
2+











Chapter 2: General Methods 
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2.1 Introduction to Methods 
 
Investigations into the EDHF response look at the resistance vessels of the 
microcirculation where this pathway is most prominent. The cremaster muscle, the 
thin skeletal muscle layer surrounding the testes, is an ideal tissue to study the 
microcirculation as the vessels can be visualised in situ using intravital microscopy 
(Vicaut & Stucker, 1990). The study of the rat cremasteric circulation has been used 
for nearly 40 years and allows the direct measurement of changes in the diameter of 
the blood vessels (Baez, 1973). By using calcium indicators this technique also allows 
for the simultaneous measurement of changes in endothelial calcium, a vital step in 
the EDHF response. Intravital microscopy also minimises damage to the vessels being 
studied as they remain in situ within the cremaster muscle and allows the study of 
smaller vessels that could not be easily dissected. Using in situ vessels allows greater 
control of variables unlike the in vivo model and removes affects of anaesthesia on 
the response (Majino et al., 1967). In the present study intravital microscopy was used 
to characterise the EDHF response in arteries in the cremasteric circulation and the 
role of ROS in this relaxation pathway. 
 
2.1.1 Intravital microscopy 
 
Intravital microscopy consists of a microscope attached to a camera which allows the 
direct visualisation of the blood vessels in situ. The tissue was prepared by setting up 
isolated perfusion of the cremasteric microcirculation and the exposed cremaster 
muscle was mounted on a viewing stage below the microscope. 
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2.1.2 Animal preparation 
 
4-6 week old male Wistar rats weighing 80-100g were killed in accordance with 
Schedule 1 guidelines of the Home Office license. The procedure involved exposure 
to an increasing concentration of carbon dioxide gas followed by cervical dislocation. 
The surgical procedure to prepare the tissue was then started immediately to avoid 
blood clotting and tissue damage. The abdomen from the xiphisternum to the scrotum 
was shaved of fur with an electric razor to allow easier manipulation during dissection 
and to avoid hair affecting visualisation under the microscope. The animal was then 
secured on a clear plastic stage in the supine position ready for the surgical procedure. 
 
2.1.3 Surgical procedure 
 
A midline incision was made along the abdomen of the rat from the xiphisternum to 
the pubic symphysis and the skin and muscle layer were retracted to expose the 
underlying organs. The intestines were moved to one side to expose the abdominal 
aorta and inferior vena cava. The aorta and surrounding vessels were cleaned using 
blunt dissection of connective tissue and fat to allow for easier manipulation. A 
microscope (Zeiss x4) was used to aid careful dissection. The inferior vena cava was 
tied off with thread at a level above the bifurcation into the common iliac veins and 
below that an incision was made to allow drainage of the blood from the lower 
extremities. An incision was made into the abdominal aorta and a 0.61mm fine bore 
polythene cannula was inserted down to the bifurcation into the common iliac arteries. 
The cannula was secured with thread and the left common iliac artery and the right 
femoral and internal iliac arteries were ligated. This ensured perfusion was only to the 
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right external iliac artery which leads to the inferior epigastric artery and then the 
cremasteric artery which supplies the cremaster muscle. The cremaster was then 
perfused through the cannula with St. Thomas’ cardioplegic solution with heparin 
(30U/ml) to remove blood and to suspend cellular function. The anticoagulant heparin 
was included to prevent thrombus formation within the cremasteric circulation while 
the blood was being drained. The circulation was flushed through with the solution 
until the blood was fully drained. The non-toxic Evan’s Blue dye (1% Evan’s Blue 
1:5 Albumin) could be used to ensure good perfusion as it is easily visualised so 
filling of vessels confirmed vascular integrity. 
 
2.1.4 Cremaster preparation 
 
The cremaster muscle is the continuation of the internal oblique muscle which forms 
the muscle layer surrounding the testes. In young rats the muscle is thin so the vessels 
can be easily visualised using a microscope. In rats younger than 4 weeks the testes 
may not have descended while in older rats the muscle and connective tissue layers 
that the vessels run through are thicker so the arteries are more difficult to visualise.  
 
The cremaster muscle was prepared by a midline 
incision along the scrotum to expose the right 
testes. Skin and connective tissue were carefully 
removed from the underlying cremaster muscle 
using careful blunt dissection to reduce tissue 
damage. The muscle was then cut longitudinally 
along the anterior surface from the apex to the 
Figure. 2.1. Exposed cremaster 
muscle pinned to Sylgard 
 76 
inguinal canal using microsurgical scissors while keeping the vascular supply and 
drainage at the base intact. The cremasteric artery enters at the base of the muscle and 
branches away from where the muscle pouch is opened so the supply is not disrupted 
(Gavins et al., 2004). Using blunt dissection the testis was separated from the 
cremaster muscle. The testis could then be pulled through the inguinal canal so that it 
did not obstruct the preparation. The muscle was then spread out onto a clear Sylgard 
disc (silicone 10:1 curing agent) using forceps ensuring only the edges are 
manipulated to avoid vascular damage. Micro pins were then used to secure the 
flattened muscle (see Fig. 2.1). The exposed muscle was kept moist using topical 
addition of physiological salt solution (PSS) via a pipette. The cardioplegic solution 
perfusion the circulation is then replaced with PSS with 0.1% albumin delivered by a 
gravity controlled reservoir.  
 
2.1.5 Stage setup 
 
The preparation was then moved to the microscope stage and the cremaster muscle 
was superfused with PSS gassed with 5% carbon dioxide at 37°C. The PSS pH of 
7.40 was maintained by the buffering with the 5% carbon dioxide (95% air). The 
superfusate was added continually using a pump, with a flow rate of 2.5ml/min, and 
temperature controlled dripper over the tissue. Excess fluid was removed using 
suction. The PSS contained the Na
+
 channel blocker lidocaine (20mg/l) to inhibit the 
cremaster muscle from contracting, which would affect recordings. The cremaster was 
continuously perfused with PSS with albumin. There was then a 30 minute 
equilibration period during which appropriate vessels for visualisation were located. 
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2.2 Experimental protocol 
 
2.2.1 Vessel selection and viability 
 
Following the set up of the stage, using transillumination a x10 magnification 
aqueous-immersion objective lens was used to visualise and select a vessel (see Fig. 
2.2). As it is the EDHF response in arteries that are being investigated in this study, an 
appropriate artery was chosen. Arteries can be distinguished from veins by having a 
less torturous route, thicker walls but narrower lumens, and can be followed back to 
the main cremasteric artery. The vessels could be visualised through the microscope 
eye piece or through the computer screen connected to the camera. Using a stage 
micrometre, each objective lens was calibrated so that the diameters could be 
measured. Second order arterioles (diameter 50-100 microns) were chosen. To reduce 
the risk of damage, the vessels chosen were close to the centre of the tissue and away 
from the periphery which may have been handled during preparation. An EDHF 
mediated relaxation of >50% was considered to signal vessel viability (protocol 
described below). If the relaxation was below 50% the arteriole was not used and 
Figure 2.2. Arteriole and venule visualised under transilluminated light with x10 objective.  
100µm.  
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viability was tested in a different vessel. The stability of the preparation over time was 




Following the 30 minutes equilibration time the arterioles were pre-constricted by 
superfusion with 30µM phenylephrine. This concentration of the selective α1-
adrenergic receptor gave a prolonged constriction. The α1-adrenergic receptor is a Gq 
protein coupled receptor. Following its activation PLC is activated causing the release 
of the second messengers IP3 and DAG leading to an increase in Ca
2+
 in the smooth 
muscle cell and constriction. 300µM N(G)-nitro-L-arginine methyl (L-NAME) and 
3µM indomethacin were co-applied as NOS and COX inhibitors to block NO and 
PGI2 mediated reactions respectively. This ensures only EDHF mediated relaxation 
were present. Unless otherwise stated the tissue was continually superfused with 
phenylephrine, L-NAME and indomethacin. There was a 20 minute equilibration time 
following application to ensure a stable baseline constriction and time for the 
inhibitors to work.  
 
2.2.3 EDHF mediated relaxation 
 
The stable acetylcholine analogue and muscarinic receptor agonist carbachol (10µM) 
was added to elicit EDHF mediated relaxation (see fig 2.2). The carbachol was added 
by superfusing for 2 minutes and gave a relaxation which was reversible following 
washout. 15 minutes was left between carbachol administrations to reduce 
tachyphylaxis and allow constriction back to baseline.  
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2.2.4 Drug application 
 
During the experiments, phenylephrine, L-NAME and indomethacin were applied 
throughout. Unless otherwise stated drugs were applied through the superfusate. A 
bubble was used to show their arrival onto the tissue. To investigate the effect on 
EDHF responses, additional drugs were added to the tissue before carbachol was 
applied to allow for an appropriate incubation time (2-20 minutes). The drugs were 
then also co-applied with the carbachol. Following application there was then a 15 
minute wash out period as long as the drugs effects are reversible.  Following the 
addition of drugs the pH of the PSS superfusate was checked and maintained at pH 
7.40.  
 
2.3 Drugs and solutions.  
 
The physiological salt solution (PSS) was made freshly each day and buffered to pH 
7.40 using a pH meter. The PSS contained 124mM NaCl, 5mM KCl, 22mM 
NaHCO3, 5mM glucose, 2mM MgSO4, 0.125mM NaH2PO4, 2mM CaCl2, gassed with 
5% CO2 - balance air to maintain the pH. The St. Thomas’ cardioplegic solution 
contained 110mM NaCl, 7.9mM KCl 34mM MgCl2, 1mM CaCl2, 11mM HEPES, 
10mM isoprenaline and the same weight of ascorbic acid as an antioxidant. The salts 
were purchased from VWR international and Sigma Aldrich.  
 
Drugs were made up freshly each day or made from stock solutions stored at -20°C 
with final concentrations made up in PSS.  
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All drugs were purchased from Sigma Aldrich other than: TRPM2 antibody 
(Cambridge bioscience), AACOCF3 (Merck Chemicals), Heparin (AAH Hospital 
Services), TRAM-34 (Tocris Bioscience), Lidocaine (Braun Medical), L-012 (Wako 
Chemicals), DCF and DHE (Invitrogen Life Technologies) and CP91 and CP85 
which were kindly donated by Prof. Robert Hider (King’s College London). Animals 




The EDHF response was investigated by measuring changes in diameter and 
endothelial cell Ca
2+
 following carbachol application. The effect of different drugs on 
the EDHF response could then be studied to investigate the role of ROS in the 
pathway.   
 
2.4.1 Diameter measurements 
 
The EDHF mediated relaxation to carbachol was measured using the Image Hopper 
software. Using the camera attached to the microscope, an image was taken once a 
second for 300 seconds which was then displayed on the video monitor producing a 
stack of images. This recording then allowed the change in diameter to be measured 
and calculate the % relaxation. A x40 aqueous-immersion objective lens was used for 
recordings. This allowed diameter measurements to be taken to an accuracy within 1 
micron. The fluorescent indicator fluoresceinisothiocyanate (FITC)-albumin (5%) was 
added to the perfusate to allow for clear visualisation of the vessels by switching from 
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transillumination to 490-530nm illumination using the correct filter. Using image 
hopper to change the threshold of the captured fluorescent signal then allowed the 
image to be displayed with the vessels appearing white and the background black for 
easier differentiation (see fig 2.3).  
At the beginning of the preparation the baseline arteriole diameter was recorded 
before the administration of phenylephrine. Following phenylephrine application 
there was constriction of the arteriole. L-NAME and indomethacin were present to 
ensure only the EDHF response was being seen. The recordings started and following 
approximately 60 seconds carbachol was added leading to EDHF mediated relaxation. 
The maximum diameter following relaxation was then measured. To measure the 
diameter a box was drawn over the arteriole, which measures the diameter in pixels 
and shows the dynamic change in diameter as well as the diameter before and after 
carbachol was added (see Fig. 2.3). The diameter can be converted to microns by 
using a stage micrometer which showed 100 microns equals 310 pixels (for the x40 
objective). The % relaxation is the dilatation to carbachol as a percentage of the full 
Figure 2.3. Dynamic change in diameter measured following carbachol application using Image 
Hopper. The red line represents the change in diameter of the vessel. 
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dilatation of the arteriole. The EDHF response could be then characterised by 
measuring the % relaxation to carbachol with and without other drugs.  
 
2.4.2 Calcium measurements 
 
An increase in endothelial cell Ca
2+
 is a vital step in the EDHF response so this was 
measured simultaneously. The Ca
2+
 indicator Fura-PE3 AM, a dimer of Fura-2 AM, 
was used as it is cell permeant but then is protonated within the cell so does not leak 
out as easily as Fura-2 AM. At room temperature 10μM Fura-PE 3 AM was injected 
into the perfusate with 1% DMSO and 0.02% pluronic acid to aid dispersion in 1% 
albumin PSS. The mixture also included the dye FITC albumin so that perfusion 
could be monitored and diameter changes recorded. This mixture was allowed to 
perfuse for 1 hour to allow for good loading. Using UV light and the video camera 
clear ‘tram lines’ indicated good loading in the endothelial cells. The mixture was 
then washed through with PSS. The superfusate was then turned back to 37°C, after 
which there was a 15 minute equilibration period before starting experiments. A water 
immersion x40 objective was used for recordings. Recordings were made using Image 
Hopper with a filter wheel switching between 360nm and 380nm excitation each 
second. The 360/380 ratio provides a semi-quantitative estimate of endothelial cell 
[Ca
2+
], and was used rather than the more conventional 340/380 ratio due to 
fluorescence being too weak from 340nm excitation. The recordings were made 
simultaneously with the diameter recordings with 1 second intervals for 300 images 
producing a stack of images. 
 
 83 
Changes in signal fluorescence were calculated using Image Hopper. Figure 2.4 
shows the analysis of a stack of images. An average of the background (yellow and 
green) was taken. The background fluorescence is then subtracted from the image, 
and the signal from the vessel (red) was normalised, producing a graph (blue) 
showing the change in fluorescence at 380nm. This was repeated for the 360 
recording and then a ratio was taken of the recordings. The % change in ratio is a 
semi-quantitative representation of the change in intracellular Ca
2+
. This allowed 
changes in endothelial cell Ca
2+
 during the EDHF response to be measured and the 
effect of different drugs to be investigated.  
 
2.4.3 Presentation of data and statistical analysis 
 
Calcium measurement data is represented as the % increase in the Fura-PE3 360/380 
ratio from the baseline, corresponding to the rise in intracellular Ca
2+
 in the 
Figure 2.4. Image analysis of change in fluorescence. 
Image analysis of emissions at 380nm – vessel recording (red) normalised to average of 
background (green and yellow) which is then subtracted. Produces change in fluorescence 




endothelium. The ratio increase is measured to the peak of the ratio rise. The diameter 
measurements are represented as the maximum % relaxation following carbachol 
administration. The response to carbachol alone is paired with the response to 
carbachol with another drug allow for comparison of the results. The paired results are 
always from the same experiment on the same arteriole. These paired results are 
represented in graphs showing how the EDHF mediated relaxation and endothelial 
cell Ca
2+
 increase to carbachol are affected by different drugs (GraphPad Prism). 
 
The means + the standard error have been calculated, with n= the number of 
experiments performed. A two-tailed paired t-test was used to analyse the results to 
measure if there was a statistically significant difference. This test is appropriate for 
paired data and where there is a normal distribution as there was for the % relaxation 
and % ratio increase. If the calculated p values were less than 0.05 the differences 
were considered significant as this means that there is more than a 95% probability 








Chapter 3: Characterising the response to carbachol 





3.1.1 Carbachol response 
 
In this chapter, I describe experiments that were performed to characterise the 
relaxation response to the muscarinic receptor agonist carbachol in rat cremaster 
arterioles. The EDHF mediated component of this relaxation was further investigated 
so that the underlying mechanism could be understood. Control experiments were 
carried out to ensure the results were reproducible and reliable. A pharmacological 
approach was then used with different channel and enzyme inhibitors so their 
involvement in the EDHF mediated relaxation pathway could be demonstrated.  
 
Carbachol was used as a muscarinic receptor agonist to elicit relaxation in the 
arterioles. Carbachol was used rather than acetylcholine because it is a more stable 
analogue as it is not easily metabolised by cholinesterases (Hamilton et al., 2001). 
Muscarinic receptor agonists have been demonstrated to cause an EDHF relaxation in 
a range of tissues and are frequently used to study the mechanisms involved (Dong et 
al., 2000; Hatoum et al., 2005). In small resistance vessels like the arterioles used in 
this study, it has been previously demonstrated that the relaxation to acetylcholine and 
its analogues is mainly due to the EDHF pathway (Bryan et al., 2005; Jin et al., 2008). 
In larger arteries NO seems to be the dominant mechanism, but in smaller vessels the 
EDHF pathway is the main relaxation mediator (Garland et al., 1995). This was 
shown by the relaxation being maintained even in the presence of L-NAME and 





3.1.2 Characterising the EDHF response  
 
The EDHF response to carbachol was characterised in the rat cremaster arterioles. 
The response is characterised by the opening of the IKCa and SKCa channels on the 
endothelium (Andersson et al., 2000). Sensitivity to the blockers of the IKCa and SKCa 
channels allows the EDHF response to be targeted. Apamin can be used to selectively 
block the SKCa channels, while TRAM-34 is a synthetic inhibitor of the IKCa channel. 
This was used in preference over charybdotoxin which is used in other studies as 
TRAM-34 is selective for the IKCa channel whereas charybdotoxin also blocks the 
BKCa channels as well (Gluais et al., 2005). The EDHF response can also be 
mimicked by using a selective and potent IKCa and SKCa channel opener, NS309 
(Tharp & Bowles, 2009). This causes an endothelium dependent hyperpolarisation 
(Leuranguer et al., 2008), allowing the specific characterisation of this part of the 
relaxation pathway as it directly targets a downstream process. During NO and PGI2 
dependent relaxation, protein kinase G is activated by cGMP production. PKG causes 
relaxation of the smooth muscle by lowering intracellular Ca
2+
. To investigate 
whether PKG is also involved in the EDHF response the PKG inhibitor Rp-8-bromo-
cGMP was used (Yao et al., 2000). 
 
3.1.3 Gap junctions and the EDHF response 
 
Different pathways have been shown to be involved in the EDHF mediated relaxation, 
including a role for myoendothelial gap junctions (MEGJs). MEGJs may be acting as 
part of an EDHF process rather than there being a single endothelial derived factor 
that acts directly on the smooth muscle cell to cause relaxation (Griffith, 2004).  The 
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role of MEGJs can be investigated using inhibitors that can block the spread of the 
electrical current through the channels. Using gap junction inhibitors, the EDHF 
response has been abolished in different arteries suggesting it has a key role in the 
relaxation pathway (Sandow et al 2002; Mather et al., 2005). 18-GA has been shown 
to block gap junction communication between cells so can be used to study the 
importance of the channels (Jin 2008). Its affects can be irreversible but it can be used 
at concentrations that do not directly affect smooth muscle tone (Griffith, 2004). 
 




An increase in endothelial cell [Ca
2+
] is a key process in the EDHF mediated 
relaxation. This increase causes the activation of the IKCa and SKCa channels leading 
to the hyperpolarisation of the endothelial cell due to the K
+
 efflux. Intracellular 
[Ca
2+
] can increase by influx of extracellular Ca
2+
 through channels on the cell 
membrane, or by release of Ca
2+
 from internal stores. This is regulated by the IP3 
receptor on the endoplasmic reticulum. To investigate the importance of these 
mechanisms different Ca
2+
 channel blockers were used. SK&F 96365 is a non-
selective inhibitor of receptor operated Ca
2+
 channels and some of the TRP family of 
cation channels so can be used to investigate extracellular Ca
2+
 entry (Groschner et 
al., 1994). This study is looking at the role of redox signalling and TRPM2 has been 
shown to be redox sensitive. The TRPM2 antibody has been used to selectively block 
the TRPM2 channel so it was used to study its role (Hecquet et al., 2008). Ca
2+
 
release from internal stores was studied by using a Ca
2+
 free PSS containing EGTA, 
under which condition Ca
2+
 influx is eliminated, whereas release is preserved. To 
further investigate Ca
2+
 release, I used the the phospholipase C inhibitor U73122, as 
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well as its inactive analogue U73343 (Volk et al., 1997). PLC causes the release of the 
signalling molecule IP3 from the cell membrane so its inhibition blocks the store 
release of Ca
2+




The basic response to carbachol in the rat cremaster arterioles was characterised using 
intravital microscopy allowing for changes in diameter and endothelial cell Ca
2+
 to be 
measured. The tissue preparation and intravital microscopy setup is described in the 




The standard protocol was that the arterioles were pre-constricted with 30µM 
phenylephrine in the presence of 300µM L-NAME and 3µM indomethacin. To 
characterise the EDHF response, 10µM carbachol was added for 2 minutes and 
changes to the diameter and endothelial cell Ca
2+
 were measured. This experiment 
was then repeated in the presence of different channel and enzyme inhibitors to 
understand the mechanisms involved in the EDHF response. The inhibitors were 
added to the preparation prior to application of carbachol. The pre-treatment with the 
inhibitors was for 2 minutes other than 20 minutes for L-NAME, 5 minutes for 
apamin, TRAM-34, U73122 and U73343, 15 minutes for 18α-GA and 1 hour 
perfusion for the TRPM2 antibody. Between experiments there was a 15 minute wash 
out period other than with SKF-96365, 18α-GA and the TRPM2 antibody which were 
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found not to be fully reversible. Experiments with inhibitors that were not fully 




 free preparation 
 
Some experiments were performed in a Ca
2+
 free preparation to ensure there was no 
influx of extracellular Ca
2+
 into the endothelial cells during the EDHF response. This 
allowed the Ca
2+
 release from internal stores to be studied. For Ca
2+
 free recordings a 
Ca
2+
 free PSS with 0.2mM ethylene glycol tetraacetic acid (EGTA), a Ca
2+
 chelator, 
replaced the normal PSS in the perfusate and superfusate. The preparation was left for 
15 minutes to allow it to become Ca
2+
 free. All drugs that were added were made up 
in solutions of the Ca
2+
 free PSS. Following a recording normal PSS with Ca
2+
 was 
applied for 15 minutes to allow the internal Ca
2+
 stores to be replenished before 
switching back to the Ca
2+
 free solutions to carry out another experiment. The pre-
constriction with phenylephrine was abolished in the Ca
2+
 free preparation so only 
changes in endothelial cell Ca
2+
 were measured.    
 
3.2.3 Control experiments 
 
Time control experiments were performed to monitor the stability of the responses to 
carbachol over time and to ensure they were reproducible and reliable (see 3.3 results 
section). Time controls were also performed to ensure the stability of the 
phenylephrine induced constriction to make sure that there was a stable baseline and 
no spontaneous relaxation. The different inhibitors and drugs were applied to the 
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arterioles before the addition of carbachol so that any direct effects of the drugs on the 
diameter or endothelial cell [Ca
2+





The responses to carbachol (% relaxation and % ratio increase) are paired with the 
response with the inhibitors present in the same arteriole to allow for direct 
comparison. These paired results are displayed in the graphs and were analysed with a  
two-tailed paired t-test. The difference between the compared results was considered 
significant if the p value was less than 0.05, represented by a * on the graph (** 








Control experiments were carried out to ensure the stability of the response to 30µM 
phenylephrine. Figure 3.1 shows a typical trace of the constriction to phenylephrine in 
the presence of 300µM L-NAME and 3µM indomethacin. This produced a stable 
constriction (32.9% + 1.9, n=55) that did not run down over time. Controls were also 
performed following the addition of 10µM carbachol to ensure a suitable relaxation 
was elicited that was prolonged enough to take an accurate reading of the maximum 
diameter. Figure 3.2 shows a typical trace with carbachol producing an immediate 
relaxation that gradually diminished down over time. A carbachol dose response 
curve showed that 10µM carbachol caused almost maximal relaxation with no further 
increase at 30µM or 100µM carbachol (see Fig. 3.3). The % relaxation to 3µM 
carbachol was only around 25% so 10µM was chosen as the lowest concentration that 
gave a consistent significant relaxation.  
 
 93 
Figure 3.1. Typical trace of the constriction to phenylephrine.  
The addition of 30µM phenylephrine, 300µM L-NAME and 3µM indomethacin 
caused a sustained constriction. There was a 32.9% ± 1.9 (n=55) constriction of the 
maximum diameter. 
 
Figure 3.2. Typical trace of the relaxation to carbachol.   
The addition of 10µM carbachol for 2 minutes, in the presence of PE, L-NAME and 
indomethacin, caused EDHF-mediated relaxation of 72.6% ± 2.4 (n=55).  
 















































































Figure 3.3. Concentration dependent relaxation to carbachol of PE-
preconstricted rat cremaster arterioles.  
Graph shows the % relaxation to carbachol (0.1-100µM) in the presence of PE, L-
NAME and indomethacin. Results are mean + standard error, n=5. 

















3.3.2 Time controls 
 
Time controls were performed by recording the % relaxation and % ratio change (i.e. 
change in the ratio of fluorescence emission at 340 and 380nm excitation) following 
two carbachol applications separated by 15 minutes. These experiments (see Fig. 3.4) 
showed that there was not a significant difference in the EDHF mediated relaxation in 
response to carbachol (75.3% + 3.5 on first application compared to 72.5% + 3.2 on 
second application, n=21, n.s). Moreover, the % change in ratio in response to 
carbachol also did not diminish over time (see Fig. 3.5). In the Ca
2+
 free preparation 
there was a transient rise in endothelial cell [Ca
2+
] which, following incubation in 
normal - [Ca
2+
] PSS for 15 min to allow store refilling, was reproducible when 
carbachol was again applied under Ca
2+
 free conditions, with no significant difference 
being observed between the two applications of carbachol (see Fig. 3.6) showing Ca
2+
 
responses are stable. These results show the effect of carbachol was stable when the 
standard protocol was used, indicating that this approach was suitable for assessing 




Figure 3.4. Time controls for the relaxation to repeated carbachol applications.  
The relaxation to 10µM carbachol addition (75.3 % + 3.5) was maintained with 
repeated carbachol application (72.5 % + 3.2). Results show mean + SE, n=21 , (n.s). 
 
Figure 3.5. Time controls  for the 360/380nm ratio increase to repeated carbachol 
applications.  
The ratio increase to 10µM carbachol addition (20.5 % + 2.5) was maintained with 
repeated applications (22.1 % + 2.6). Results show mean + SE, n= 10, (n.s) 




































Figure 3.6. Time controls for the 360/380nm ratio increase to carbachol in Ca
2+
 
free preparation.  
In the Ca
2+
 free preparation the increase in the ratio is maintained with repeated 
carbachol applications (from 21.4 % + 2.0 to 20.1 % + 1.7. Results show mean + SE, 


























3.3.3 Relaxation pathways in the rat cremaster arteriole 
 
10µM carbachol was added with and without different inhibitors in order to assess the 
contribution of EDHF to endothelium-dependent vasodilation (see Fig. 3.7). The 
addition of carbachol alone (without L-NAME and indomethacin present) caused 
almost complete relaxation. Blocking the NO and PGI2 pathways with L-NAME and 
indomethacin only slightly (but significantly) inhibited relaxation. When the EDHF 
pathway was blocked with SKCa and IKCa channel blockers apamin and TRAM-34, 
there was >80% inhibition of the L-NAME and indomethacin independent relaxation, 
showing the importance of the EDHF pathway in these vessels. When apamin and 
TRAM-34 were applied alone, without L-NAME and indomethacin the relaxation to 
carbachol was reduced from 95.7 % + 1.2 to only 22.4 % + 1.4 (not shown). This 
shows that the EDHF response is not just in response to NO and PGI2 inhibition and 
is always present. 
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Figure 3.7. Relative contribution of relaxation pathways in rat cremaster 
arterioles.  
The relaxation of PE-preconstricted cremaster arterioles to carbachol (95.7 % + 1.2) 
was attenuated by the NOS and COX inhibitors L-NAME + indomethacin (79.1 % + 
1.4). The addition of the SKCa and IKCa antagonists apamin (500nM) and TRAM-34 
(10μM) which block the EDHF response significantly inhibited the relaxation (14.7 % 


























SK&F 96365 inhibits Ca
2+
 entry through receptor mediated Ca
2+
 channels and some 
non-specific cation channels such as TRP channels. EDHF-mediated relaxation to 
carbachol was inhibited by 10μM SK&F 96365 (see Fig. 3.8). SK&F 96365 also 
caused a significant inhibition of the [Ca
2+
]i rise in response to carbachol during 
EDHF induced relaxation (see Fig. 3.9), with an almost 50% reduction in the ratio 
increase.  As would be expected, in the Ca
2+
 free preparation the SK&F 96365 did not 
affect the % ratio increase as the [Ca
2+
]i rise under these conditions is entirely due to 
release from internal stores
 
(results not shown). TRPM2 is a cation channel present on 
endothelial cells which is thought to be ROS sensitive. Pre-treatment with a TRPM2 
antibody that blocks the channel specifically however had no effect on the EDHF 
response to carbachol with no inhibition of the relaxation or endothelial cell Ca
2+
 rise 
(see Fig. 3.10 & 3.11). 
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Figure 3.8. The effect of SK&F 96365 on relaxation to carbachol.  
The relaxation of PE-preconstricted cremaster arterioles to carbachol (75.4 % + 6.8) 
was inhibited by the receptor operated Ca
2+
 channel blocker SK&F 96365 (10μM) 
(42.9 % + 9.7). Results show mean + SE, n=6 , * p < 0.05. 
 
Figure 3.9. The effect of SK&F 96365 on the 360/380nm ratio increase to 
carbachol.  
The 360/380nm ratio increase to carbachol (21.3 % + 3.8) was inhibited by the 
receptor operated Ca
2+
 channel blocker SK&F 96365 (10μM) (10.5 % + 1.2). Results 
show mean + SE, n=6 , * p < 0.05. 




































Figure 3.10. The role of TRPM2 channels in the relaxation to carbachol.  
The relaxation of PE-preconstricted cremaster arterioles to carbachol (76.8 % + 2.8) 
was not affected by the TRPM2 antibody (5µg/ml) which blocks the TRPM2 channel 
(73.9% + 2.7). Results show mean + SE, n=5, (n.s).  
 
 
Figure 3.11. The role of TRPM2 channels in the 360/380nm ratio increase to 
carbachol.  
The ratio increase to carbachol (23.8 % + 2.6) was not significantly affected by the 
TRPM2 antibody (5µg/ml) which blocks the TRPM2 channel (22.7 % + 2.0). Results 
show mean + SE, n=5, (n.s).




































3.3.5 The role of K
+
 channels  
 
As previously described, blocking the IKCa and SKCa channels caused a significant 
inhibition of the EDHF response to carbachol, almost totally abolishing the relaxation 
and also reducing the endothelial cell [Ca
2+
] rise, albeit to a lesser degree (see Fig. 
3.12 & 3.13). The importance of the channels was confirmed by using NS309, a 
selective IKCa and SKCa channel opener. This directly caused a relaxation which 
though smaller than the one elicited by carbachol was still significant (65.2% + 1.8, 
n=6). NS309 also caused a small increase in endothelial cell [Ca
2+
]i (Fig. 3.18 and 
3.19). The BKCa channel blocker iberiotoxin however had no affect on the EDHF 
response to carbachol with no inhibition of relaxation of the endothelial cell Ca
2+
 
increase (see Fig. 3.14 & 3.15).   
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Figure 3.12. The effect of apamin and TRAM-34 inhibition on the relaxation to 
carbachol.  
The % relaxation to carbachol (79.4 % + 1.1) was almost abolished by the SKCa and 
IKCa blockers apamin (500nM) and TRAM-34 (10μM) (14.7 % + 1.8). Results show 
mean + SE, n= 9, *** p < 0.001. 
 
 
Figure 3.13. The effect of apamin and TRAM-34 on the ratio increase to 
carbachol.  
The % 360/380nm ratio increase to carbachol (26.1 % + 4.5) was inhibited by the 
SKCa and IKCa blockers apamin (500nM) and TRAM-34 (10μM) (19.0 % + 4.3). 
Results show mean + SE, n=5 , ** p < 0.01.





































Figure 3.14. The role of BKCa channels in the relaxation to carbachol.  
The relaxation to carbachol (80.2 % + 3.6) was not significantly affected by the BKCa 
channel blocker iberiotoxin (100nM) (79.7 % + 1.6). Results show mean + SE, n=5, 
(n.s).  
 
Figure 3.15. The role of BKCa channels on the ratio increase to carbachol.  
The 360/380nm ratio increase to carbachol (23.1 % + 2.3) was not significantly 
changed by the BKCa channel blocker iberiotoxin (100nM) (23.1 % + 1.6). Results 
show mean + SE, n=5, (n.s). 


































3.3.6 The role of gap junctions 
 
Gap junctions have been suggested to have an important role in the EDHF pathway. 
To investigate this, the gap junction inhibitor 18α-GA was applied to see the effect on 
the response to carbachol. The gap junction blocker almost completely abolished the 
relaxation to carbachol while having no effect on the endothelial cell Ca
2+ 
(see Fig. 
3.16 & 3.17). NS309 mimics the EDHF response by opening the IKCa and SKCa 
channels which will lead to hyperpolarisation of the endothelial cell. Similar to the 
effect on the response to carbachol, 18α-GA almost completely inhibited the 
relaxation to NS309 while having no effect on the endothelial cell [Ca
2+
] rise (see Fig. 
3.18 & 3.19). This suggests that the role of gap junctions is downstream from the 
opening of the IKCa and SKCa channels and is a vital step in the pathway that leads to 




Figure 3.16. The role of gap junctions on the relaxation to carbachol.  
The relaxation to carbachol (75.7 % + 1.8) was significantly inhibited by the gap 
junction blocker 18-GA (10µM) (14.1 % + 2.8). Results show mean + SE, n=5, *** 
p < 0.001. 
 
Figure 3.17. The role of gap junctions on the ratio increase to carbachol.  
The 360/380nm ratio increase to carbachol (29.4 % + 5.0) was not significantly 
affected by the gap junction blocker 18-GA (10µM) (28.4 % + 4.2). Results show 
mean + SE, n=5, (n.s). 




































Figure 3.18. The role of gap junctions in the NS309 induced relaxation. 
 The relaxation to NS309 (10µM) (65.8 % + 1.9) was almost abolished by the gap 
junction inhibitor 18-GA (10µM) (12.9 % + 2.6). Results show mean + SE, n=5, *** 
p < 0.001. 
 
Figure 3.19. The role of gap junctions in the ratio increase to NS309.  
The 360/380nm ratio increase to NS309 (10µM) (6.3 % + 0.5) was not significantly 
affected by the gap junction blocker 18-GA (10µM) (5.7 % + 0.6). Results show 
mean + SE, n=5, (n.s). 



































3.3.7 The role of PKG in the EDHF response  
 
Protein kinase G (PKG) is an important enzyme in the relaxation pathway of NO and 
also potentially PGI2, as cAMP can stimulate PKG (Caravajal et al., 2000). To 
investigate its role in the EDHF pathway the selective PKG inhibitor Rp-8-Bromo-
cGMP was added to the preparation. The PKG inhibitor had no effect on the EDHF 
mediated relaxation to carbachol with the relaxation and endothelial cell [Ca
2+
] rise 
maintained (see Fig. 3.20 & 3.21). This is consistent with the concept that EDHF 




Figure 3.20. The role of PKG in the carbachol mediated relaxation.  
The relaxation to carbachol (77.8 % + 3.1) was not significantly affected by the PKG 
blocker Rp-8-bromo-cGMP (100µM) (75.5 % + 3.6). Results show mean + SE, n=5, 
(n.s). 
Figure 3.21. The role of PKG in the ratio increase following carbachol 
application.  
The 360/380nm ratio increase to carbachol (22.7 % + 2.5) was not affected by the 
PKG blocker Rp-8-bromo-cGMP (100µM) (22.0 % + 2.4). Results show mean + SE, 
n=5, (n.s). 



































3.3.8 The role of PLC in the EDHF response 
 
Phospholipase C (PLC) is an important enzyme involved in signal transduction which 
can lead to the release of Ca
2+
 from internal stores that then has other downstream 
effects, and can be selectively inhibited by the drug U73122. Since this might have 
non-specific effects, an inactive analogue U73443 was applied as a negative control in 
other experiments. Whereas U73443 had no effect on either EDHF mediated 
relaxation or the associated increase in endothelial cell [Ca
2+
] (Fig. 3.22 & 3.23), both 
responses were almost completely abolished in the presence of U73443 (Fig. 3.24 & 
3.25). This suggests that the activation of PLC is a vital step in the EDHF pathway 
and that the rise in endothelial cell Ca
2+
 requires store release.  
 112 
Figure 3.22. The affect of U73343 on the relaxation to carbachol.  
The relaxation to carbachol (75.3 % + 2.7) was not affected by U73343 (3µM), the 
inactive analogue of the PLC inhibitor U73122 which acts as a negative control (75.0 
% + 2.2). Results show mean + SE, n=5, (n.s). 
 
Figure 3.23. The affect of U73343 on the ratio increase to carbachol.  
The 360/380nm ratio increase to carbachol (22.9 % + 1.7) was unaffected by U73343 
(3µM), the inactive analogue of the PLC inhibitor U73122 (22.9 % + 2.5). Results 
show mean + SE, n=5, (n.s). 




































Figure 3.24. Comparison of the effects of U73343 and U73122 on the relaxation 
to carbachol.  
The relaxation to carbachol (with U73343 as inactive analogue) (75.0 % + 2.2) was 
almost abolished by PLC inhibition by U73122 (3µM) (10.4 % + 1.9). Results show 
mean + SE, n=5, *** p < 0.001. 
 
Figure 3.25. Comparison of the effects of U73343 and U73122 on 360/380 ratio. 
 The 360/380nm ratio increase to carbachol (with U73343 as inactive analogue) (22.9 
% + 2.5) was significantly inhibited by the PLC blocker U73122 (3µM) (3.2 % + 0.6). 
Results show mean + SE, n=5, *** p < 0.001. 









































3.4.1 Response to carbachol in rat cremaster arterioles 
 
The results presented in this chapter demonstrate that EDHF was the dominant 
mechanism for endothelium dependent vasodilatation, since L-NAME and 
indomethacin, which block NO and PGI2 production respectively, only slightly 
reduced the relaxation to carbachol. This implied that the EDHF mediated relaxation 
amounted to ~80% of the overall response. The addition of apamin and TRAM-34, 
which block the SKCa and IKCa channels that are involved in the EDHF response, 
almost abolished the relaxation to carbachol, confirming that the L-NAME- and 
indomethacin-resistant relaxation was EDHF mediated. This supports the idea that in 
small vessels such as arterioles, EDHF is the prime endothelium dependent relaxation 
mechanism (Gluais et al., 2005), and is consistent with a previous study in rat 
cremaster arterioles where 70% of the relaxation to acetylcholine was found to be 
resistant to L-NNA, another NOS inhibitor (Bakker et al., 1997). The EDHF response 
worked via a different pathway to NO and PGI2 as the PKG inhibitor Rp-8-bromo-
cGMP had no effect on the response, whereas PKG is a major mediator of relaxation 
for these pathways by reducing Ca
2+
 in the VSM (Hare et al., 2003).  
 
The EDHF vasodilatation to carbachol seemed to be mainly mediated through 
opening of the IKCa and SKCa channels, with the inhibition of the BKCa channel 
having no effect on the vasodilatation or the rise in endothelial cell [Ca
2+
]. This 
supports the view that the BKCa channel is not involved in the EDHF response 
(Coleman et al., 2004). However, others have shown that activation of the BKCa 
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channel is important in tissues such as in the small mesenteric arteries in mice (Huang 
et al., 2001). This suggests that there could be species and tissue differences between 
the mechanisms involved in the EDHF response. There could also be differences 
depending on the agonist used with one study noting that the EDHF response to 
bradykinin involved activation of the BKCa channel, while the response to 
acetylcholine was not sensitive to BKCa blockade (Pannirselvam et al., 2006). 
 
The relaxation and increase in endothelial cell [Ca
2+
] in response to carbachol was 
shown to be sustained and repeatable, as demonstrated by the time controls in which  
there was no decrement in these responses over time. In addition to being consistent 
with the pathway having an important physiological role, the stability of the responses 
upon multiple applications of carbachol also meant that each arteriole could be used 
as its own control, allowing paired results to be analysed from the experiments. A 
dose response to carbachol showed that 10µM caused an almost maximal relaxation 
of ~80% so this concentration was used throughout for the experiments.  
  
The rise in endothelial cell [Ca
2+
] is known to be key to the EDHF response. It was 
found that using SK&F 96365 which blocked receptor operated Ca
2+
 channels and 
some members of the TRP family of cation channels significantly blocked the rise in 
endothelial [Ca
2+
], and correspondingly blocked the relaxation. This supports other 
studies which have shown the importance of extracellular Ca
2+
 influx in the EDHF 
response (Doan et al., 1994). However, the TRPM2 antibody was used to specifically 
block the TRPM2 channel and this was found to have no effect on the EDHF 
response. Previous studies have described the role of TRPM2 in Ca
2+
 entry but none 




 free preparation was used to look at release of Ca
2+
 from intracellular stores in 
the endothelial cells. This produced a transient rise in [Ca
2+
] in response to carbachol, 
consistent with store release without any extracellular influx. The stores could be 
replenished by the addition of the normal buffer with Ca
2+
 and then returned to Ca
2+
 
free conditions to re-examine the effect of carbachol, and using this approach I found 
that the amplitude of this response was maintained. This was important, because it 
allowed the effects of drugs on Ca
2+
 release from stores to be investigated, as 
described in later chapters. The role of Ca
2+
 release was also investigated (in the 
presence of extracellular Ca
2+
) using the PLC inhibitor U73122. This blocks PLC 
from releasing the second messenger IP3 from the cell membrane. IP3 binds to the IP3 
receptor on the endoplasmic reticulum and opens Ca
2+
 channels. The PLC blocker 
almost completely abolished the relaxation and the endothelial [Ca
2+
] rise in response 
to carbachol. This suggests that the release from the intracellular stores is needed for 
Ca
2+
 entry, which is presumably responsible for the sustained carbachol induced rise 
in [Ca
2+
]i observed in the presence of extracellular Ca
2+
, and which probably occurs 
via store operated Ca
2+
 channels. This is supported by others’ findings which have 
shown the importance of store release of Ca
2+
 in the EDHF response and even that the 
response could be mimicked by using an agonist that empties the Ca
2+
 store (Edwards 
et al., 2008). This was shown to be due to the Ca
2+
 release leading to 
hyperpolarisation of the endothelial cell via IKCa and SKCa channel activation (Fukao 
et al., 2005).  
  
The gap junction inhibitor 18α-GA almost totally blocked the relaxation to carbachol, 
supporting a role for MEGJs in the EDHF response that has been found in other 
tissues such as the rat mesenteric artery, in which 18α-GA abolished the response to 
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acetylcholine (Jin 2008). In the rat cremaster arterioles it has been previously shown 
that electrical coupling through MEGJs was vital in the EDHF response as this was 
blocked using gap junction inhibitors (McSherry 2006). However in mouse cremaster 
electrical coupling has shown to be weak and not important for the EDHF response 
(Siegl 2005). This probably represents a difference between species, as the expression 
of MEGJ proteins varies between tissues (de Wit 2010). During the experiments, the 
arterioles were strongly pre-constricted with phenylephrine so were under a large 
level of excitation. The efficacy of 18-GA in blocking the carbachol response is 
consistent with the finding that MEGJs are the predominant pathway when VSM are 
highly stimulated (Dora 2008). This has been proposed to be due to the opening of 
BKCa channels on the VSM due to the rise in [Ca
2+
]i associated with a high level of 
stimulation, leading to K
+
 efflux. This would increase the K
+
 concentration in the 
myoendothelial space meaning that the K
+
 released via the SKCa and IKCa channels on 
the endothelium during the EDHF response is swamped by the ‘K+ cloud’ (Edwards 




 ATPase on the VSM so K
+
 
cannot act as an EDHF (Mather et al., 2005), resulting in MEGJs becoming the 
dominant mechanism in this state, and could explain differences in the findings 
between some studies.  
 
The selective IKCa and SKCa channel opener NS309 was used to mimic the EDHF 
response. It has been shown by others to open the IKCa and SKCa channels, leading to 
hyperpolarisation of the endothelial cell and relaxation of the smooth muscle 
(Leuranguer et al., 2008). It caused a significant vasodilatation in the rat cremaster 
arterioles, demonstrating the importance of this pathway in these vessels. 18α-GA was 
used to block the MEGJs and this was found to almost abolish the relaxation to 
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NS309. This supports the previous finding that shows the EDHF response is working 




These results show that in the rat cremaster arterioles, the EDHF relaxation pathway 
is the dominant mechanism in response to carbachol. The EDHF pathway is primarily 
mediated through the SKCa and IKCa channels, and is dependent on MEGJs to cause 
relaxation in the smooth muscle, at least under the conditions used in these 
experiments. Ca
2+
 release from intracellular stores in the endothelial cell was also 

















4.1.1 ROS in the EDHF response 
 
ROS, in particular H2O2, have been suggested to be involved in the EDHF response 
(Faraci 2006). Studies have shown that H2O2 can act as an endothelium dependent 
diffusible factor acting on the smooth muscle directly to cause hyperpolarisation and 
relaxation (Rojas 2006). However, it also appears that H2O2 may act on the 
endothelial cell itself to promote the EDHF response, possibly by increasing 
intracellular Ca
2+
 (Edwards 2008). I therefore carried out experiments designed to 
explore how ROS were involved in the EDHF response to carbachol.  
 
To investigate the dependency on ROS during the relaxation, I used the antioxidants 
SOD and catalase. SOD dismutates superoxide into H2O2, and catalase breaks down 
H2O2 to water (Halliwell and Gutteridge, 2007). These antioxidants have been used to 
scavenge ROS in other studies and using ROS sensitive fluorescent indicators they 
have been shown to reduce ROS levels (e.g. Samora et al., 2008). H2O2 can be 
converted into the reactive hydroxyl radical by the Fenton reaction. This reaction 
requires the presence of iron (Kayyali et al.,1998). Iron chelators were used to block 
this reaction to investigate whether the hydroxyl radical was involved in the EDHF 
response. Desferrioxamine has been used widely as an iron chelator and was used in 
these experiments, but desferrioxamine can also scavenge ROS directly (Suematsu et 
al., 1993). For this reason, I used the specific iron chelators CP85 and CP94 which do 
not scavenge ROS (Rai et al., 1998). The hydroxyl radical can cause lipid 
peroxidation which can affect cell signalling and protein function (Smith et al., 1994). 
Vitamin E or α-tocopherol is a lipid soluble antioxidant which can scavenge ROS in 
the cell membrane (Mabile et al., 1995). This was used to prevent lipid peroxidation 
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to see if this is involved in the EDHF response. To investigate whether ROS are 
acting on the intracellular Ca
2+
 release, a Ca
2+
 free preparation was used. This 
prevented extracellular Ca
2+
 influx while maintaining the release from the Ca
2+
 stores 
(Hu et al., 1998).  
 
4.1.2 Source of ROS 
 
ROS can be produced by a number of sources as part of normal physiological 
processes (Takaki et al., 2008). To confirm that ROS generation was being blocked, 
ideally measuring ROS levels during the response would have been carried out while 
using different inhibitors. However, a number of different fluorescent ROS indicators 
and protocols were tested, but it was not possible to successfully load the cells with 
the ROS indicator, as preliminary experiments failed to produce any controls or 
reliable readings. This could be because the preparation is small or that the tissue is in 
situ, while many protocols are based on use in cultured cells (Suematsu et al., 1993). 
The interpretation of observations arising from commonly used ROS indicators is also 
controversial (Dunstan et al., 2000; Wardman et al., 2007). As an alternative, I 
investigated the source of ROS in the rat cremaster arterioles by examining the effects 
of inhibitors of different enzymes and processes that are known to generate ROS on 
the EDHF response to carbachol. Antioxidants were also used to show the 
involvement of ROS during the EDHF response. The different mechanisms involved 







EETs are produced by the metabolism of arachidonic acid by cytochrome P450, in the 
same pathway that can produce ROS (Fleming et al., 2001). They have been 
suggested to be a potential EDHF in some tissues (Fleming et al., 2004; Hercule et al., 
2009). The role of EETs in the EDHF response in rat cremaster arterioles was 
investigated in several ways. Exogenous EETs were applied to study the direct effect 
on vascular tone and endothelial Ca
2+
. The role of EETs during the carbachol 
response was studied by blocking EET breakdown by soluble epoxide hydrolase 
(sEH) using the inhibitor AUDA (Campbell & Fleming, 2010). This would increase 
EETs concentration in the preparation. The EETs antagonist EEZE was also used to 
block any response that EETs may have during the EDHF response to carbachol (de 
Wit et al., 1999).  
 
4.2 Methods  
 
The role of ROS in the EDHF mediated response to carbachol was investigated using 
intravital microscopy and the tissue preparation and setup as described in the general 
methods chapter. Different antioxidants were used to scavenge ROS and to 
understand their role in the EDHF pathway and to identify the particular species of 
ROS involved. Selective inhibitors of the enzymes that are potentially involved in 





4.2.1 Protocol  
 
The rat cremaster arterioles were pre-constricted with 30µM phenylephrine and the 
experiments took place in the presence of 300µM L-NAME and 3µM indomethacin to 
ensure only EDHF-mediated relaxation was present. 10µM carbachol was added to 
the preparation and the response was compared to the response in the presence of 





 free experiments were carried out as previously 
described in Chapter 3. The pre-treatment time was 2 minutes for the antioxidants and 
inhibitors that were added other than 10 minutes for EEZE, AUDA, ATZ, AACOCF3 
allopurinol and Ro 31-8220, and 15 minutes for 18α-GA, NDGA, PPOH and 17-
ODYA. 18α-GA and 17-ODYA were not fully reversible so experiments were 
performed at the end of the run.  
 
4.2.2 Electrophysiology experiments 
 
The EDHF response is characterised by a hyperpolarisation of the endothelial and 
smooth muscle cells leading to relaxation. To support the experiments involving 
intravital microscopy, electrophysiology experiments were carried out in Dr Kim 
Dora’s lab at the University of Oxford. This allowed for the direct measurement of 
changes in the membrane potential of the smooth muscle cells of the artery. 
 
An isolated perfused rat cremasteric artery was used for these experiments. 200-270g 
Wistar rats were used as the cremaster artery has to be dissected and mounted onto the 
micropipettes for perfusion and therefore must be larger than the arterioles used in the 
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intravital microscopy preparation (diameter ~200 microns). The rats were killed in 
accordance with Schedule 1 by overdose of the anaesthetic urethane. The cremaster 
muscle was then exposed as previously described in the General Methods. A second 
order artery with a diameter of around 200 microns was chosen and carefully 
dissected out and the surrounding connective tissue was removed. A length of about 
5mm was then mounted onto cannulation pipettes to allow perfusion. A microscope 
was used to aid careful dissection and mounting of the artery. A Perspex plate was 
attached to the movable stage of a microscope allowing for visualisation of the artery. 
The cannulation pipettes were fixed and held by two micromanipulators. The arteries 
were continually superfused (4ml/min) with a heated solution of PSS at 37ºC. 
Intracellular recordings of the membrane potential were made using glass 
microelectrodes filled with 2M KCl (giving tip resistances of 90-150 MΩ), and a 
Neurolog amplifier system, and data were acquired using Clampex 8.0.2 software. 
The microelectrodes were used to carefully impale the smooth muscle cell. This was 
done manually using a third piezoelectric precision micromanipulator, which was 
placed on a stand to hold the microelectrodes at a 45º angle to impale smooth muscle 
cells above the midplane of the vessels. Successful recordings were characterised by 
an abrupt deflection of signal on impalement of cells and an approximate return to the 
pre-impalement values on removal of the microelectrode. Following successful 
impalement of the microelectrode drugs were then added to the superfusate to elicit 
changes in the resting membrane potential of the smooth muscle cell using the same 
protocol as used for the intravital microscopy setup. L-NAME and indomethacin were 
present throughout. The K
+
 channel opener cromakalim (3µM) was added as a 
positive control to elicit hyperpolarisation to ensure the microelectrode was measuring 
the membrane potential of the smooth muscle cell.  
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4.2.3 Analysis  
 
The results of the carbachol controls and the experiments with an inhibitor present 
were paired so comparison was made on the same arteriole. The % relaxation and % 
360/380 ratio increase are displayed in graphs as the control paired with the test 
experiment with the different inhibitors present. The electrophysiology experiments 
were also paired showing the change in membrane potential to carbachol and then the 
change with antioxidants present. The means + the standard errors were calculated 
and a two-tailed paired t-test was used to compare the results. The difference between 
the compared results was considered significant if the p value was less than 0.05, 
















The simultaneous application of the anti-oxidant enzymes SOD and catalase 
(100U/ml each) significantly reduced the EDHF mediated relaxation following 
carbachol application from 75.0% + 7.6 with carbachol alone to 36.8% + 11.4 in the 
presence of the anti-oxidants (see Fig. 4.1). The EDHF-mediated relaxation in 
response to carbachol with SOD and catalase was less than 60% of the relaxation to 
carbachol alone. There was also a reduction in the rise in endothelial cell Ca
2+
 when 
ROS were scavenged. Carbachol alone caused a ratio increase of 19.1% + 3.5 whereas 
with the addition of SOD and catalase the increase was only 5.5% + 2.1. This shows 
that the anti-oxidants significantly reduced the Ca
2+
 rise in the endothelial cells in 
response to carbachol with the increase inhibited by almost 75% (see Fig. 4.2).  
 
The electrophysiology experiments showed that following carbachol application there 
was a hyperpolarisation of the smooth muscle membrane, characteristic of an EDHF 
response (see Fig. 4.3). In the presence of the antioxidants SOD and catalase the 
membrane hyperpolarisation in response to carbachol was reduced by nearly 75% (see 
Fig. 4.4), consistent with the findings from the intravital microscopy experiments 




 free preparation, the addition of SOD and catalase reduced the transient 
rise in Ca
2+
 from 20.5% + 2.8 to 10.4% + 1.5 (see Fig. 4.6). A typical trace 
demonstrates this inhibition in the Ca
2+
 rise is shown in Fig. 4.7. This result suggests 
 127 
that ROS are important in the release of Ca
2+
 from internal stores and that this is a 
vital step in the EDHF response. The application of SOD did not affect the Ca
2+
 rise 
significantly with a 22.3% + 1.8 increase compared to 22.8% + 1.9 with carbachol 
alone (see fig 4.7). Catalase alone however did reduce the ratio increase with a rise of 
10.6% + 1.6 in the presence of catalase following carbachol application compared to 
23.3% + 2.1, showing a reduction of nearly 60% (see Fig. 4.8). 
 
The IKCa and SKCa channel opener NS309 has previously been shown to mimic the 
EDHF response leading to relaxation. The presence of SOD and catalase had no effect 
on the NS309 induced relaxation (see Fig. 4.9 & 4.10). This suggests that ROS 
involved in the EDHF pathway might be important upstream of the opening of the 
IKCa and SKCa channels.  
 
Vitamin E or α-tocopherol is a fat soluble antioxidant that in particular targets lipid 
peroxidation in cell membranes. Treatment of the arterioles with α-tocopherol had no 
effect on the EDHF response to carbachol with no inhibition of relaxation or effect on 
the Ca
2+
 rise (see Fig. 4.11 & 4.12).  
 
To further study the importance of ROS in the EDHF response I determined whether 
increasing ROS had any effect. Atz is a catalase inhibitor which will lead to an 
increase in H2O2. Pre-treatment with Atz had no effect on its own but when carbachol 
was added the EDHF response was enhanced with an increase in relaxation and a 
larger rise in endothelial cell Ca
2+ 
(see Fig. 4.13 & 4.14). This suggests that increasing 




Figure 4.1. Effect of antioxidants on relaxation to carbachol.  
The % relaxation to carbachol (75.0 % + 7.6) was inhibited by the addition of the 
antioxidants SOD and catalase (100U/ml each) (36.8 % + 11.4). Results show mean + 
SE, n= 7, * p < 0.05. 
 
Figure 4.2. Effect of antioxidants on the ratio increase to carbachol.  
The 360/380nm ratio increase to carbachol (19.4 % + 3.0) was inhibited by the 
presence of the antioxidants SOD and catalase (100U/ml each) (5.3 % + 1.8). Results 
show mean + SE, n=7 , *** p < 0.001. 
 








































Figure 4.3. A typical trace showing the change in membrane potential in a 
smooth muscle cell in rat cremaster arteriole.  
The hyperpolarisation to carbachol was reduced when the preparation was treated 
with the antioxidants SOD and catalase.  
 
Figure 4.4. The effect of antioxidants on the change in smooth muscle membrane 
potential in response to carbachol.  
The hyperpolarisation (change in mV from resting membrane potential) to carbachol 
(18.5 % + 3.5) was inhibited by treatment with the antioxidants SOD and catalase 
(100U/ml each) (4.2 % + 0.8). Results show mean + SE, n=5 , ** p < 0.01. 





















































Figure 4.5. The effect of antioxidants on the ratio increase to carbachol in the 
Ca
2+
 free preparation.  
The 360/380nm ratio increase to carbachol (20.5 % + 2.8) was attenuated by the 
antioxidants SOD and catalase (100U/ml each) (10.4 % + 1.5). Results show mean + 
SE, n=5, ** p < 0.01. 
Figure 4.6. Typical trace of the increase in 360/380nm ratio in response to 
carbachol in a Ca
2+
 free preparation.  
The addition of the antioxidants SOD and catalase inhibited the release of Ca
2+
 from 
the intracellular stores.  













































The 360/380nm ratio increase to carbachol (22.8 % + 1.9) was not significantly 
affected by the antioxidant SOD (100U/ml) (22.3 % + 1.8). Results show mean + SE, 
n=5, (n.s). 
 
Figure 4.8. The effect of catalase on the ratio increase to carbachol in the Ca
2+
 
free preparation.  
The 360/380nm ratio increase to carbachol (23.3 % + 2.1) was inhibited by the 
antioxidant catalase (100U/ml) (10.6 % + 1.6). Results show mean + SE, n=5, ** p < 
0.01.









































Figure 4.9. Antioxidants did not affect NS309 induced relaxation.  
The relaxation to the SKCa and IKCa channel opener NS309 (10µM) (65.6 % + 2.2) 
was not significantly affected by the antioxidants SOD and catalase (100U/ml each) 
(64.3 % + 2.0). Results show mean + SE, n=5, (n.s). 
 
 
Figure 4.10. Antioxidants did not affect the 360/380nm ratio increase to NS309.  
The 360/380nm ratio increase to NS309 (10µM) (4.3 % + 0.8), was not significantly 
altered by the antioxidants SOD and catalase (100U/ml each) (4.1 % + 0.6). Results 
show mean + SE, n=5, (n.s). 







































Figure 4.11. Vitamin E did not affect the relaxation to carbachol.  
The relaxation to carbachol (73.8 % + 2.6) was not significantly affected by the lipid 




Figure 4.12. Vitamin E did not affect the 360/380nm ratio increase to carbachol. 
 The 360/380nm ratio increase to carbachol (21.8 % + 1.8) was not changed by the 
lipid soluble antioxidant vitamin E (100μM) (20.7 % + 2.2). Results show mean + SE, 
n=5, (n.s). 



































Figure 4.13. Catalase inhibition potentiated the relaxation to carbachol.  
The relaxation to carbachol (77.4 % + 2.1) was increased by the catalase blocker Atz 
(50mM) (90.1 % + 1.7). Results show mean + SE, n=5, ** p < 0.01. 
 
 
Figure 4.14. Catalase inhibition potentiated the 360/380nm ratio increase to 
carbachol.  
The 360/380nm ratio increase to carbachol (28.5 % + 5.4) was enhanced by the 
catalase blocker Atz (50mM) (34.9 % + 5.8). Results show mean + SE, n=5, *** p < 
0.001. 






































4.3.2 Iron Chelators 
 
Application of the iron chelator desferrioxamine (DFO; 100μM) significantly reduced 
the relaxation in response to carbachol from 64.5% + 15.0 to 20.6% + 3.5 (see Fig. 
4.15). The addition of DFO also caused a significant reduction in the Ca
2+
 increase 
during the EDHF response from 31.7% + 11.4 with carbachol alone to only 9.4% + 
6.5 with DFO present (see Fig. 4.16). However, DFO also scavenges free radicals 
directly, so the effects of the hydroxypyridine iron chelators CP85 and CP94, which 
do not directly scavenge free radicals, were also tested. The cell impermeant CP85 
(100μM) reduced the relaxation from 77.8% + 7.5 with carbachol alone to 44.0% + 
5.3 in the presence of CP85 (see Fig. 4.17), and inhibited the recorded rise in Ca
2+
 
significantly from 20.2% + 3.5 to 11.3% + 2.8 (see Fig. 4.18). The cell permeant 
CP94 (100μM) also significantly reduced the EDHF mediated relaxation to 38.7% + 
7.7 (see Fig. 4.19). The Ca
2+
 rise in the presence of CP94 was less than 30% of the 
rise in response to carbachol alone (see Fig. 4.20.). The ratio increase was reduced 




 free preparation the cell impermeant CP85  did not significantly reduce the 
Ca
2+
 increase (18.5% + 2.7) compared to carbachol alone (18.8% + 1.3) (see Fig. 
4.21). On the other hand, the cell permeant CP94 did cause significant reduction in 
the Ca
2+
 increase in comparison to carbachol alone with a fall from 18.0% + 3.7 to 
only 3.4% + 1.2 (see Fig. 4.22). These data indicate that, unlike CP85, CP94 inhibits 
Ca
2+
 release from stores. 
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Figure 4.15. Relaxation to carbachol in the presence of DFO.  
The iron chelator DFO (100μM) inhibited the relaxation to carbachol from 64.5 % + 
15.0 to 20.6 % + 3.5. Results show mean + SE, n= 5, * p < 0.05. 
 
 
Figure 4.16. The effect of DFO on the 360/380nm ratio increase in response to 
carbachol. 
 The 360/380nm ratio increase to carbachol (31.7% + 11.4) was inhibited by the iron 
chelator DFO (100μM) (9.4 % + 6.5). Results show mean + SE, n=5 , * p < 0.05. 







































Figure 4.17. The effect of the iron chelator CP85 on carbachol relaxation.  
The % relaxation to carbachol (77.8 % + 7.5) was inhibited by the cell impermeant 
iron chelator CP85 (100μM) (43.9 % + 5.3). Results show mean + SE, n=5 , * p < 
0.05. 
 
Figure 4.18. The effect of CP85 on the 360/380nm ratio increase to carbachol. 
The 360/380nm ratio increase to carbachol (20.2 % + 3.5) was inhibited by the cell 
impermeant iron chelator CP85 (100μM) (11.3 % + 2.8). Results show mean + SE, 
n=5 , ** p < 0.01. 



































Figure 4.19. Effect of iron chelation with CP94 on the relaxation to carbachol.  
The % relaxation to carbachol (77.7 % + 7.5) was attenuated by the cell permeant iron 
chelator CP94 (100μM) (38.7 % + 7.2). Results show mean + SE, n=5, ** p < 0.01. 
 
Figure 4.20. Effect of iron chelation with CP94 on the ratio increase to carbachol.  
The 360/380nm ratio increase to carbachol (20.2 % + 3.5) was inhibited by the cell 
permeant iron chelator CP94 (100μM) (5.5 % + 0.9). Results show mean + SE, n=5, 
** p < 0.01. 
 



































Figure 4.21. The effect of the cell impermeant iron chelator CP85 on the ratio 
increase to carbachol in a Ca
2+
 free preparation.  
The 360/380nm ratio increase to carbachol (18.8 % + 1.3) was not affected by CP85 
(100μM) (18.5 % + 2.7). Results show mean + SE, n=5 , (n.s). 
Figure 4.22. The effect of the cell permeant iron chelator CP94 on the ratio 
increase to carbachol in the Ca
2+
 free preparation.  
The 360/380nm ratio increase to carbachol (18.0 % + 3.7) was inhibited by the iron 
chelator CP94 (100μM) (3.4 % + 1.2). Results show mean + SE, n=5 , * p < 0.05. 








































4.3.3 ROS producing enzymes 
 
I used a range of inhibitors to investigate the role of the various pathways that can 
lead to cellular ROS production in the response to carbachol.  
 
Lipoxgenase (LOX) is a potential source of ROS, and can be blocked with the drug 
NDGA. I found that NDGA had no effect on the EDHF response to carbachol with no 
reduction in relaxation or endothelial cell Ca
2+ 
(see Fig. 4.23 & 4.24), indicating that 
in rat cremaster arterioles that LOX is not a major source of ROS.  
 
Mitochondria are known to be a major source of ROS, through their production in the 
electron transport chain. Rotenone is a poison that inhibits the transfer of electrons to 
complex I, thus blocking ROS production at both complexes 1 and 3. In these 
experiments rotenone had no effect on the response to carbachol (see Fig. 4.25 & 
4.26). This suggests that mitochondrial production of ROS is not an important part of 
the EDHF mechanism in this tissue. 
 
The enzyme xanthine oxidase can produce ROS, in particular superoxide. Allopurinol 
is a xanthine oxidase inhibitor. Pre-treatment with allopurinol was found to have no 
effect on the EDHF response to carbachol (see Fig. 4.27 & 4.28). This pathway 
therefore does not appear to be involved in the EDHF mechanism in these arterioles.  
 
The NADPH oxidase enzymes have been shown to be an important source of ROS in 
different tissues and have been implicated in the EDHF response. Apocynin is an 
inhibitor of NADPH oxidase so was used to study their role in this tissue bed. Pre-
 141 
treatment with apocynin had no effect on the EDHF response to carbachol (see Fig. 
4.29 & 4.30). Protein kinase C (PKC) is an enzyme which is important in signal 
transduction and is involved in increasing NADPH oxidase activation. The PKC 
inhibitor Ro 31-8220 had no effect on the EDHF response (see Fig. 4.31 & 4.32). This 
suggests that although NADPH oxidase is an important source of ROS, in rat 
cremaster arterioles this pathway is not important for the EDHF response, at least 
under basal conditions (see below).  
 
The cytochrome P450 enzymes are a large family of enzymes that are present in many 
tissues and involved in the metabolism of many endogenous and exogenous 
compounds. They have also been shown to be a source of ROS in some tissues. To 
investigate this, different CYP450 inhibitors were used. PPOH and 17-ODYA are 
both non-specific CYP450 blockers that work through different mechanisms. Both 
blockers were found to significantly inhibit the EDHF response to carbachol with a 
reduction in both the relaxation and the endothelial cell [Ca
2+
] rise (see Fig. 4.33, 
4.34. 4.35 & 4.36). To investigate this further, the experiments were carried out in the 
Ca
2+
 free preparation. The non-specific CYP450 blockers were also found here to 
inhibit the transient rise in Ca
2+
 in response to carbachol (see Fig. 4.40 & 4.41). To 
narrow down the member of the CYP450 family which is involved, a more specific 
inhibitor was used. Previous work has implicated CYP2C9 as the isoform involved in 
ROS production, and it has been shown in endothelial cells. Sulfaphenazole is a 
specific CYP2C9 inhibitor and it was found to inhibit the EDHF response to 
carbachol (see 4.37 & 4.38). A typical trace shows this inhibition (see Fig. 4.39). In 
the Ca
2+
 free preparation sulfaphenazole also inhibited the transient increase in Ca
2+
 
in response to carbachol (see Fig. 4.42). A typical trace showing the inhibition by 
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sulfaphenazole of the transient rise in Ca
2+
 from store release is shown in Fig. 4.43. 
These results suggest that CYP2C9 is important in the EDHF pathway, possibly as a 
source of ROS.  
 
To further investigate the role of CYP2C9 in producing ROS, upstream mechanisms 
were studied. Arachidonic acid is a fatty acid that is released from the phospholipid 
membrane by phospholipase A2 (PLA2). It is metabolised by CYP2C9 and ROS are 
produced during this process. To study the involvement of this pathway the PLA2 
inhibitor AACOCF3 was used. AACOCF3 was found to significantly inhibit the 
EDHF response to carbachol (see Fig. 4.44 & 4.45). This suggests PLA2 is an 
important part of the EDHF pathway, possibly as a source of arachidonic acid which 




Figure 4.23. The effect of LOX inhibition on the relaxation to carbachol.  
The relaxation to carbachol control (70.1 % + 5.0) was not affected by the 
lipoxgenase inhibitor NDGA (50µM) (66.6 % + 5.6). Results show mean + SE, n=5, 
(n.s) 
 
Figure 4.24. The effect of LOX inhibition on the 360/380nm ratio increase to 
carbachol.  
The 360/380nm ratio increase to carbachol (24.6 % + 4.1) was not significantly 
affected by the lipoxgenase blocker NDGA (50µM) (24.0 % + 4.6). Results show 
mean + SE, n=5, (n.s) 



































Figure 4.25. The role of mitochondrial ROS production in the relaxation to 
carbachol.  
The relaxation to carbachol (80.5 % + 2.4) was not affected by the complex I inhibitor 
rotenone (10µM) (76.0 % + 2.9). Results show mean + SE, n=5, (n.s) 
 
Figure 4.26. The role of mitochondrial ROS production in the 360/380nm ratio 
increase to carbachol.  
The 360/380nm ratio increase to carbachol (22.3 % + 3.7) was not significantly 
affected by the complex I blocker rotenone (10µM) (21.2 % + 3.9). Results show 
mean + SE, n=5, (n.s) 
 



































Figure 4.27. The effect of xanthine oxidase inhibition with allopurinol on 
relaxation to carbachol.  
The % relaxation to carbachol (79.2 % + 4.7) was not changed by the xanthine 
oxidase inhibitor allopurinol (100μM) (75.8 % + 3.6). Results show mean + SE, n=5, 
(n.s) 
 
Figure 4.28. The effect of xanthine oxidase inhibition with allopurinol on the 
360/380nm ratio increase to carbachol.  
The 360/380nm ratio increase to carbachol (27.3 % + 3.1) was unaffected by the 
xanthine oxidase inhibitor allopurinol (100μM) (26.5 % + 2.5). Results show mean + 
SE, n=5, (n.s) 




































Figure 4.29. The role of NADPH oxidase in the relaxation to carbachol.  
The relaxation to carbachol (70.7 % + 5.3) was not significantly changed by the 
presence of the NADPH oxidase blocker apocynin (1µM) (66.8 % + 5.6). Results 
show mean + SE, n=5, (n.s) 
 
Figure 4.30. The role of NADPH oxidase in the 360/380nm ratio increase to 
carbachol.  
The 360/380nm ratio increase to carbachol (26.2 % + 5.0) was not affected by 
NADPH oxidase inhibition by apocynin (1µM) (25.4 % + 3.9). Results show mean + 
SE, n=5, (n.s) 






































Figure 4.31. The role of PKC in the relaxation to carbachol.  
The relaxation to carbachol (64.1 % + 5.8) was not significantly affected by the PKC 
blocker Ro31-8220 (3µM) (63.0 % + 4.9). Results show mean + SE, n=5, (n.s). 
 
Figure 4.32. The role of PKC in the 360/380nm ratio increase to carbachol.  
The 360/380nm ratio increase to carbachol (23.6 % + 6.7) was not changed by the 
PKC inhibitor Ro31-8220 (3µM) (22.6 % + 6.0). Results show mean + SE, n=5, (n.s). 




































Figure 4.33. The effect of CYP450 inhibition on carbachol relaxation.  
The % relaxation to carbachol (65.3 % + 7.9) was inhibited by the CYP450 blocker 
PPOH  (10μM) (18.8 % + 5.5). Results show mean + SE, n=5, ** p < 0.01. 
 
Figure 4.34. The effect of CYP450 inhibition on the 360/380 nm ratio increase to 
carbachol.  
The CYP450 blocker PPOH (10μM) attenuated the 360/380nm ratio increase to 
carbachol from 22.2 % + 2.2 to 9.1 % + 1.0). Results show mean + SE, n=5, ** p < 
0.01. 
 



































Figure 4.35. The effect of CYP450 inhibition on the relaxation to carbachol.  
The % relaxation to carbachol (62.9 % + 8.8 ) was inhibited by the CYP450 blocker 
17-ODYA (50μM) (21.9 % + 3.2). Results show mean + SE, n=4 , ** p < 0.01. 
 
Figure 4.36. The effect of CYP450 inhibition on the 360/380nm ratio increase to 
carbachol.  
The 360/380nm ratio increase to carbachol (21.5 % + 2.7) was inhibited by the 
CYP450 blocker 17-ODYA (50μM) (6.3 % + 1.5). Results show mean + SE, n=4 , ** 
p < 0.01. 
 



































Figure 4.37. The role of CYP2C9 in the relaxation to carbachol.  
The relaxation to carbachol (80.2 % + 3.6) was inhibited by the CYP2C9 blocker 
sulfaphenazole (10μM) (23.7 % + 2.6). Results show mean + SE, n=5, *** p < 0.001. 
 
 
Figure 4.38. The role of CYP2C9 in the 360/380nm ratio increase to carbachol.  
The 360/380nm ratio increase to carbachol (23.1 % + 2.3) was inhibited by the 
CYP2C9 blocker sulfaphenazole (10μM) (8.6 % + 1.2). Results show mean + SE, 
n=5, ** p < 0.01. 



































Figure 4.39. A typical trace of the 360/380nm ratio increase following carbachol 
application.  
The CYP2C9 blocker sulfaphenazole inhibited the increase in Ca
2+
.  



















Figure 4.40. The effect of CYP450 inhibition on the 360/380nm ratio increase to 
carbachol in the Ca
2+
 free preparation.  
The 360/380nm ratio increase to carbachol (19.8 % + 3.2) was inhibited by the 
CYP450 blocker PPOH (10μM) (6.1 % + 1.0). Results show mean + SE, n=5, ** p < 
0.01. 
 
Figure 4.41. The effect of CYP450 inhibition on the 360/380nm ratio increase to 
carbachol in the Ca
2+
 free preparation.  
The 360/380nm ratio increase to carbachol (18.3 % + 3.2) was inhibited by the 
CYP450 blocker 17-ODYA (50μM) (7.2 % + 1.4). Results show mean + SE, n=5, ** 
p < 0.01. 
















































The 360/380nm ratio increase to carbachol (17.0 % + 2.0) was inhibited by the 
CYP2C9 blocker sulfaphenazole (10μM) (7.7 % + 0.8). Results show mean + SE, 
n=5, ** p < 0.01. 
Figure 4.43. A typical trace of the increase in 360/380nm ration in response to 
carbachol in a Ca
2+
 free preparation.  
The co-application of the CYP2C9 blocker sulfaphenazole inhibited the 360/380nm 
rise.  











































Figure 4.44. The effect of PLA2 inhibition on relaxation to carbachol.  
The % relaxation to carbachol (68.7 % + 3.7) was inhibited by the PLA2 blocker 
AACOCF3 (3μM) (17.1 % + 4.4). Results show mean + SE, n=5, ** p < 0.01. 
 
 
Figure 4.45. The effect of PLA2 inhibition on the 360/380nm ratio increase to 
carbachol.  
The 360/380nm ratio increase to carbachol (27.6 % + 6.0) was inhibited by the PLA2 
blocker AACOCF3 (3μM) (5.9 % + 0.4). Results show mean + SE, n=5 , * p < 0.05. 






































4.3.4 EETs and EDHF 
 
EETs have been suggested to be a possible candidate for EDHF, and CYP450 
enzymes are an important source of EETs. Since the experiments described in the 
previous section showed that CYP450 is involved in the EDHF pathway, I 
investigated whether this could be due to EETs rather than ROS. EEZE is a selective 
EETs antagonist that blocks their action by being an inactive analogue. When the 
preparation was pre-treated with EEZE there was no change in the EDHF response to 
carbachol (see Fig. 4.46 & 4.47). Figure 4.48 shows a typical trace with EEZE not 
affecting the Ca
2+
 rise to carbachol. This was further investigated by enhancing EET 
levels by blocking the enzyme which breaks down EETs using the inhibitor AUDA. It 
was found that enhancing EET levels with AUDA had no effect on the relaxation or 
endothelial cell [Ca
2+
] rise to carbachol (see Fig. 4.49 & 4.50). Exogenous 11,12-
EETs were applied to the rat cremaster arterioles and they produced a significant 
relaxation of over 60% (relaxation 62.9 % + 2.3, n=5; see Fig. 4.51). However this 
reaction was almost completely abolished by the BKCa channel inhibitor iberiotoxin 
(see Fig. 4.52). As I had previously shown that iberiotoxin had no effect on the EDHF 
response to carbachol (Section 3.3.5), these results suggested that though exogenous 
11,12-EETs can lead to relaxation via activation of BKCa channels, in this tissue the 
channels are not involved in the EDHF response.  
 156 
Figure 4.46. The effect of blocking EETs on the relaxation to carbachol.  
The relaxation to carbachol (72.3 % + 5.5) was not affected by the EETs blocker 
EEZE (10µM) (73.4 % + 4.8). Results show mean + SE, n=5, (n.s) 
 
Figure 4.47. The effect of blocking EETs on the 360/380nm ratio increase to 
carbachol.  
The 360/380nm ratio increase to carbachol (24.7 % + 3.2) was not significantly 
affected by the EETs blocker EEZE (10µM) ( 22.7 % + 2.7). Results show mean + 
SE, n=5, (n.s) 




































Figure 4.48. A typical trace showing the lack of effect of EEZE on the increase in 
the 360/380 ratio in response to carbachol application.  
The EETs antagonist EEZE had no affect on the Ca
2+
 rise to carbachol.  






















Figure 4.49. The effect of sEH inhibition, which will block the breakdown of 
EETs, on the relaxation to carbachol.  
The relaxation to carbachol (72.7 % + 4.4) was not affected by the sEH blocker 
AUDA (1μM) (69.6 % + 4.9). Results show mean + SE, n=5, (n.s). 
 
 
Figure 4.50. The effect of sEH inhibition on the ratio increase to carbachol.  
The 360/380nm ratio increase to carbachol (35.9 % + 4.6) was not changed by the 
sEH blocker AUDA (1μM) (35.2 % + 4.0). Results show mean + SE, n=5, (n.s). 




































Figure 4.51. Typical trace of the relaxation to 11,12-EETs.  
Trace shows the change in diameter in arterioles pre-constricted with phenylephrine 
in the presence of L-NAME and indomethacin showing relaxation following the 
addition of 11,12-EETs (1µM). 
  
Figure 4.52. The role of BKCa channels in the relaxation to 11,12-EETs. 
 The relaxation to 11,12-EETs (1µM) (62.9 % + 2.3) was significantly inhibited by 
the BKCa channel blocker iberiotoxin (100nM) (10.1 % + 1.9). Results show mean + 
SE, n=5, *** p < 0.001. 








































4.4.1 The role of ROS in the EDHF response 
 
These results demonstrated the important role of ROS in the EDHF response, with the 
antioxidants SOD and catalase blocking the relaxation and endothelial cell [Ca
2+
] rise 
by >50%. This was confirmed by the electrophysiology study which showed the 
antioxidants strongly inhibited the smooth muscle hyperpolarisation to carbachol. The 
relaxation and [Ca
2+
] rise to carbachol were potentiated in the presence of the catalase 
inhibitor Atz, further supporting the role of ROS in the response. The experiments 
conducted in the absence of extracellular Ca
2+
 demonstrated that the release of Ca
2+
 
from intracellular stores is also partly ROS dependent, with the Ca
2+
 rise halved in the 
presence of SOD and catalase. That the action of the ROS was on Ca
2+
 release was 
supported by SOD and catalase having no effect on the relaxation to the SKCa and 
IKCa channel opener NS309, which suggests that the ROS are exerting their action on 
the endothelial cells at a step before these channels open.  
 
The ROS may be acting to potentiate Ca
2+
 release from endothelial stores. This could 
be through redox modification of the IP3 receptor which makes it more sensitive to 
activation by IP3, most likely via oxidation of thiol groups on the cysteine residues of 
the IP3 receptor. This means that in the presence of ROS, Ca
2+
 release from the stores 
would be enhanced. This increase in endothelial cell Ca
2+
 would lead to the activation 
of the IKCa and SKCa channels and the hyperpolarisation of the endothelial cell, and 
the subsequent hyperpolarisation and relaxation of the smooth muscle.  
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The role of ROS in potentiating rather than causing the EDHF response would explain 
why the antioxidants only partially block the response rather than abolishing it, but 
supports previous findings which have demonstrated the importance of ROS in the 
EDHF response. In mouse mesenteric arteries, antioxidants were shown to block the 
EDHF response to acetylcholine (Matoba et al., 2000). The potentiation by ROS of 
Ca
2+
 release from stores due to redox modification of the IP3 receptor was suggested 
by Edwards and colleagues, who showed that H2O2 enhanced the store release of 
Ca
2+
, and this was mimicked by a the use of a thiol oxidant (Edwards et al., 2008). 
The finding that ROS may be acting on the endothelium rather than the smooth 
muscle during the EDHF response has been shown in other tissues as well; for 
example H2O2 was required for the EDHF response in human gut mucosal arteries but 
did not itself cause smooth muscle relaxation (Hatoum et al., 2005). These results 
suggest that rather than being the EDHF itself, ROS potentiate the response by 
enhancing the release of Ca
2+
 from intracellular stores.  
 
4.4.2 ROS species 
 
I also attempted to determine which ROS species was involved in the EDHF response. 
In the Ca
2+
 free preparation, SOD alone had no effect on the response suggesting that 
superoxide is not the active species. On the other hand catalase alone did reduce the 
Ca
2+
 release from stores, suggesting that H2O2 is involved in the response. However, 
in this case it might have been predicted that SOD would have enhanced the response 
as this should have increased H2O2 production. One possible explanation for this lack 
of effect was that SOD levels in the tissue were already sufficiently high to ensure 
maximal conversion of superoxide to H2O2.  
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The use of DFO and the iron chelators CP85 and CP94 indicates that iron is important 
for the EDHF mediated relaxation and the rise in [Ca
2+
] during the EDHF response. 
The iron chelators significantly inhibited relaxation and reduced the [Ca
2+
] rise caused 
by carbachol. This suggests a role for the Fenton reaction (1) which coverts H2O2 to 
the more reactive hydroxyl radical (
.
OH) and requires iron: 
 
(1) Fe2+ + H2O2 → Fe3+ + .OH + OH− 
 
Although DFO chelates iron, it also scavenges ROS. However, the hydroxypyridine 
iron chelators are more specific and have a greater affinity for iron, providing clearer 
evidence for involvement of the Fenton reaction (Kayyali et al., 1998). Other research 
has found that following generation of the hydroxyl radical there is an increase in 
intracellular [Ca
2+
] (Az-ma et al., 1999). Taken together, these results imply that 
conversion of H2O2 to hydroxyl radical could be important for raising intracellular 
Ca
2+
 and thus causing EDHF-mediated relaxation, although work by others suggests 
that it is H2O2 rather than the hydroxyl radical that is important in raising intracellular 
Ca
2+
 (Volk et al., 1997). However the use of the iron chelator ophenanthroline in the 
Volk study may not have significantly inhibited the Fenton reaction within the cell, as 
it is not as cell permeant as CP94. CP94 strongly (80%) inhibits the transient rise in 
Ca
2+
 following carbachol application, while CP85 had no effect. CP94 is cell 
permeant so it can block intracellular hydroxyl radical generation by the Fenton 
reaction. This suggests that is the hydroxyl radical that is acting to potentiate release 
from the Ca
2+
 stores. This is consistent with findings by Doan who reported that H2O2 
increased intracellular [Ca
2+
], possibly through release from stores, although this and 
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other studies did not investigate whether it was H2O2 acting directly or through its 
conversion the hydroxyl radical.,  
 
On the other hand, H2O2 seems the more likely signalling species as it is more stable 
and can act specifically to target thiol groups (Janssen-Heininger et al., 2008) whereas 
the hydroxyl radical is unstable with a short half life so is considered not to be well 
suited for being a signalling molecule (Halliwell & Gutteridge, 2007). This may mean 
that the removal of iron by the chelators is having another effect on the pathway, 
separate to inhibiting the Fenton reaction, possibly by affecting the redox state of the 
endothelial cells.  
 
4.4.3 Source of ROS 
 
The results of my experiments with inhibitors of different pathways involved in ROS 
generation indicates that cytochrome P450 appears to be involved. Inhibition of 
enzymes such as NADPH oxidase and xanthine oxidase had no effect on the EDHF 
response, whereas using the non-specific CYP450 inhibitors PPOH and 17-ODYA 
significantly blocked the response to carbachol. Sulfaphenazole was used as a 
selective CYP2C9 inhibitor, as this isoform has been demonstrated to be a significant 
source of ROS in endothelial cells (Fleming et al., 2001). In the rat cremaster 
arterioles it almost abolished the relaxation and endothelial [Ca
2+
] rise to carbachol. 
Its role as the source of ROS was supported by the observation that sulfaphenazole 
mimicked the antioxidants by also blocking the release of Ca
2+
 from the intracellular 
stores as shown in the Ca
2+
 free preparation.  
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Blocking iPLA2 also inhibited the responses to carbachol, supporting the idea of 
CYP450 being the ROS generating pathway. iPLA2 releases arachidonic acid from the 
phospholipid membrane. Arachidonic acid can then be metabolised by CYP450, 
specifically CYP2C9, to produce ROS and other products including EETs. This is 
consistent with work in porcine coronary arteries where H2O2 was found to cause an 
EDHF response, and exogenous arachidonic acid mimicked the relaxation suggesting 
that it was a source of ROS (Barlow et al., 1998). Inhibition of PLA2 in rat coronary 
arteries almost abolished the EDHF response to bradykinin, suggesting that the 
mechanism involved the PLA2 pathway in this preparation was well (Fulton et al., 
1996). CYP2C9 has been shown to be a significant source of ROS and is expressed in 
endothelial cells with overexpression leading to an increase in ROS production (Bolz 
et al., 2000; Fleming et al., 2001). In human coronary arteries, a metabolite of 
CYP2C9 was shown to be important in the EDHF response suggesting that it is also 
important physiologically in humans (Larsen et al., 2008). The results together 
suggest that a metabolite of iPLA2 – CYP2C9 pathway is important in the EDHF 
response through the release of Ca
2+




As EETs are also produced following the metabolism of arachidonic acid by 
CYP2C9, they rather than H2O2 could be the active product. I therefore investigated 
their role in the response to carbachol using the EETs inhibitor EEZE. However, 
EEZE had no effect on the EDHF response to carbachol, and moreover blocking 
EETs breakdown with AUDA did not potentiate the response either.  
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On the other hand, the application of exogenous EETs did lead to a relaxation in the 
rat cremaster arterioles. This response was abolished by blocking the BKCa channels 
with iberiotoxin. However, since as I described in Chapter 3 the EDHF response in 
this tissue is working primarily through the IKCa and SKCa channels rather than the 
BKCa channel, my results suggest that while EETs can cause relaxation, they are not 
involved in the EDHF response in rat cremaster arterioles. There is evidence in rat 
mesenteric arteries of EETs being EDHF and that EEZE blocks the response (Fleming 
et al., 2007). However another study in mouse ductus arteries found that a CYP450 
metabolite was involved in the EDHF response, but using mass spectrometry did not 
find an increase in EETs so they suggest that it was another product of the CYP450 
pathway (Baragatti et al., 2009). These results suggest that there are tissues and 
species differences but that in the rat cremaster arterioles, EETs are not the active 




These results demonstrate an important role for ROS in the EDHF response, and this 
primarily seems to be through potentiating the release of Ca
2+
 from intracellular 
stores. I conclude that the ROS therefore are acting on the endothelial cells to enhance 
the EDHF response, rather than being the factor which is released by the endothelium 
and acts on the smooth muscle. The inhibition of the response with iron chelators 
suggests that the hydroxyl radical could be important in the pathway, however the 
weight of previous evidence is behind H2O2 being the signalling molecule due to is 
properties. The iPLA2 and CYP2C9 pathway appears to be the major source of the 
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5.1.1 Characterising the response to H2O2 
 
In this chapter, I describe experiments in which the effect of exogenous H2O2 on 
vascular diameter and endothelial [Ca
2+
] was measured in rat cremaster arterioles, and 
the mechanisms behind these responses were examined in a manner similar that used 
to characterise the carbachol response – in other words by employing various 
pharmacological blockers. H2O2 has been suggested to be an EDHF, and much of this 
work has been based on the addition of exogenous H2O2 (Matoba et al., 2000). In 
previous chapters it has been shown that ROS play an important role in the EDHF 
response, and they appear to be acting in part through the release of Ca
2+
 from 
intracellular stores. The use of exogenous H2O2 allows this response to be compared 
to that of carbachol, and the determination of whether these share the same properties 
and susceptibilities to different blockers. 
 
H2O2 has been shown to be able to directly cause relaxation in a number of different 
vascular beds. It has been shown to act directly on the BKCa channels on VSM to 
cause K
+
 efflux and hyperpolarisation which leads to relaxation (Sobey et al., 1998). 
It also may be able to directly open other channels, such as the IKCa and SKCa 
channels and the redox sensitive TRPM2 channel (Hequet et al., 2008; Winterbourn et 
al., 2008). PKG has been shown to be redox sensitive and exogenous H2O2 can 
directly activate the kinase leading to relaxation in the VSM cell using a similar 
mechanism to NO (Burgoyne et al., 2007). These pathways by which H2O2 could be 




5.1.2 H2O2 and the carbachol response 
 
In previous chapters I have shown that ROS are involved in the EDHF response to 
carbachol with antioxidants inhibiting the relaxation and rise in endothelial [Ca
2+
]. To 
investigate the role of H2O2 during the response to carbachol, exogenous H2O2 was 
added. The concentrations of H2O2 used in these experiments had no effect on 
relaxation or endothelial [Ca
2+
] levels when applied on its own (see Fig. 5.1). This 
ensured that only any effect on the carbachol response would be seen.  
 
Sulfaphenazole, the CYP2C9 blocker, was shown to inhibit the EDHF response to 
carbachol. This could be because CYP2C9 is the important source of ROS during the 
response. To investigate this H2O2 was added in the presence of sulfaphenazole to see 
if it could rescue the EDHF response to carbachol by providing an alternate source of  
ROS.  
 
5.2 Methods  
 
The effect of H2O2 on rat cremaster arterioles was characterised using intravital 
microscopy to measure changes in vessel diameter and endothelial cell Ca
2+
 levels. 




The arterioles were pre-constricted with 30µM phenylephrine with 300µM L-NAME 
and 3µM indomethacin present. This was to ensure that the only the effects of H2O2 
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which were independent of NO and PGI2 would be observed. H2O2 was applied for 2 
minutes to elicit a response and there was a 15 minute wash off period between 
experiments. Different inhibitors were then used to characterise the mechanism 
behind the H2O2 response in the arterioles. The preparation was pre-treated with the 
drugs for 2 minutes other than 5 minutes for apamin and TRAM-34, 10 minutes for 




The responses to H2O2 (% relaxation and % 360/380nm ratio increase) are paired with 
the response with the inhibitors present in the same arteriole to allow for direct 
comparison. These paired results are displayed in the graphs and were analysed with a  
two-tailed paired t-test. The difference between the compared results was considered 
significant if the p value was less than 0.05, represented by a * on the graph (** 





5.3.1 H2O2 mediated relaxation 
 
Concentration-response experiments with application of exogenous H2O2 
demonstrated that 100µM was required to give a consistent relaxation comparable to 
10µM carbachol (relaxation 73.7 % + 1.4, n=16; see Fig. 5.1 & 5.2). 100µM H2O2 
also caused a significant increase in endothelial cell Ca
2+
 (ratio increase 23.0 % + 1.2, 
n=16; see Fig. 5.3). This suggests that although quite high concentrations are 
required, H2O2 can directly cause relaxation in rat cremaster arterioles.  
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 Figure 5.1. Concentration-dependent relaxation of rat cremaster arterioles to 
exogenous H2O2.   
Graph showing the % relaxation to the addition of exogenous H2O2 (1-300µM). 





















Figure 5.2. Typical trace showing vasodilatation of PE-preconstricted rat 
cremaster arteriole to 100 M H2O2.  
 
Figure 5.3. Typical trace of the increase in 360/380nm ratio to H2O2  








         PE + L-NAME + Indomethacin




























5.3.2 H2O2 and EDHF response 
 
To investigate whether exogenous H2O2 is working through the same mechanisms as 
the EDHF response various inhibitors were co-applied. The SKCa and IKCa channel  
blockers apamin and TRAM-34 have previously been shown to almost abolish the 
EDHF response to carbachol. With H2O2 application, thse drugs caused a partial 
inhibition of the relaxation and rise in [Ca
2+
]i, suggesting in part that H2O2 is causing 
relaxation through the opening of IKCa and SKCa channels (see Fig. 5.4 & 5.5). 
Addition of the BKCa channel blocker iberiotoxin was found to strongly inhibit the 
relaxation to H2O2, whereas it has no effect on the carbachol induced relaxation (see 
Fig. 5.6 & 5.7). Similarly, the PKG inhibitor Rp-8-Bromo-cGMP which had no effect 
on the carbachol response, did greatly inhibit the relaxation in response to H2O2 (see 
Fig. 5.8 & 5.9). PLA2, was suggested to be part of the ROS producing pathway (see 
section 4.3.3). Its inhibition had no affect on the response to H202 (see Fig. 5.10 & 
5.11). The TRPM2 blocker ACA and the TRPM2 antibody which blocks the cation 
channel also significantly inhibited the relaxation and also the [Ca
2+
] rise in response 
to H2O2 (see Fig. 5.12, 5.13, 5.14 & 5.15). The iron chelator CP94 had no affect on 
the response to H2O2 suggesting that it H2O2 is the reactive species rather than 
hydroxyl radicals (see Fig. 5.16 & 5.17). These observations suggest that exogenous 
H2O2 causes relaxation by a number of mechanisms.  
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Figure 5.4. The role of the SKCa and IKCa channels in the relaxation to H2O2.  
The relaxation to H2O2 (74.8 % + 1.2) was inhibited by the SKCa and IKCa blockers 
apamin (500nM) and TRAM-34 (10μM) (47.3 % + 2.8). Results show mean + SE, 
n=5, *** p < 0.001. 
 
Figure 5.5. The role of SKCa and IKCa channels in the ratio increase to H2O2.  
The 360/380nm ratio increase to H2O2 (23.7 % + 3.4) was partially inhibited by the 
SKCa and IKCa blockers apamin (500nM) and TRAM-34 (10μM) (19.4 % + 3.4). 
Results show mean + SE, n=5, ** p < 0.01. 







































Figure 5.6. The role of BKCa channels in the relaxation to H2O2.  
The relaxation to H2O2 (72.3 % + 1.9) was attenuated by the BKCa channel blocker 
iberiotoxin (100nM) (29.1 % + 4.1). Results show mean + SE, n=5, *** p < 0.001. 
 
Figure 5.7. The role of BKCa channels in the ratio increase to H2O2.  
The 360/380nm ratio increase to H2O2 (25.1 % + 2.5) was not significantly affected 
by the BKCa channel blocker iberiotoxin (100nM) (24.3 % + 1.6). Results show mean 
+ SE, n=5, (n.s). 
 





































Figure 5.8. The role of PKG in the H2O2 mediated relaxation.  
The relaxation to H2O2 (69.8 % + 1.8) was significantly inhibited by the PKG 
inhibitor Rp-8-bromo-cGMP (100µM) (25.8 % + 3.3). Results show mean + SE, n=5, 
*** p < 0.001. 
 
 
Figure 5.9. The role of PKG in the ratio increase to H2O2. 
 The 360/380nm ratio increase to H2O2 (19.2 % + 1.8) was not affected by the PKG 
blocker Rp-8-bromo-cGMP (100µM) (19.0 % + 1.1). Results show mean + SE, n=5, 
(n.s).



































Figure 5.10. The role of PLA2 in the relaxation to H2O2.  
The relaxation to H2O2 (69.8 % + 1.8) was not affected by the PLA2 inhibitor 
AACOCF3 (3μM) (68.7 % + 2.9). Results show mean + SE, n=5, (n.s). 
 
Figure 5.11. The role of PLA2 in the ratio increase to H2O2. 
 The 360/380nm ratio increase to H2O2 (19.2 % + 1.8) was not changed by the PLA2 
blocker AACOCF3 (3μM) (18.3 % + 1.1). Results show mean + SE, n= 5, (n.s). 
 


































Figure 5.12. The role of TRPM2 channels in the relaxation to H2O2.  
The H2O2 relaxation (69.8 % + 1.8) was significantly inhibited by the TRPM2 blocker 
ACA (20µM) (28.3 % + 2.8). Results show mean + SE, n=5, *** p < 0.001. 
 
Figure 5.13. The role of TRPM2 channels in the ratio increase to H2O2.  
The 360/380nm ratio increase to H2O2 (19.2 % + 1.8) was attenuated by the TRPM2 
blocker ACA (20µM) (5.1 % + 1.2). Results show mean + SE, n=5, *** p < 0.001. 



































Figure 5.14. The role of the TRPM2 channel in the relaxation to H2O2.  
The relaxation to H2O2 (73.2 % + 2.4) was partially blocked by the TRPM2 antibody 
(5µg/ml) which blocks the TRPM2 channel (53.2 % + 2.8). Results show mean + SE, 
n=5, ** p < 0.01. 
 
Figure 5.15. The role of the TRPM2 channel in the ratio increase to H2O2. 
 The 360/380nm ratio increase to H2O2 (20.9 % + 1.4) was inhibited by the TRPM2 
antibody (5µg/ml) which blocks the TRPM2 channel (7.3 % + 0.8). Results show 
mean + SE, n=5, *** p < 0.001. 



































Figure 5.16. The effect of iron chelation on the relaxation to H2O2.  
The relaxation to H2O2 (78.1 % + 2.5) was not significantly affected by the iron 
chelator CP94 (100μM) (77.0 % + 2.1). Results show mean + SE, n=5, (n.s).  
 
Figure 5.17. The effect of iron chelation on the ratio increase to H2O2.  
The 360/380nm ratio increase to H2O2 (25.7 % + 4.1) was not significantly changed 
by the iron chelator CP94 (100μM) (25.2 % + 3.3). Results show mean + SE, n=5, 
(n.s). 



































5.3.3 H2O2 and carbachol response 
 
As shown in section 4.3.3, inhibition of CYP2C9 by sulfaphenazole almost abolished 
the EDHF response. I have also shown that ROS scavenging inhibited the response to 
carbachol, while increasing ROS levels by reducing the breakdown of H2O2 using a 
catalase inhibitor enhanced it. This suggests that a role for ROS in the EDHF response 
and that CYP2C9 inhibition blocks their production. To investigate whether the 
response could be recovered by the addition of ROS, a lower concentration of H2O2, 
which had little effect on its own, was applied with carbachol in the presence of 
sulfaphenazole. It was found that the co-application of 10µM H2O2 rescued the 
response to carbachol (see Fig. 5.18 & 5.19). 10µM H2O2 also rescued the carbachol 
response when PLA2 was inhibited (see Fig. 5.20 & 5.21). To support this finding, in 
a Ca
2+
 free preparation, 1µM H2O2, which has no effect on its own, when applied with 
carbachol, enhanced the Ca
2+




Figure 5.18. Exogenous H2O2 rescued the relaxation to carbachol following 
inhibition by sulfaphenazole.  
The relaxation to carbachol (77.7 % + 4.1) was inhibited by the CYP2C9 blocker 
sulfaphenazole (10μM) (26.2 % + 2.3). This relaxation recovered when pre-treated 
with 10µM H2O2 (72.6 % + 4.2). Results show mean + SE, n=5, p < 0.01, *** p < 
0.001. 
Figure 5.19. Exogenous H2O2 rescued the ratio increase to carbachol following 
inhibition by sulfaphenazole.  
The 360/380nm ratio increase to carbachol  (23.7 % + 1.9) was attenuated by the 
CYP2C9 blocker sulfaphenazole (10μM) (9.3% + 1.8). This inhibition by 
sulfaphenazole could be recovered by pre-treatment with 10µM H2O2 (21.5 % + 1.8). 
Results show mean + SE, n=5, ** p < 0.01. 





































Figure 5.20. The relaxation to carbachol when inhibited by AACOCF3, was 
rescued by H2O2. 
 The relaxation to carbachol (75.7 % + 4.5) was inhibited by the PLA2 blocker 
AACOCF3 (3μM) (24.4 % + 3.0). Pre-treatment with H2O2 (10µM) could recover this 
response (71.0 % + 6.8). Results show mean + SE, n=5, *** p < 0.001. 
Figure 5.21. Exogenous H2O2 rescued the response to carbachol following PLA2 
inhibition.  
The 360/380nm ratio increase to carbachol (22.8 % + 2.4) was blocked by the PLA2 
inhibitor AACOCF3 (3μM) (8.0 % + 1.0). 10µM H2O2 pre-treatment recovered the 
response (21.2 % + 3.1). Results show mean + SE, n=5, ** p < 0.01.









































Figure 5.22. The effect of exogenous H2O2 on the ratio increase to carbachol in 
the Ca
2+
 free preparation.  
The 360/380nm ratio increase to carbachol (18.8 % + 2.3) was enhanced by pre-
treatment with H2O2 (1µM) (28.7 % + 2.5). Results show mean + SE, n=5, ** p < 
0.01. 























5.4.1 H2O2 response in rat cremaster 
 
The dose response curve to H2O2 demonstrates that 100µM exogenous H2O2 was 
required to give a consistent good relaxation in rat cremaster arterioles. This is a high 
concentration of H2O2 to add, but is entirely in keeping with the concentrations used 
in other studies where 100-300µM H2O2 was needed to elicit substantial responses 
(Matoba et al., 2000; Hecquet et al 2008). This has consequences for the relevance of 
the conclusions that can be drawn from the results as these concentrations are 
probably much higher than physiological levels. However, microdomains may be able 
to exist where there are locally high concentrations of H2O2 and catalase action may 
mean that the H2O2 concentration when measured in the tissue as a whole is much 
lower than it is in certain compartments (Forman et al., 2004). The iron chelator CP94 
had no effect on the response to H2O2 suggesting that it is the H2O2 itself that is 
active, rather than its metabolite the hydroxyl radical.  
 
The relaxation to H2O2 was found to be partially blocked by TRAM-34 and apamin, 
suggesting that H2O2 is directly activating IKCa and SKCa channels, presumably 
leading to endothelial cell and VSM hyperpolarisation. Iberiotoxin inhibited the 
relaxation more strongly, implying that H2O2 is partly operating through direct 
opening of the BKCa channels on the smooth muscle leading to hyperpolarisation and 
relaxation. This is supported by others who have shown that H2O2 can directly open 
the BKCa channel through redox modification with the response blocked by catalase 
and iberiotoxin in rat cerebral arteries (Sobey et al., 1998). However other studies 
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have shown that H2O2 can actually reduce the open probability of the BKCa channels 
where a reducing agent instead enhanced opening (DiChiara et al., 1997). In human 
coronary arterioles, shear stress mediated relaxation was found to be caused by H2O2 
through BKCa channel activation (Liu et al., 2011). This suggests there could be some 
tissue differences, and possibly variation depending on the concentration of H2O2 
used.   
 
The activation of PKG by cGMP is involved in the NO and PGI2 mediated relaxation 
pathways. It has been shown previously that concentrations of 100µM H2O2 can 
directly activate PKG as it acts as a redox sensor. PKG is modified by H2O2 causing 
the formation of a disulfide bridge which directly activates the kinase allowing it to 
phosphorylate its downstream targets leading to relaxation (Burgoyne et al., 2007). In 
the rat cremaster arteriole, the PKG inhibitor Rp-8-bromo-cGMP strongly blocked the 
relaxation to H2O2 suggesting it is working through direct activation of PKG in the 
VSM by redox modification.  
 
TRPM2 is a redox sensitive member of the TRP family of cation channels and it has 
been shown to be expressed in endothelial cells (Kwan et al., 2007). ACA is a non-
specific TRPM2 channel inhibitor that was found to significantly block the relaxation 
and endothelial [Ca
2+
]i rise to H2O2. To further investigate this the more specific 
TRPM2 antibody was used to block the channel. This also blocked the response to 
H2O2, suggesting that it opens the channel directly to increase endothelial cell [Ca
2+
]. 
It cdo this via redox modification of TRPM2 or possibly by increasing ADP ribose 
formation which activates the channel. H2O2 has been shown in endothelial cells to 
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increase the open probability of the channel which was blocked by use of the antibody 
(Hecquet 2008). 
 
5.4.2 H2O2 and carbachol 
 
It has previously been shown that the EDHF response to carbachol is inhibited if ROS 
are blocked by antioxidants, or by blocking the pathways that generate them. 
Sulfaphenazole blocks CYP2C9 and AACOCF3 blocks2 iPLA2, both of which appear 
to be involved in ROS production in the rat cremaster arterioles. I found that 10µM 
H2O2 application had no effect on the diameter or endothelial [Ca
2+
]. However, when 
the arteries were pre-treated with 10µM H2O2, in the presence of sulfaphenazole or 
AACOCF3, the EDHF response to carbachol was restored. This supports the finding 
that CYP2C9 and iPLA2 are part of the ROS production pathway as H2O2 replaces the 
lost ROS and thereby rescues the response to carbachol. Further evidence of this was 
that 1µM H2O2 enhanced the store release of Ca
2+
 in response to carbachol, as shown 
by its effect in the Ca
2+
 free preparation. This is supported by the findings by Edwards 
which showed that H2O2 potentiated the release of Ca
2+





Exogenous H2O2 at high concentrations could directly cause relaxation and an 
increase in endothelial [Ca
2+
] in rat cremaster arterioles. The H2O2 worked by a 
number of different mechanisms including opening of KCa channels, TRPM2 and 
activation of PKG. The EDHF mediated relaxation to carbachol, when inhibited by 
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blockers of CYP2C9 or iPLA2, could be restored by low concentrations of H2O2 
which themselves had no effects, supporting the idea that low concentrations of ROS, 
which may be more physiologically relevant than the high concentrations which I and 
others have shown have direct effects on VSM, can potentiate the EDHF response by 












In previous chapters I have shown that the EDHF response to carbachol is ROS 
dependent. This response could be potentiated by the addition of exogenous H2O2, or 
by increasing [ROS] by blocking its breakdown by catalase. To investigate this 
further, the cytokine interleukin-1β (IL-1β) was used to increase ROS production. IL-
1β is a pro-inflammatory cytokine which is also involved in the immune response. It 
is produced by a number of cells including macrophages, fibroblasts and endothelial 
cells (Limatola et al., 1997). IL-1β can bind to the IL-1 cytokine receptor to activate a 
range of signalling pathways. It has been shown that IL-1β can increase ROS 
production (Woodfin et al., 2011). It does this by increasing the activation of NADPH 
oxidase, possibly by enhancing expression of the Nox-2 subunit (Bedard et al., 2005). 
This was demonstrated by NADPH oxidase inhibition blocking an increase in ROS 
levels in cells treated with IL-1β (Yasuhara et al., 2005). Part of the action of IL-1β 
may be through the stimulation of PKC, possibly through increasing PKC 
autophosphorylation which would lead to enhanced NADPH oxidase assembly 
(Limatola et al., 1997).  PKC is required for p47phox phosphorylation which is 
needed for the translocation of the regulatory subunits within a cell to cause NADPH 
oxidase activation. Previous studies have shown that pre-treatment of endothelial cells 
with IL-1β increases ROS production within 10 minutes and could potentiate ROS 
dependent responses such as increasing cell permeability following bradykinin 
stimulation (Woodfin et al., 2011). As the EDHF response to carbachol has been 
shown to be ROS dependent, the tissue was pre-treated with IL-1β to see if this could 
potentiate the relaxation and endothelial cell [Ca
2+
] increase. The mechanism behind 
IL-1β’s effects was also investigated using different blockers of NADPH oxidase and 
its activation.    
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6.2 Methods  
 
The role that IL-1β has on the EDHF response to carbachol was investigated using the 
intravital microscopy preparation as previously described in the general methods. This 
allowed the effect on relaxation and endothelial Ca
2+




The arterioles were pre-constricted with 30µM phenylephrine and the experiments 
were done in the presence of 300µM L-NAME and 3µM indomethacin. The effect of 
IL-1β (30pM) was measured by pre-treatment for 15 minutes with the cytokine before 
the addition of carbachol, this concentration was based on previous studies carried out 
in the Fraser Lab. The mechanism behind IL-1β was investigated by the addition of 
different inhibitors and their effects on the EDHF response were measured. SOD, 
catalase and apocynin were added 2 minutes before carbachol whereas Ro 31-8220 
was pre-treated for 10 minutes. The Ca
2+
 free preparation was carried out as 




The results of the EDHF response to carbachol with and without IL-1β were paired. 
The means + standard error were calculated and the paired data is displayed in graphs 
showing the effect of IL-1β on the response to carbachol and then the effect of the 
different inhibitors. A two-tailed paired t-test was performed to test the difference in 
 193 
the results. The difference between the compared results was considered significant if 






6.3.1 IL-1β and EDHF response 
 
IL-1β has been shown to increase NADPH activation which leads to an increase in the 
production of ROS levels. In this preparation, NADPH oxidase does not appear to be 
a major source of ROS during the response to carbachol under basal conditions. 
However, conditions designed to increase ROS levels have enhanced the response. 
The preparation was pre-treated with IL-1β for 15 minutes. The EDHF response to 
carbachol was found to be increased with a larger relaxation and increased endothelial 
cell Ca
2+
 rise (see Fig. 6.1 & 6.2). A typical trace shows this enhanced increase in 
Ca
2+
 in response to carbachol when pre-treated with IL-1β (see Fig. 6.3). This was 
supported by repeating the experiment in the Ca
2+
 free preparation which showed an 
increase in the release of Ca
2+





Figure 6.1. The effect of the IL-1β on relaxation to carbachol.  
The relaxation to carbachol (64.8 % + 3.8) was increased by the cytokine IL-1β 
(30pM) (82.5 % + 4.8). Results show mean + SE, n=7, *** p < 0.001 
 
 
Figure 6.2. The effect of the IL-1β on the ratio increase to carbachol.  
The 360/380nm ratio increase to carbachol (22.9 % + 4.7) was potentiated by the 
cytokine IL-1β (30pM) (30.3 % + 5.9). Results show mean + SE, n=7, ** p < 0.01. 













































Figure 6.3. A typical trace of the 360/380nm ratio increase following carbachol 
application. 





Figure 6.4. The effect of IL-1β on the ratio increase to carbachol in the Ca2+ free 
preparation.  
The 360/380nm ratio increase to carbachol (20.4 % + 1.7) was potentiated by the 
cytokine IL-1β  (30pM) (27.7 % + 2.1). Results show mean + SE, n= 5, ** p < 0.01. 











































6.3.2 IL-1β mechanism 
 
To investigate the mechanism behind the enhanced response when pre-treated with 
IL-1β, the ROS scavengers SOD and catalase were used. The antioxidants abolished 
the enhanced response and inhibited the EDHF response to carbachol suggesting that 
IL-1β was working via increased ROS (see Fig. 6.5 & 6.6).  
 
To study whether the increase in ROS is due to an increase in NADPH oxidase 
activation, the inhibitor apocynin was used. Apocynin abolished the IL-1β-mediated 
enhanced response to carbachol but did not inhibit the base response (see Fig. 6.7 & 
6.8). The PKC inhibitor Ro 31-8220 was also applied and this also inhibited the 
enhanced response (see Fig. 6.9 & 6.10). These results suggest that IL-1β was 
working via a mechanism that involved the NADPH oxidase pathway.    
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Figure 6.5. The effect of IL-1β when antioxidants are present on relaxation to 
carbachol.  
The relaxation to carbachol (65.9 % + 5.2) was inhibited when pre-treated with IL-1β 
(30pM) in the presence of the antioxidants SOD and catalase (100U/ml each) (20.6 % 
+ 2.7). Results show mean + SE, n=5, *** p < 0.001. 
 
 
Figure 6.6. The effect of IL-1β when antioxidants are present on the relaxation to 
carbachol.  
The 360/380nm ratio increase to carbachol (18.6 % + 3.5) was inhibited by IL-1β 
(30pM) when the antioxidants SOD and catalase (100U/ml each) were present (5.5 % 
+ 0.9). Results show mean + SE, n=5 , * p < 0.05, ** p < 0.01, *** p < 0.001 



































Figure 6.7. The effect of IL-1β on relaxation to carbachol in the presence of 
apocynin.  
The relaxation to carbachol (59.2 % + 4.8) was not affected by IL-1β (30pM) when 
the NADPH oxidase inhibitor apocynin (1µM) was present (61.2 % + 5.6). Results 
show mean + SE, n=4, (n.s). 
 
 
Figure 6.8. The effect of IL-1β  on the ratio increase to carbachol in the presence 
of apocynin.  
The 360/380nm ratio increase to carbachol (22.0 % + 8.7) was not affected by the 
cytokine IL-1β  (30pM) when the NADPH oxidase blocker apocynin (1µM) was 
present (20.7 % + 7.6). Results show mean + SE, n=4, (n.s). 




































Figure 6.9. The effect of IL-1β on the relaxation to carbachol when PKC is 
inhibited. 
 The relaxation to carbachol (66.2 % + 4.3) was not affected by IL-1β (30pM) pre-
treatment when the PKC inhibitor Ro31-8220 (3µM) was present (62.4 % + 3.7). 
Results show mean + SE, n=4, (n.s). 
 
 
Figure 6.10. The effect of IL-1β  on the ratio increase to carbachol when PKC is 
inhibited.  
The 360/380nm ratio increase to carbachol (27.5 % + 7.0) was not significantly 
affected by IL-1β (30pM) when the PKC inhibitor Ro31-8220 (3µM) was present 
(27.7 % + 8.4). Results show mean + SE, n=4, (n.s). 












































6.4.1 IL-1β and the carbachol response 
 
In previous chapters it has been shown that enhancing ROS levels, through exogenous 
H2O2, or blocking the breakdown of ROS, potentiates the EDHF response. IL-1β is a 
cytokine that can increase ROS production. When pre-treated with IL-1β, the EDHF 
response to carbachol was enhanced with an increase in relaxation and endothelial 
[Ca
2+
]. In the Ca
2+
 free preparation, IL-1β also increased the response to carbachol, 
indicating that it was increasing the Ca
2+
 release from intracellular stores. When the 
antioxidants SOD and catalase were present, the EDHF response to carbachol was 
inhibited and IL-1β did not have any effect. This suggests that the response is through 
ROS production rather than a different mechanism. 
 
6.4.2 IL-1β mechanism  
 
The NADPH oxidase inhibitor apocynin and the PKC inhibitor Ro-31 8220 both 
blocked the enhanced IL-1β response to carbachol, but not the baseline response to 
carbachol. This supports the previous work that has shown that IL-1β works by 
increasing NADPH oxidase assembly and activation which then causes an increase in 
ROS production. It was shown in endothelial cells that IL-1β increased ROS 
production, and enhanced a ROS dependent mechanism, in that case increased 





This is the first time IL-1β has been used to investigate the IL-1β response. IL-1β 
increased NADPH oxidase activation and ROS production. This enhanced the EDHF 
response to carbachol, partly by potentiating the Ca
2+
 release from intracellular stores 
















The results in this thesis have demonstrated an important role for ROS in the EDHF 
response in rat cremaster arterioles. The EDHF response to carbachol, measured by 
relaxation and the increase in endothelial [Ca
2+
], was inhibited by antioxidants. The 
ROS appeared to act by enhancing the release of [Ca
2+
] from intracellular stores. This 
increase in endothelial [Ca
2+
] would potentiate the EDHF response by activating the 
IKCa and SKCa channels, leading to K
+
 efflux and hyperpolarisation of the endothelial 
cell, this then leading to the hyperpolarisation and relaxation of the VSM. Since this 
relaxation was almost completely blocked by 18-GA, it is likely that the EDHF-
associated VSM relaxation under these conditions was primarily due to electrical 
coupling through the MEGJs in rat cremaster arterioles (see Fig. 7.1).  
 
I found that a product of the pathway involving arachidonic acid production and 
metabolism, via PLA2 and CYP2C9 respectively, was needed for the EDHF response 
Figure 7.1. Scheme showing the pathway that mediates the EDHF relaxation to 
carbachol.  















































to carbachol. With the evidence that 11,12-EETs were not involved in the relaxation, 
taken with the results from the antioxidant experiments it seems likely that ROS are 
the active product. Indeed, when the EDHF response was inhibited using PLA2 and 
CYP2C9 blockers, the response could be rescued with pre-treatment with H2O2 
suggesting that it was loss of ROS that attenuated the response. This was supported by 
the Ca
2+
 release from intracellular stores and the EDHF response being enhanced by 
increased ROS levels, either through the addition of exogenous H2O2, or through 
increasing ROS production via activation of NADPH oxidase with the cytokine IL-
1β.  
 
Taken together, these results suggest that in rat cremaster arterioles ROS, produced by 
CYP2C9, potentiate the EDHF response by enhancing Ca
2+
 release from intracellular 
stores. This leads to hyperpolarisation of the endothelial cell which can spread via 
electrical coupling through MEGJs to the smooth muscle leading to relaxation. 
 
7.1.1 Differences between H2O2 and carbachol responses. 
 
The role of ROS during the EDHF response to carbachol was investigated. H2O2 is 
suspected to be the most likely species of ROS involved in cell signalling, and others 
have previously proposed that H2O2 is EDHF (Matoba et al., 2000). To study this 
directly, the effect of exogenous H2O2 in rat cremaster arterioles was looked at. 
100µM H2O2 caused relaxation and a rise in endothelial [Ca
2+
]. H2O2 appeared to be 
working through a number of mechanisms to cause relaxation (see Fig. 7.2). 
Carbachol and H2O2 worked through opening of the IKCa and SKCa channels, but 
while their inhibition almost abolished relaxation to carbachol it was only partially 
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blocked in the H2O2 mediated relaxation. Inhibition of the BKCa channels had no 
effect on the response to carbachol whereas it reduced the relaxation to H2O2 
suggesting that H2O2 was acting directly on the BKCa channels. PKG inhibition also 
did not affect the EDHF response to carbachol while it did block the response to 
H2O2. This suggests that when a high concentration of exogenous H2O2 is added, it 
can cause relaxation by acting directly on mechanisms on VSM to cause 
hyperpolarisation and lower intracellular [Ca
2+
]. However in the carbachol response, 
though ROS are involved, they are not acting directly on the VSM but rather on the 
release of Ca
2+
 from the endothelial stores as previously described. In rat coronary 
arteries exogenous H2O2 has also been shown to act through direct activation of PKG 
leading to relaxation using 100µM H2O2 (Burgoyne et al., 2007). Exogenous H2O2 
has been demonstrated to increase the opening of the BKCa channel on smooth muscle 
as well in path clamp studies in rat mesenteric artery (Bryan et al., 2005). However, it 
has also been shown that BKCa channel activation occurs under normal conditions 
without the addition of exogenous H2O2. In human coronary arterioles, the EDHF 
response to shear stress was iberiotoxin and catalase sensitive suggesting that H2O2 
was opening BKCa channels (Liu et al., 2011). These differing results between tissues 
could be due to a concentration dependency of the effect of H2O2, or through different 
tissue distribution of channels as BKCa was not involved in the EDHF response to 
carbachol in the rat cremaster arterioles.  
 
Use of the TRPM2 antibody to block the redox sensitive TRPM2 channel reduced the 
rise in endothelial [Ca
2+
] following H2O2 application, but had no effect on the EDHF 
response to carbachol. This activation of the TRPM2 channel by H2O2 in endothelial 
cells has been shown by others with the H2O2 increasing the cation current following 
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application H2O2 (Hecquet et al 2008). This could be a concentration dependent effect 
as in this study and the study by Hecquet et al., 100µM was needed to open the 
TRPM2 channels so this may not be relevant under physiological conditions where 
[H2O2] is likely to be much lower. 
 
The differences between the response to carbachol and the response to H2O2 could 
explain some of the variation in results in previous studies. This study demonstrates a 
role for ROS in the EDHF response, and lower concentrations of H2O2 could 
potentiate the response to carbachol and rescue it when ROS production was blocked. 
However, unlike with exogenous H2O2, the ROS in the carbachol response appeared 
to be acting on the release of intracellular Ca
2+
 in the endothelial cells, rather than 
directly on the VSM. This may explain why in studies with exogenous H2O2, it has 
been suggested to be EDHF, produced by the endothelium and then activating BKCa 
Figure 7.2. Scheme showing the mechanisms that mediate the relaxation to H2O2. 
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channels and other mechanisms on the smooth muscle leading to relaxation (Barlow 
et al., 1998; Matoba et al., 2001). Others however have found that H2O2 was not 
acting on the VSM, as it had no effect in endothelium denuded arteries (Hatoum et al., 
2005). While this could be partly due to species and tissues differences, it could also 
be due to a concentration dependent effect with potentially erroneous conclusions 
being drawn from experiments using high exogenous levels of H2O2. The results of 
this study are therefore important as they demonstrate a difference between the 
mechanisms of exogenous H2O2, and the EDHF response to carbachol where ROS 
levels are likely to be lower and more regulated (compare Fig. 7.1 & 7.2).  
 
7.1.2 ROS signalling 
 
This study has demonstrated the important of ROS in the EDHF response. They 
appear to be acting through the release of Ca
2+
 from endothelial stores, possibly 
through the IP3R. While it was not investigated in this study, this could be through the 
redox medication of the IP3 receptor. This has been suggested previously the 
mechanism by which H2O2 can potentiate the EDHF response (Edwards et al., 2008). 
H2O2 can selectively target thiol groups on cysteine residues. The oxidation of the 
groups can lead to a conformational change in the structure of the protein which can 
affect its functioning (Janssen-Heininger et al., 2008). This could sensitise the IP3 
receptor to IP3 activation which would enhance the response (Hidalgo et al., 2008). 
This would mean following simulation by an agonist such as carbachol there would 
be an increase in Ca
2+
 release from the stores which would potentiate the EDHF 
response (Hu et al., 2002). This study is therefore important as it supports the growing 
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evidence for ROS having a vital role in physiological cell signalling as in rat 
cremaster arterioles it is part of the regulation of vascular tone. 
 
7.1.3 The EDH factor 
 
Since the discovery of a third endothelium dependent pathway, many studies have 
looked for a universal endothelium dependent hyperpolarising factor (EDHF). This 
study was looking at the role of ROS in the EDHF response to carbachol. It was found 
that CYP2C9 derived ROS, potentiated the EDHF response to carbachol. They did 
this by increasing the release of Ca
2+
 from endothelial stores. CYP2C9 has been 
shown to be a source of ROS in endothelial cells and metabolites of CYP450 pathway 
have been demonstrated to be involved in EDHF mediated relaxation (Bolz et al., 
2000; Fleming et al., 2001). However, this is the first time that CYP2C9 derived ROS 
have been shown to be involved in the EDHF response. This study supports the 
growing evidence that rather than there being a single universal EDH factor, that 
EDHF is a process that leads to hyperpolarisation of the smooth muscle cell (Griffith, 
2004). This involves an increase in endothelial cell [Ca
2+
] which opens the IKCa and 
SKCa channels leading to hyperpolarisation of the endothelial cell. This then cause the 
hyperpolarisation and relaxation of the smooth muscle cell. In this study, electrical 
coupling through MEGJs appeared to be involved, but at lowers levels of excitation it 
is possible that that K
+





leading to hyperpolarisation of the smooth muscle cell (Mather et al., 2005, Edwards 
et al., 2010). This, however, remains to be established.  
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In conclusion, CYP2C9 derived ROS act as cell signalling molecules in the EDHF 
response to carbachol in rat cremaster arterioles. Rather than being the EDH factor 
itself, the ROS potentiate the EDHF response by increasing endothelial cell Ca
2+
 
release from stores. This study provides further evidence of the important role of ROS 
in cell signalling through redox modification of proteins, and demonstrates how ROS 




This study primarily focused on the use of intravital microscopy to measure changes 
in vessel diameter and endothelial [Ca
2+
] during the EDHF response. This limited 
some of the experiments that could take place. Ideally ROS measurements would 
have been carried out to confirm the source of the ROS and show the increase during 
the EDHF response. However it was not possible to successfully load the cells with a 
ROS indicator despite attempts using several different protocols and indicators. This 
problem has been found by others where high levels of exogenous H2O2 (100µM) 
were needed to increase fluorescence so changes at physiological levels could not be 
measured (Edwards et al., 2008). This could be partly due to the tissue being studied 
in situ while most studies where ROS have been successfully measured were in 
cultured cells (Dickinson et al., 2010).  
 
Therefore, a primarily pharmacological approach was used to investigate the 
mechanisms involved in the EDHF response. While the use of inhibitors followed 
protocols used in previous studies, antagonists can often have varying selectivity. 
Where possible the inhibitor with the greatest selectivity for its target was chosen, and 
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I also used multiple inhibitors where these were available. However, there still could 
be interactions of these drugs with other receptors and channels which could influence 
the results.  
 
A strict experimental protocol was followed so that there were no confounding factors 
in the experiments. However, a limitation of using this model with rat tissue is that 
there will be individual variation between animals. This could be effected by sleep or 
stress levels prior to the study. Also while drugs were sourced from the same 
companies each time, there could be possible difference in activity between batches. 
The effects of these confounding factors were limited by the use of the same animals 
as they control, with all data paired. This should ensure that the comparison between 
results on the same vessel are reliable.  
 
A further limitation was that only arterioles in one tissue bed were investigated. This 
limits the conclusions that can be drawn as from other studies it appears that there are 
tissue and species differences, possibly because of variation in channel and receptor 
expression (Samora et al., 2008).  
 
7.1.5 Further work 
 
A number of further types of experiment could be carried out to support and extend 
the findings of this study.  
 
The importance of the described pathway could be investigated in other tissues and 
species, ideally in human arteries. This would show if the results are reproducible and 
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generalisable, and highlight the potential importance of the ROS signalling pathway 
in other tissues.  
 
KO mice could be used to provide greater selectivity than the pharmacological 
approach used. Firstly the importance of the pathway would have to be demonstrated 
in wild type mice. The effect on the EDHF response in a CYP2C9 KO mice would be 
able to support its role in ROS production. Also, further studies that could 
successfully use ROS indicators to demonstrate an increase in ROS levels in response 
to carbachol would support the finding that it is ROS that are the active metabolite.  
 
Further work could investigate the exact target of the ROS. This could show if redox 
modification of the thiol group on the IP3 receptor is the downstream target of the 
ROS. The use of a different agonist to pre-constrict the arterioles, or using a lower 
concentration could be carried out. This would investigate whether the contribution of 
MEGJs is reduced while K
+
 becomes the main signalling mechanism between the 
endothelium and smooth muscle. This has been shown when there are lower levels of 
excitation (Dora et al., 2008). The experiments could also be reproduced using 
different stimuli such as bradykinin, or the more physiologically relevant shear stress. 
Demonstrating that this pathway is involved in the EDHF response to flow would 
show that this mechanism is relevant in physiological conditions. This could also be 
investigated in disease models such as diabetes to see if there is variation in the 
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